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Associated molecule with SH3 domain of molecule (STAM), or AMSH, is a 
zinc metallo deubiquitinase (DUB) associated with endosomal-lysosomal receptor 
trafficking.  AMSH is responsible for downregulation and lysosomal degradation of 
cell-surface receptors (cargo) or autophagic cargo mediated by the endosomal sorting 
complexes required for transport (ESCRT) machinery. AMSH displays high 
specificity towards Lys63-linked ubiquitin chains, which acts as a signal for ESCRT 
machinery. This specificity is due to the simultaneous binding of AMSH to both the 
distal and proximal ubiquitin groups in a Lys63-linked diubiquitin substrate. The same 
specificity precludes it from accepting mono-ubiquitinated cargos as substrates; thus, 
it can disassemble a Lys63-linked polyubiquitin chain attached to a cargo but not 
completely deubiquitinate it.  Therefore, the recruitment of AMSH at ESCRT-0 has 
led to the speculation that it may modulate the ubiquitin chains of the targeted 
endosomal cargo and facilitate the transfer of cargo from ESCRT-0 to subsequent 
complexes and eventually to its degradation. In an attempt to crystallographically 
characterize activation of AMSH at ESCRT-0, the crystal structures of the catalytic 
domain of AMSH orthologue Sst2 from fission yeast, its ubiquitin (product)-bound 
form, and its Lys63-linked diubiquitin (substrate)-bound form at 1.45 Å, 1.7 Å, and 
2.3 Å, respectively were determined. The structural analysis provided insight into the 
mode of substrate recognition and revealed that the distal ubiquitin can remain bound 
to the enzyme after cleaving Lys63-linked diubiquitin substrate, resulting in the 
formation of product bound form. A comparable value of KD (∼10 μM) for ubiquitin 
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binding to the enzyme and KM of the enzyme catalyzing hydrolysis of Lys63-linked 
diubiquitin substrate (∼20 μM) and that the intracellular concentration of free 
ubiquitin (approximately 20 μM) exceeds that of Lys63-linked polyubiquitin chains, 
suggested that the free, cytosolic form of the enzyme remains inhibited by being 
tightly bound to free ubiquitin. Comparison of all the Sst2 structures with that of the 
substrate-bound form suggested the importance of dynamics of a flexible flap near the 
active site in catalysis, including product release. Structural analysis of AMSH and its 
homologs, AMSH-LP (AMSH-like protein) and Sst2, revealed a conserved Phe 
residue in the flap, which may be critical for substrate binding and/or catalysis. 
Mutation of this Phe residue to Ala and Trp in Sst2 (Phe403) revealed that the Phe 
residue in the flap contributes key interactions during the transition state but not to 
substrate binding Interestingly, molecular dynamics simulations indicated that the Trp 
mutant was quite flexible, allowing almost free rotation of the indole side-chain which 
may affect the transition-state stabilization of the enzyme. The ability of Trp mutant to 
cleave Lys48-linked and Lys11-linked diubiquitin better than the wild-type enzyme 
also indicated altered mobility and hence reduced selectivity. Since mutations in 
AMSH lead to Microcephaly-Capillary (MIC-CAP) syndrome, mutational studies in 
Sst2 or AMSH were performed using various biophysical tools, which revealed that 
most of the mutations lead to a local change around the site of mutation. As a result, 
either substrate binding or integrity and stability of the enzyme were affected, which 
may have profound functional effect leading to the disease. 
The project was then extended to include another disease associated DUB, 
Salmonella-secreted factor L, or Ssel which is a prokaryotic DUB secreted by 
Salmonella typhimurium. It is responsible for slowing down the lysosomal degradation 
of selective autophagy. Ssel acts as a virulence factor that completely removes 
ubiquitin from bacteria-containing vesicles and protein aggregates, and prevents them 
from autophagic clearance; thus, favoring the intracellular replication of Salmonella. 
In an effort to understand the mechanism of ubiquitin recognition by Ssel, different 
constructs of Ssel (Full-length Ssel, SselΔ121 and SselΔ157) were generated and the 
crystal structure of the shortest construct was determined. Surprisingly, both SselΔ121 
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and SselΔ157 constructs showed pronounced defect in the catalytic activity of the 
enzyme compared to full-length Ssel. The full-length Ssel showed strong preference 
for Lys63-linked diubiquitin over Lys48- and Lys11-linked diubiquitin substrate. 
Moreover, this prokaryotic DUB also also uses Glu40 patch in binding to its substrate 
as seen in SdeA from Legionella Pneumophila. To further understand the catalytic 
inefficiency of the shorter constructs, ITC experiments were performed, which 
confirmed that the N-terminal residues of Ssel may be required to bind ubiquitin. 
According to Pruneda et al., three variable regions and one constant region are 
responsible for ubiquitin binding. Although, SselΔ121 construct consisted of all the 
regions for ubiquitin binding, it still showed impaired activity. Taken together, these 
data suggests that Ssel may bind its substrate in at least two steps: First, the VHS 
domain which has higher affinity for ubiquitin (KD: 5.26 µM) may be used to capture 
the substrate. Then, through protein dynamics (for example, the flexible loop that links 
VHS domain to the catalytic domain), VHS domain would present ubiquitin to the 












CHAPTER ONE: INTRODUCTION 
1.1 Ubiquitin and Ubiquitination 
 Ubiquitin is a small regulatory protein that is covalently attached to the target 
protein via an isopeptide bond between the carboxyl group of the ubiquitin C–terminus 
and the epsilon-amino group of lysine of the target protein.1,2 Ubiquitination is a 
reversible post-translation modification. It is involved in various cellular processes such 
as DNA repair, kinase activation, cell cycle progression, protein quality control, gene 
transcription and endosomal sorting.1,3-5 
Ubiquitination requires the sequential action of E1 (ubiquitin-activating enzyme), 
E2 (ubiquitin-conjugating enzyme) and E3 (ubiquitin ligase).6 Initially, the E1 enzyme 
coupled to ATP hydrolysis activates the C-terminal glycine residue of ubiquitin and 
generates ubiquitin adenylate.6,7 This is the only energy dependent process, followed by a 
cysteine residue of E1 enzyme attacking ubiquitin adenylate complex to form a high 
energy thiol ester intermediate, with the release of pyrophosphate.8  The conformational 
change in E1 results in the transfer of activated ubiquitin moiety from E1 to E2 catalytic 
cysteine, a second high thiol ester intermediate.9 Finally, the C-terminus of the ubiquitin 
is ligated to the lysine residue of the substrate by E3 ligases.10  
There are 2 E1s, 38 E2s and hundreds (600-1000) of E3s known in humans.8,10,11 
E1 can functions with multiple cognate E2s, and initiates the ubiquitination process.8 
There are two classes of E2: one involved in ubiquitin chain initiation and recognition of 
substrate while other E2s are involved in ubiquitin chain elongation.9 Likewise, there are 
three families of E3 ubiquitin ligases: homologous to the E6-AP C-terminus (HECTs), 
really interesting new genes (RINGs) and ring-between-ring (RBR).12-15 RING domain 
ligases facilitate direct transfer of ubiquitin from E2 to target proteins, whereas HECT 
domain ligases bear a catalytic cysteine that forms an E3-Ub intermediate prior to the 
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transfer of ubiquitin to the substrate. The RBR family possesses both RING domain and a 
catalytic cysteine like HECT domain ligases; therefore, this family functions through 
RING-HECT hybrid mechanism. The interaction of RING domain and E2-Ub facilitates 
the formation of ubiquitin-thioester intermediate prior to the transfer of ubiquitin to the 
substrate. These three enzymes work in tandem to transfer a single ubiquitin moiety or 
polyubiquitin chains directly to protein substrates. 
Ubiquitin contains seven lysine residues and the N-terminal methionine residue 
which can function as an acceptor for another ubiquitin moiety and results in the 
formation of polyubiquitin chains of different linkages (Lys6, Lys11, Lys27, Lys29, 
Lys33, Lys48, Lys63 and Met1).4,5,16 In polymeric chains of ubiquitin, a lysine residue of 
one ubiquitin, called the proximal ubiquitin, is covalently attached to the last carboxylate 
group, Gly 76, of the other ubiquitin, called the distal ubiquitin. Such chains can be in the 
form of homogeneous ubiquitin chain, branched and unanchored ubiquitin chain.5 
Additionally, different ubiquitin linkages can have distinct architecture and biological 
outcomes. For example, monoubiquitination is involved in DNA repair, regulation of 
histone function, and gene expression.17-19 Both monoubiquitination and 
multimonoubiquitination can serve as a signal for receptor endocytosis.19 
Polyubiquitination through Lys48 is the most studied homogeneous chain which adopts 
compact conformations and targets protein for proteasomal degradation.19-22 Likewise, 
Lys63-linked polyubiquitination which displays the open conformation is involved in 
endosomal lysosomal sorting, DNA damage tolerance, kinase activation and signal 
transduction.19,23,24 Lys11 linkage is involved cell cycle progression and in proteasomal 
degradation like Lys48-linked polyubiquitin, but has less compact conformation.19,25,26 
Linear polyubiquitination through N-terminal methionine of ubiquitin has open 
conformation and is important for NF-KB activation and Wnt signaling.27,28 Currently, the 
roles of the homotypic ubiquitin chain linked through Lys6, Lys27, Lys29 and Lys33 are 
less known. On the other hand, heterotypic linkages such as branched ubiquitin chains are 




1.2 Deubiquitination and Deubiquitinases 
The conjugation of ubiquitin is a reversible process. The removal of ubiquitin 
from the target protein after the terminal carbonyl of Gly76 of ubiquitin is called 
deubiquitination which is carried out by deubiquitinases (DUBs).29 Deubiquitination is 
also involved in various cellular processes like ubiquitination such as cell cycle 
regulation, lysosomal and proteasomal degradation, kinase activation, DNA repair and 
gene expression.30,31 DUBs play several roles in the ubiquitin pathway. DUBs are 
involved in processing mature ubiquitin monomer from precursor protein fused with 
multiple copies of ubiquitin by cleaving at the C-terminal glycine. They also edit the 
ubiquitination process of the ‘wrong’ protein and rescue the protein from degradation. 
DUBs also prevent degradation of ubiquitin along with the target protein and maintain 
the overall free ubiquitin pool. Likewise, they also help in dissembling the polyubiquitin 
chains and recycle the ubiquitin. Therefore, ubiquitin is a long-lived protein due to its 
efficient removal by DUBs. 32 
 DUBs regulate various proteins and pathways in cellular physiology whose 
dysregulation is associated with various human diseases. Interestingly, a number of 
pathogenic bacteria and viruses acquire genes encoding DUBs that interfere with the host 
ubiquitin pathway for their selective advantage.33 Moreover, mutations in DUBs also link 
to various diseases ranging from cancer to neurodegenerative disorders.34,35 Therefore, 
DUBs have emerged as important targets for therapeutic drug development to treat 
various diseases.   
There are almost 100 putative DUBs in human which are divided into following 
sub-families: ubiquitin C-terminal hydrolases (UCH), ubiquitin specific protease 
(USP/UBP), ovarian tumor (OTU) related proteases, Machado-Joseph domain- 
containing (MJD) proteases and Jab1/MPN/Mov34 domain-containing (JAMM) 
proteases.30 Recently, a new family of DUB was identified as motif interacting with Ub-
containing novel DUB family (MINDY).36 The first four sub-families including MINDY 
are cysteine proteases that consist of catalytic triad/dyad comprising of Cys-His-Asp/Asn 
residues.37,38 These proteases cleave the isopeptide linkage by deprotonating the thiol 
group in the enzyme’s active site by a histidine residue, resulting in the nucleophilic 
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attack on the carbonyl residue of the conjugated ubiquitin. A tetrahedral intermediate is 
formed, which is stabilized by an oxyanion hole formed by a nearby hydrogen-donating 
residue, followed by releasing of the lysine side chain, and formation of a stable acyl 
intermediate. The reaction is completed by the nucleophilic attack of water molecule to 
acyl intermediate which then restores the enzyme to its apo form. There are 
approximately 56 USP, 16 OTU, 4 UCH and 4 MJD proteins respectively.32,39 
The sixth sub-family is a zinc dependent metalloprotease which consist of a 
putative zinc binding motif called a JAMM motif comprising two His residues and one 
Asp residue. These three residues along with a water molecule coordinate a zinc ion 
required for proteolytic activity.39,40 There is also a conserved glutamate residue that 
serves as a general acid-base catalyst. The catalytic activity requires an abstraction of 
proton from zinc bound water molecule by the glutamate residue; as a result, water acts 
as a nucleophile and attack the carbonyl carbon from the isopeptide bond. A transient 
tetrahedral intermediate is formed which is stabilized by an oxyanion hole residue, serine. 
The intermediate is collapsed after donating a proton from glutamate and eliminating the 
ε-amino group.41  There are 14 JAMM proteins among which seven contain a complete 
set of conserved residues needed for zinc ion coordination.42 
DUBs display specificity at a number of levels due to the complexity of the 
ubiquitin system.39 Like ubiquitin, SUMO, Nedd8, ISG15, FAT 10 and ATG12 are other 
ubiquitin-like molecules (UBLs) which share characteristics of the ubiquitin fold and 
modify proteins using a similar mechanism. However, DUBs are able to distinguish 
ubiquitin from UBLs due to the C-terminal amino acid stretch (LRLR) preceding the 
Gly-Gly motif.39 There are DUBs which are cross-reactive to different UBLs. 
Additionally, DUBs can cleave both isopeptide bond formed between ubiquitin and the ε-
amino group of lysine residue of the target protein or other ubiquitin and peptide bond 
between ubiquitin and α-amino group of the N-terminus.  
Due to different ubiquitin chain linkages, DUBs have specificity for towards 
particular chain types. For instance, USP and OTU family have specificity towards Lys48 
and Lys63-linked chains whereas, JAMM family has specificity for Lys63-linked 
ubiquitin chains.43 While cleaving these chains, some DUBs are exo-specific and bind to 
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single ubiquitin to cleave the chain from the end while the other are endo-specific and 
cleaves within the chain by accommodating ubiquitin on either side of the cleavage site.39  
Furthermore, some DUBs cannot completely remove ubiquitin and leave the substrate 
monoubiquitinated. However, there are DUBs which act on monoubiquitinated substrates 
and hydrolyze monoubiquitin or the entire ubiquitin chain en bloc.32  
DUBs contain numerous ubiquitin binding domains (UBD) or motifs along with 
catalytic domain. These domains regulate localization, protein-protein interactions, target 
recognition, activity and specificity.44,45 Ubiquitin interacting motif (UIM), zinc-finger 
ubiquitin binding domain (ZnF) and ubiquitin associated domain (UBA) are some UBDs. 
OUT DUB A20 contains ZNF which has ligase activity and a catalytic domain. 
Therefore, A20 can edit substrate ubiquitination by dissembling Lys63-linked chain and 
replace with Lys48-linked chains.46 UBD can bind to either monoubiquitin or multiple 
monoubiquitinated proteins. Most individual UBD bind to ubiquitin with low affinity.44 
However, multiple UBDs within a DUB or a protein complex can result in a cooperative 
binding enhancing the binding affinity due to avidity interactions.47 Many endocytic 
adaptors contain UIM to build up a large complex required for endocytosis. The 
endosomal DUBs, AMSH and USP8 are activated by association with UIM containing 
signal transducing adaptor molecule 2 (STAM2).48 
 
1.3 ESCRT Machinery 
 Ubiquitination acts as a signal for cellular trafficking mediated by the endosomal 
sorting complexes required for transport (ESCRT) machinery. ESCRT proteins are a 
group of Class E vps (vacuolar protein sorting) proteins that interact to generate a distinct 
molecular machine.49 The ESCRT machinery was initially identified in Saccharomyces 
cerevisiae as having a role in endosomal sorting and trafficking of ubiquitinated cell-
surface receptors to the lysosome for degradation, and is conserved from archaea to 
mammals.49,50 This machinery is implicated not only in biogenesis of multivesicular body 
(MVB), but also in cytokinesis, viral budding and spontaneous budding of the plasma 
membrane.50-53 The ESCRT machinery constitute of five distinct complexes: ESCRT-0, 
ESCRT-I, ESCRT-II, ESCRT-III and ESCRT disassembly subcomplex (Vps4-Vta1) that 
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have a division of labor and are recruited in a serial fashion during endosomal-lysosomal 
sorting of receptors.52 However, all these complexes are not required for other functions. 




 The ESCRT-0 complex is the first complex of ESCRT machinery which recruits 
the ubiquitinated receptors (cargo) and initiates protein sorting and trafficking via 
multivesicular bodies (MVB) pathway.23,54 This complex recruits the ubiquitinated cargo 
via phosphatidylinositol-3-phosphate (PtdIns3P) binding, which is highly abundant in 
endosomal membrane.51 ESCRT-0 complex consists of two components: HRS 
(Hepatocyte growth factor (HGF) - regulated Tyrosine kinase substrate) and STAM 
(signal transducing adaptor molecule), Vps27 and Hse1 in yeast respectively.52,55-57 HRS 
is further comprised of VHS (Vsp27, HRS, and STAM) domain, FYVE (Fab1p, YOTB, 
Vac1, and EEA1) domain, DUIM (double-sided ubiquitin interacting motif), PSAP (Pro-
(Ser/Thr)-X-Pro, X is any amino acid) motif, a coiled-coil domain and a clathrin box.57-60 
Likewise, STAM also has its own VHS domain, UIM and SH3 (Src- homology 3) motif 
and coiled-coil domain.57,61  
 Ubiquitination is used as a signal for ESCRT-mediated lysosomal degradation. 
Once the receptors are ubiquitinated, the N-terminus FYVE domain of HRS directs 
ESCRT-0 to the endosome by binding phosphatidylinositol-3-phosphate (PtdIns3P).23,62 
HRS interacts with STAM with the help of a coiled coil GAT (GGA and Tom1) domain; 
as a result STAM also gets recruited to endosome.63,64 HRS appears to have low affinity 
to monoubiquitin (KD= 300µM); therefore, VHS and UIM domain of both HRS and 
STAM bind to ubiquitin molecules by increasing the avidity.65 Thus, ESCRT-0 can bind 
to five different ubiquitinated receptors or multiple ubiquitin moieties from a 
polyubiquitinated receptor. Additionally, HRS and STAM complex oligomerizes and 
form a 2:2 heterotetramer which further increases the affinity for ubiquitin resulting in 
receptor sequestration and concentration.66 Recently, it has been shown that SH3 domain 
of STAM also contribute in ubiquitin binding which results in six ubiquitin binding 
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domains/motifs in a single ESCRT-0.67,68  HRS also recruits clathrin by its C-terminus 
clathrin box that helps in co-localizing both ubiquitinated receptor and HRS.23 After 
binding to the endosome and ubiquitinated receptors, HRS then recruits ESCRT-I 
complex via its C-terminus PSAP motif.51 
 
1.3.2 ESCRT-I 
ESCRT-I complex is comprised of four subunits forming a heterotetramer: 
TSG101 (tumor susceptibility gene 101, Vps23 in yeast), Vps28, four isotypes of Vps37 
(A-D) and two isotypes of Mvb12 ((A and B), multivesicular body 12) or UBAP1 
(ubiquitin associated protein 1) with a region resembling with Mvb12.69-71  The crystal 
structure of yeast ESCRT-I shows a rigid 25 nm long structure consisting of a stalk 
region and headpiece region.72 The stalk region is composed of anti-parallel coiled-coil 
from Vps23, Vps37 and Mvb12, whereas a headpiece region is composed of three pairs 
of antiparallel helices from Vps23, Vps28 and Vps37. TSG101/Vps23  subunit consists 
of N-terminus ubiquitin E2 variant (UEV) domain that interacts with PSAP motif of 
ESCRT-0, followed by proline rich region with GPPX3Y motif.73,74 This motif helps to 
recruit ESCRT-I during cytokinesis.75 This UEV domain also binds to ubiquitin moiety 
of the receptor. In yeast, Vps28 consists of short linker and a C-terminus four helix 
domain that interacts with ESCRT-II.76 Not much is known about the mammalian 
ESCRT-I and ESCRT-II interactions. VPS37 subunit helps ESCRT-I in membrane 
binding via its N-terminus basic helix.72 Additionally, Mvb12 or UBAP1 helps in binding 
ubiquitinated receptor.51 Thus, ESCRT-I can bind two ubiquitin moieties attached to 
receptor which is transferred from ESCRT-0 complex. The functional importance of 
different isotypes of Vps37 and Mvb 12 is not known. 
 
1.3.3 ESCRT-II 
 Like ESCRT-I, ESCRT-II also consist of multiple subunits which forms a Y-
shaped heterotetramer: EAP45 (ELL-associated protein of 45 kDa), EAP30 (ELL-
associated protein of 30kDa) and two copies of EAP20 (ELL-associated protein of 20 
kDa). In yeast, the corresponding subunits are Vps36, Vps22 and Vps25 respectively.77,78 
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The crystal structure of yeast ESCRT-II shows that Vps36 and Vps22 forms the base of 
the Y-shape, while two copies of Vps25 form the arms. All these subunits have two 
repeats of a WH (winged-helix) domain which help in interactions with each other.57 
Along with WH domain, Vps36 contain a GLUE (GRAM-like-ubiquitin-binding in 
EAP45) domain at the N-terminus which is responsible for binding to PtdIns3P, like 
ESCRT-0.79 In the yeast GLUE domain of Vps36, there are two insertions present called 
Npl4-type zinc-finger (NZF-1 and NZF-2, respectively). NZF-1 interacts with C-terminal 
four helix domain of VPS28 of ESCRT-I complex and NZF-2 binds to an ubiquitin 
moiety of the receptor.79 Mammalian EAP45 consists of GLUE domain, but lacks these 
NZF insertions; however, GLUE domain can bind to ubiquitin, but not much is known 
about the ESCRT-I interaction. Vps25, on the other hand, is the locus for binding to the 
ESCRT-III subunit. The second WH domains of both Vps25 are essential for ESCRT-III 
interaction.80 The recruitment of ESCRT-II is well characterized in yeast, however, 
poorly understood in mammals. 
 ESCRT I recruits ESCRT-II in 1:1 stoichiometry and work in tandem in MVB 
biogenesis by inducing a curvature at the membrane and stabilizing the membrane bud in 
which the ubiquitinated receptors/cargo are confined. The open and closed conformations 
of the ESCRT-I and II supercomplex helps in transfer of ubiquitinated cargo into the bud 
neck.81 ESCRT-II then recruits ESCRT-III for membrane scission.  
 
1.3.4 ESCRT-III 
 Unlike ESCRT-0, I and II which consist of multiple subunits that remains stable 
in the cytoplasm, ESCRT-III is comprised of subunits that are transiently held on 
endosomes. ESCRT-III complex consists of four core subunits: charged multivesicular 
body proteins (CHMPs) CHMP6, CHMP4, CHMP3, CHMP2 and their isoforms and 
three accessory components: CHMP1, CHMP5 including their isoforms, CHMP7 and 
increased sodium tolerance-1 (IST-1).82,83 In yeast, the corresponding core subunits are 
Vps20, Snf7, Vps24 and Vps2, respectively and accessory subunits are Doa4-
independent degradation-2 (Did2), Vps60 and Ist-1, respectively.51,84 There is no yeast 
homologue of CHMP7. The structure of subunits of ESCRT-III in yeast is not known; 
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however, the crystal structure of human CHMP3 reveals five helical fold that consists of 
7 nm hairpin structure formed by first two helices.85 The structure of the subunits of 
ESCRT-III is generally conserved. 
The different subunits of ESCRT-III exist in an autoinhibited monomer state in 
cytoplasm; however, the ordered assembly is initiated after Vps25 of ESCRT-II binds to 
Vps20.78,85 The activated Vps20 then recruits Snf7 which homo-oligomerizes around the 
neck of the membrane bud. The oligomerization of Snf6 is capped by the recruitment of 
Vps24 followed by Vps2; thus completing the assembly of ESCRT-III.86,87 Vps20, a 
major component Snf7, and Vps24 are sufficient for membrane scission and formation of 
intraluminal vesicles (ILV); but Vps2 is required to recruit Vps4 recycling machinery, 
which disassembles the ESCRT-III complex to replenish the cytosolic pool of ESCRT-III 
subunits for next cycle of membrane scission.88 CHMPs in mammals have the potential to 
form similar complexes as in yeast. The extreme C-terminus of different subunits of 
ESCRT-III contain microtubule interacting and transport (MIT) domain interacting motif 
(MIM).  
 
1.3.5 Vps4-Vta1 Complex 
Vps4-Vta1 complex consist of type I AAA-ATPase Vps4 and its co-factor Vta1 
which releases ESCRT-III subunits from endosomes into the cytoplasm via energy 
produced from ATP hydrolysis.89 The mechano-enzyme Vps4 consists of MIT domain 
and a single AAA domain separated by a flexible linker.90,91 The MIT domain of Vps4 
binds to the MIT interacting motif (MIM) of CHMP2/Vps2 along with accessory subunits 
(CHMP1/Did2 and Ist-1) of ESCRT-III members.84,87 Vta1 also consists of two MIT 
domains that bind to MIM of CHMP5/Vps60.92 In yeast, Vps4 assembles into a 
dodecamer with two hexameric rings stabilized by dimers of Vta1. The Vta1 binding 
forms an active Vps4-Vta1 complex that enhances ATPase activity.93 The exact 
mechanism of ESCRT disassembly by Vps4-Vta1 complex is not clear. However, the 
complex formation accelerates the ATPase activity that promotes ESCRT-III disassembly 
by translocating the ESCRT-III subunits through the central pore of the ATPase; as a 
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result, ESCRT-III conformation changes releasing from oligomers into its inactive 
state.92,94 This complex terminates each round of MVB formation.  
 
1.3.6 Deubiquitinases in the ESCRT Machinery 
Prior to packaging the ubiquitinated cargo into ILV, ESCRT-III recruits 
deubiquitinases (DUBs) to cleave the ubiquitin and maintain the free ubiquitin pool. In 
yeast, there is only one DUB, Degradation of alpha4 (Doa4) associated with MVB 
sorting machinery.95 Snf7 of ESCRT-III along with an interacting protein, Bro1, recruits 
Doa4 to endosomes to cleave ubiquitin from the cargo.96,97 Interestingly, the mammalian 
ESCRT machinery recruits two DUBs, associated molecule with the SH3 domain of 
STAM (AMSH), and ubiquitin specific protease Y (UBPY/USP8).95,98-100 Both DUBs 
interact with two of the ESCRT complexes: ESCRT-0 and ESCRT-III. DUBs bind to 
STAM component of ESCRT-0 by SH3-binding motif and ESCRT-III by MIT 
domain.101-104 AMSH only recognizes Lys63-linked polyubiquitin chains, whereas UBPY 
cleaves both Lys48 and Lys63-linked polyubiquitin chains.100 UBPY is the mammalian 
ortholog of yeast Doa4, whereas AMSH has no homology in S. cerevisiae. However, it 
has a clear homologue in Schizosazzharomyces pombe named Sst2.95 It is not understood 
why the mammalian ESCRT system requires the function of both AMSH and UBPY.  
 
1.4 Altering the Host Ubiquitin System 
 Among various post-translational modifications (PTMs) such as phosphorylation, 
methylation, glycosylation, etc, ubiquitination is the most common PTM that regulates 
virtually every cellular process in mammals including a cellular response to 
pathogens.105,106 When a pathogen is recognized by a host defense cell, it is phagocytosed 
and fuse with lysosome for degradation, and ubiquitination plays a major role in this 
process. As a result, pathogens have developed multiple ways to interfere with host 
ubiquitination machinery to impede the host defense systems for their survival.107,108 
Many pathogenic bacteria and viruses have evolved to produce a set of proteins called 
specific effectors that are delivered into host cells to infringe the cellular signaling 
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machinery.109 There are increasing numbers of pathogenic proteins that hijack the 
ubiquitin pathway by either mimicking host E3 ligases or DUBs.108 
 Viruses not only encode their own ubiquitin gene which is distantly related with 
ubiquitin identified, but also encode their own E3 ligases.110,111 Eukaryotes possess two 
functionally distinct classes of E3 ligases: RING-finger and HECT-type.15 However, in 
viruses, all the known viral E3 ligases belong to RING-finger class.110 Along with its own 
E3 ligases, viruses also have adaptor proteins that recruits host E3 ligases to ubiquitinate 
host protein, which often leads to degradation. Conversely, bacterial pathogens lack 
ubiquitin and its related machinery making this system an effective target. Bacterial 
effectors mimic both RING-finger and HECT-type ligases, and also include a newly 
discovered third class named novel E3 ligases (NEL).112 
 In order to escape clearance and favor proliferation in the host cell, pathogens 
have exploited different mechanism to regulate the functions of their effector proteins. 
Along with E3 ligases, viruses encode DUBs to influence ubiquitin-mediated host cell 
processes. These viral DUBs are modelled after eukaryotic cysteine protease OTU-
domain containing DUB, a papain-like protease or USP subfamily.113 The interesting 
characteristic of these viral DUBs is their lack of specificity.114 Some of the viral DUBs 
are only ubiquitin specific while others can cleave UBLs. For instance, UL36 cleaves 
Lys48-linked diubiquitin chains while AVP and CCHFV show activity against both 
ubiquitin and ISG15.115,116 Likewise, pathogenic bacterial DUBs also belong to cysteine 
protease (CE clan). These DUBs resemblance certain eukaryotic UBL proteases; however 
like viral DUBs, these DUBs show very different specificity than eukaryotic enzymes. 
For example, ElaD from E.coli cleaves ubiquitin and SdeA from L. pneumophila cleaves 
both ubiquitin and Nedd8.117,118  
Among various bacterial DUBs, Salmonella typhimurium DUB, Ssel is widely 
studied. Recently determined structures of different prokaryotic DUBs including Ssel 
highlighted the flexibility of CE protease fold that is responsible for its functional 
adaptation.119,120  Moreover, the structure of SdeA DUB bound to ubiquitin vinyl methyl 
ester (Ub-VME) revealed a unique molecular contact in ubiquitin recognition which is 
different from eukaryotic DUBs.118 Since both SdeA and Ssel have similar Ulp fold and 
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little sequence identity, understanding the mode of ubiquitin binding in Ssel might 
provide insight into its substrate and linkage specificity.   
  Within this work, the crystal structures of the catalytic domain of eukaryotic 
metallo-protease Sst2 and its mutants in their free form, as well as the ubiquitin and 
diubiquitin bound forms, are presented which provide insight into the mechanism of 
AMSH related family. Moreover, the structural analyses provide a better picture 
regarding the substrate specificity of the enzyme and its regulation within the cytosol. 
Since AMSH is related to the MIC-CAP syndrome, a detailed analysis of the MIC-CAP 
mutants is presented with the hope of understanding how the mutations can lead to a 
disease. Finally, a study of a prokaryotic DUB, Ssel is provided to advance the 
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Figure 1.2: Ubiquitinating and deubiquitinating cycle: Ubiquitination is a reversible post 
translational modification. Through E1, E2 and E3 enzymes, the C-terminus of ubiquitin 





Figure 1.3: Different forms of ubiquitination. A) Crystal structure of ubiquitin (PBD ID: 
1UBQ) showing seven different lysine residues that can be conjugated to another 
ubiquitin moiety. B) Ubiquitin chains with different topology. Ubiquitin can be attached 
to a single site or multisite resulting in mono- or multi-monoubiquitination. Multiple 
ubiquitin molecules can be added to one site (Lysine residue) resulting in different 




Figure 1.4: Schematic representation of different types of deubiquitinases. DUBs are 
classified under two different families: cysteine proteases and metalloprotease which are 
further divided into six different sub-families. UCHs, USps. MJDs, OTUs and novel sub-








Figure 1.5: Lysosomal degradation mediated by ESCRT pathway. When cell-surface 
receptors are endocytosed and tagged by Lys63-linked polyubiquitin chains, ESCRT 
machinery gets recruited due to the ubiquitination signal. Different complexes of 
machinery help in the multivesicular bodies (MVB) biogenesis. MVB pathway involves 
forming of membrane buds, sorting of ubiquitinated receptors into the buds and cleaving 
of the buds to form intraluminal vesicles (ILVs). Deubiquitinases are also recruited to 
cleave the ubiquitin tag from receptors prior to forming ILVs. Finally, the ILVs fuse with 


























































































































































































































































Figure 1.7: Domain diagram of Deubiquitinases (DUBs) involved in ESCRT pathway. 
AMSH and UBPY are two DUBs recruited by human ESCRT machinery at ESCRT-0 
and ESCRT-III complexes. Both of these DUBs consist of microtubule interaction and 
transport (MIT) domain at the N-terminus that can bind to CHMP3 component of 
ESCRT-III. Likewise, they both contain SH3-binding motif (SBM) that can bind to 
STAM component of ESCRT-0. The catalytic domain of AMSH can only cleave Lys63-
linked ubiquitin chains, whereas, UBPY can cleave both Lys63- and Lys48-linked 
ubiquitin chains. UBPY also consist of Rhodanese like domain (RHOD) which is known 
to bind E3 ligase, Nrdp1.  
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Figure 1.8: Different mechanisms used by pathogens to manipulate host ubiquitin system. 
After the pathogen is engulfed by the macrophages, pathogens use their secretory system 
to inject special proteins called effectors (shown in red) into the host cell. These effectors 
can either i) act as E3 ligases and ubiquitinate the substrate for degradation, ii) inhibit the 
essentials steps during ubiquitination or iii) act as a DUB and cleave ubiquitin to slow 




CHAPTER TWO: CHARACTERIZATION OF DUB DOMAIN OF AMSH 
ORTHOLOGUE, SST2 
2.1 Introduction 
 AMSH, associated molecule with the SH3 domain of signal transducing adaptor 
molecule (STAM), belongs to the JAMM (JAB1/ MPN/ MOV34) family of 
deubiquitinating enzymes (DUBs).1-3 It is an endosome-associated DUB with high 
specificity towards Lys63-linked diubiquitin and is involved in downregulation and 
lysosomal degradation of cell-surface receptors mediated by the endosomal sorting 
complexes required for transport (ESCRT) machinery.1,2,4 This machinery consists of 
four different macromolecular assemblies, ESCRT-0, -I, -II and –III, which captures 
polyubiquitinated cell-surface receptors and shuttle through the ESCRT complexes into 
multivesicular bodies (MVBs) which then eventually fuse with a lysosome leading to 
degradation.5-7 AMSH is one of the two DUBs recruited to ESCRT-0 and ESCRT-III 
complexes that remove ubiquitin tags from membrane proteins.2,8-10 It binds to the STAM 
component of ESCRT-0 through its SH3 binding motif (SBM) that enhances its catalytic 
activity, and the chromatin modifying proteins (CHMPs) of ESCRT-III complex via its 
microtubule interacting and transport (MIT) domain.10-13 The underlying mechanism of 
how AMSH controls receptor trafficking remains elusive; however, the recent discovery 
of a genetic defect known as Microcephaly capillary malformation (MIC-CAP) syndrome 
caused by recessive mutations in AMSH gene suggests that AMSH plays an important 
role  in the cell.14,15 
Sst2, known as suppressor of ste12 deletion protein 2, is a predicted orthologue of 
mammalian AMSH or its homologous AMSH-like protein (AMSH-LP), found in the 
fission yeast Schizosaccharomyces pombe.16,17 It shares 29% sequence identity with 
human AMSH and 31% identity with AMSH-LP.17 Phenotypically, Sst2 belongs to a 
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class of E vacuolar protein sorting (E-Vps) proteins involved in sorting the cargo into 
MVBs which later fuse with lysosome for degradation.16 Mutational studies of Sst2 have 
suggested its importance in the regulation of MVB and endosomal trafficking. The 
localization of Sst2 in cytoplasmic spots and septa, the active site of endocytosis, further 
indicates its involvement in endocytosis.18 Moreover, fission yeast is a genetically 
tractable model system, and the presence of ESCRT machinery and Sst2 may help in 
deciphering mechanistic details of AMSH’s function.19 However, before embarking on 
genetic studies of the organism, it is important to establish biochemical characteristics of 
Sst2.  
The catalytic domain of Sst2 (residues 245-435) shares 60% sequence similarity 
with that of AMSH (Figure 2.1). According to SWISS-MODEL homology server, the 
segment spanning the first 130 residues of Sst2 are homologous to the MIT domain of 
AMSH (Figure 2.2A).20 It is not known if the predicted MIT domain of Sst2 binds MIM 
(MIT interacting motif) of CHMPs. The sequence alignment of predicted MIT domain of 
Sst2 and AMSH reveals some conserved residues and some unique residues of Sst2 that 
might be involved in binding MIM of CHMP3 (Figure 2.2B). Sst2 seems to have a 
putative SH3 binding motif, required for the interaction with STAM. It contains a motif 
“PIYTRTSEP” which is similar to the SBM of AMSH except for valine (V), aspartic acid 
(D) and lysine (K) - the residues involved in binding STAM (Figure 2.2C). On the other 
hand, Sst4/Vps27p and Hse1, homologs of mammalian Hrs and STAM respectively, are 
believed to have similar functions as their mammalian counterparts, which may function 
as substrates for Sst2.16 The conserved sequence (catalytic JAMM domain) between 
AMSH and Sst2 as shown in Figure 2.2D implies a similar function within the ESCRT 
pathway; however it still remains to be proven. 
The purpose of the experiments in this chapter is to confirm that Sst2 is indeed an 
AMSH in fission yeast. To achieve this goal, the crystal structures of catalytic domain of 
Sst2 were determined and compared with its two closely related homologs, AMSH and 
AMSH-LP. Additionally, the kinetics and thermal stability of Sst2 were also analyzed. 
Models for catalytic domain of Sst2 bound to diubiquitin were generated to gain insight 
into how Sst2 would recognize Lys63-linked diubiquitin.   
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2.2 Materials and Methods 
 
 
2.2.1 Cloning, Expression and Purification 
Full length Sst2 was amplified by polymerase chain reaction using 
Schizosacchzromyces pombe cDNA library (a kind gift from Kathy Gould, Vanderbilt 
University, Nashville, TN). The catalytic domain of Sst2 (residues 245-435), here 
referred as Sst2cat, was sub-cloned into pGEX-6P1 vector using a standard cloning 
protocols. The resulting recombinant DNA construct was transformed into Escherichia 
coli Rosetta cells to be expressed as a recombinant protein fused with a glutathione-S-
transferase (GST) tag at its N-terminus. Six liters of Luria Bertani (LB) cultures were 
grown until the optical density reached 0.4-0.6 and then induced with 0.1-0.3 mM 
isopropyl-β-D- thiogalactoside (IPTG) to overexpress the protein at 18°C overnight. The 
cells were harvested, lysed by French press and centrifuged at 100,000 x g for an hour. 
The supernatant was applied to Glutathione-Sepharose column from GE Biosciences and 
the protein was purified according to the manufacturer’s protocol, followed by the 
removal of the tag by PreScission protease (GE Biosciences) via overnight dialysis. The 
protein was  further purified by  size-exclusion Superdex S75 column (GE Biosciences) 
using a buffer containing 50 mM Tris-HCl, pH 7.6,  50 mM NaCl and 1 mM DTT. 2 ml 
fractions of eluent were collected and each sample was analyzed on SDS-PAGE gel for 
purity (Figure 2.3). Pure fractions were concentrated down, flash frozen and stored at -
80°C. 
 
2.2.2 Crystallization and Structure Determination 
Crystallization was performed by sitting drop at room temperature using ~200 
different crystallographic screening conditions. A hit was identified in three days in two 
different conditions: 0.2 M Ammonium phosphate dibasic (pH 8.0), 20% (w/v) PEG 
3,350 and 0.03 M citric acid, 0.07 M BIS-TRIS propane (pH 7.6), 20% (w/v) PEG 3,350. 
Since the crystals obtained were multi-latticed, optimization was performed by additive 
screening (Figure 2.4A). Single long crystals (Figure 2.4B) were produced with the 
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condition 0.2 M Ammonium phosphate dibasic (pH 8.0), 20% (w/v) PEG 3,350 using 
different additives 30% w/v 1,6- hexanediol, 1.0 M glycine, 40% (v/v) 1, 3-propanediol, 
0.1 M Yttrium (III) chloride hexahydrate and 30% (v/v) 2-propanol separately. With the 
help of additives, the crystals attain their maximum size in 1- 5 days. 
 Crystals formed were briefly soaked in cryoprotectant solution (25% v/v ethylene 
glycol) and were flask frozen by plunging into liquid nitrogen. Crystals formed from 
additives 30% (w/v) 1, 6-hexanediol were soaked in 2.5 mM zinc for 45 mins and washed 
with 25% ethylene glycol. Finally, the crystals were flask frozen into liquid nitrogen. X-
ray diffraction data (Figure 2.4C) were collected at 100K using Mar300 CCD detector at 
beamline 23-ID-D at the Advanced Photon Source at Argonne National Laboratory. All 
data were processed with HKL2000 program.21 
Three crystal structures from different additives in the same mother liquor were 
obtained for Sst2cat in two different space groups. Crystals grown in glycine additive 
crystallized in P212121 space group and in 1, 6-hexanediol additive crystallized in P21 
space group; data for which were collected up to 1.8Å and 1.45Å respectively. The 
structure for P212121 space group was determined by molecular replacement using 
MolRep22 of ccp4 suite.23 The catalytic domain of AMSH-LP (PDB: 2ZNR)24 was used 
as a search model using SWISS-MODEL homology modeling server.20 Rounds of 
refinement and model building were carried out in PHENIX25,26 using TLS refinement27,28 
(with the entire asymmetric unit taken as one TLS group) and Coot29 respectively. The 
final model had an Rcrys of 20.2% and an Rfree of 23.8% (refer to Table 2.1 for 
crystallographic data and refinement statistics). Residues Thr320 of chain B and C were 
within disallowed regions of the Ramachandran plot. Residue Glu327 of chain A and C, 
Leu402, Lys426, Val434 of chain B and Ser314, Glu407, Lys409 of chain C had weak 
density or no density at 1σ. The structure for P21 space group was determined by 
MolRep22 using the Sst2cat as a search model. Rounds of refinement and model building 
in PHENIX25,26 using TLS refinement27,28 (with the entire asymmetric unit taken as one 
TLS group) and Coot29 respectively yielded Rcryst and Rfree values of 16.7% and 19.2% 




 Native Sst2 consists of two zinc metals, one in the active site and the other, which 
is away from the active site, has a structural role. However, the crystals of Sst2cat were 
soaked in 2.5 mM zinc. The data for this crystal was collected at the zinc peak, 1.283Å 
for single-wavelength anomalous dispersion (SAD) phasing by running a fluorescence 
edge scan (f’ and f” values of -8.03 and 5.71 respectively). The crystal diffracted to 
1.67Å in P21 space group, and the structure was determined using Zn-SAD for which the 
experimental phasing was performed using Autosol30 in the PHENIX25,26 suite. 
Refinement was carried out in the same method as described above, yielding an Rcrys and 
Rfree of 17.7% and 21.1% respectively. Residue Gln297 of chain A was within disallowed 
regions of the Ramachandran plot and Glu327, Glu407 of chain A and Glu407 of chain B 
had weak density or no density at 1σ. All figures for the structure were rendered with 
PYMOL (version 1.7.0.0).31 
 
2.2.3 Determination of Kinetic Parameters 
Kinetic parameters were determined by incubating the enzymes (25 nM Sst2cat) 
with four concentration of Lys63-linked diubiquitin, purified by Dr. Judith Ronau, 
ranging from 20-100 µM. Each reaction was carried out in a reaction buffer consisting of 
50 mM Tris-HCl (pH 7.0), 20 mM KCl, 5 mM MgCl2, and 1mM DTT for 15 mins on the 
basis of the activity for initial velocity measurements. Reactions were quenched by 
adding 5X SDS-PAGE sample buffer. Samples were loaded and run on an SDS-PAGE 
gel. Ubiquitin standards ranging from 6-40 μM were used to draw calibration plots. 
Monoubiquitin bands were integrated using ImageJ software32, which were used to 
quantify the amount of ubiquitin produced through cleavage of diubiquitin.  All kinetic 
data were analyzed using the program Kaleidagraph and fit to the Michaelis-Menten 
equation Vi = Vmax[S]/(KM+[S]) to determine the kinetic parameters for each mutant. 
 
2.2.4 Thermal Denaturation using Circular Dichroism Spectroscopy 
 Thermal denaturation curves of the proteins were obtained by change in ellipticity 
at 222 nm against increasing temperature (20ºC-86ºC). The linear rate for temperature 
increase was 0.5ºC/min. Data were recorded after every increase of 0.5ºC. The proteins 
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were dissolved in 100mM phosphate buffer (pH 7.4) to make a final concentration of 0.2 
mg/ml and a cuvette with path length of 0.1 cm was used. The thermal denaturation 
processes of all proteins examined were irreversible under this condition. The midpoint 
transition temperature (T1/2) at which 50% of the protein is denatured was calculated 
from curve fitting of the resultant circular dichroism (CD) values versus temperature data 




2.3.1 Structure of Catalytic Domain of Sst2 
 Sst2cat crystallized in two different space groups, P21 and P212121. The P21 form 
has two subunits and P212121 form has three subunits in the asymmetric group. The 
structures were determined by molecular replacement with the catalytic domain of 
AMSH-LP (PDB code: 2ZNR)24 as the search model, and zinc single-wavelength 
anomalous dispersion (Zn-SAD). After multiple rounds of refinement the structures 
yielded satisfactory Rcrys and Rfree as shown in Table 2.1. The different oligomeric states 
of Sst2cat in different crystallization conditions are the results of crystallographic packing. 
Moreover, the gel filtration chromatogram clearly indicates the monomeric state of 
Sst2cat. The structure of Sst2cat in P21 space group solved by molecular replacement will 
be used for the structural analysis as it has the highest resolution.  
 The structure of Sst2cat consists of the JAMM core with two insertions: insertion 1 
(Ins-1, residues 308-333) and insertion 2 (Ins-2, residues 388-413), a characteristic 
feature shared by AMSH and AMSH-LP that contributes to ubiquitin recognition and 
catalysis (Figure 2.5A).2,24 Ins-1 is composed of a pair of antiparallel beta sheets (β4 and 
β5) followed by alpha helix (α2); whereas, Ins-2 is composed of one α helix (α4) 
followed by long loop. The JAMM core is very similar to other JAMM domain proteins 
such as AfJAMM and Prp8 that comprises a mixed beta sheets sandwiched between two 
α helices, α1 on top and α3 on bottom.33-36 In the JAMM core, the catalytic zinc is 
coordinated by His341, His343 (located on β6 and the loop following it), Asp354 
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(located on α3) and a water molecule that is hydrogen bonded to Glu286 (located on the 
loop following α1), in a manner similar to that of AMSH and AMSH-LP (Figure 2.5B). 
Along with the zinc coordinating residues, the conserved Ser351 is also located on α3 
which serve as the oxyanion-stabilizing side chain. Approximately 14Å away from the 
active-site zinc, the second zinc was determined by the presence of strong electron 
density in the 2Fobs-Fcalc map. This zinc has a structural role and is coordinated by the 
same set of residues involved in AMSH and AMSH-LP: Cys397, His404 and His406 
(located on the long loop) from Ins-2 and His356 (located on α3) from the JAMM core 
(Figure 2.5C). 
Sst2cat also contains a loop, referred here as the flap, and located at the top of the 
active site, as seen in the structure of apo form of AMSH and AMSH-LP. The flap in 
Sst2 consists of tripeptide segment with three residues Gly401-Leu402-Phe403 coming 
from Ins-2, whereas the corresponding residues, Gly394-Phe395 in AMSH and Gly406-
Phe407 in AMSH-LP occurs as a dipeptide segment with two residues (Figure 2.6B and 
C). The Phe residue in the flap makes van der Waals interaction with residues on the 
opposite side of the cleft particularly with Asp side chain (Asp315 in Sst2), both of which 
are highly conserved in AMSH and AMSH-LP (Figure 2.7A). Such interaction stabilizes 
the flap in a closed state when the enzyme is not bound to its substrate.  
The overall three-dimensional architecture of Sst2cat is very similar to the catalytic 
domain of AMSH and AMSH-LP with Cα root-mean-square deviation (rmsds) of 0.71 
and 0.59Å respectively (Figure 2.6A). However, further inspection reveals the presence 
of a cis peptide unit (Asp387-Pro388) in Sst2cat, which results in hydrogen bond 
formation between the carbonyl group of Pro 388 and the backbone NH group of Gly256 
from the turn segment of N-terminal β-hairpin (Figure 2.7B).   
 
2.3.2 A Reactive Cysteine Adjacent to the Active-Site 
In one of the structure of Sst2cat, the presence of a potential disulfide bond 7.9Å 
away from the catalytic zinc was identified. A cysteine pair (Cys288 and Cys317) 
appears to be conserved within AMSH-like DUBs, as seen by sequence comparison 
among AMSH, AMSH-LP and Sst2. One of the cysteines (Cys317) is adjacent to the 
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catalytic site and solvent-exposed. The other cysteine (Cys288) appears to have residual 
positive density that could be interpreted as an alternative rotameric conformation in the 
Fobs-Fcalc map (Figure2.7C), a conformation that places the two cysteines within disulfide-
forming distance (Sγ-Sγ distance of 4.4 Å). It is possible that under oxidative conditions 
this pair may form a disulfide bridge. The presence of DTT in the purification buffer may 
be responsible for reduction of the disulfide bond formation; thus giving only a partial 
population of the oxidized form and none in other structures. A similar observation was 
also made in the case of AMSH and also in AfJAMM, the first ever JAMM domain 
protein to be structurally characterized.2,33 
 
2.3.3 Kinetic Characterization of Sst2 
Sst2cat shares the conserved architecture and active-site residues as catalytic 
domain of AMSH and AMSH-LP; therefore, the catalytic activity of Sst2 towards Lys63-
linked diubiquitin was compared with both AMSH and AMSH-LP to explore the 
similarities between the enzymes kinetically. Interestingly, Sst2cat shows a similar 
efficiency as AMSH with both kcat and KM relatively unchanged.2 However, compared to 
AMSH-LP, Sst2 suffers a ten-fold decrease in kcat with slightly better KM (2-fold lower), 
indicating that Sst2 is catalytically less efficient, just like AMSH (Table 2.2, Figure 2.8).2  
Although the cataytic domain of Sst2 is similar to both AMSH and AMSH-LP, 
kinetically more comparable to AMSH.  
 
2.3.4 Comparison of Thermal Stability of Catalytic Domain of Sst2 and AMSH 
To futher explore the similarity between Sst2 and AMSH, the thermal stability of 
two proteins were compared. The stability of the catalytic domain of Sst2 and AMSH 
were analyzed by monitoring the change in circular dichroism (CD) spectroscopy at 222 
nm as a function of increasing temperature. Thermal denaturation of these proteins was 
irreversible under the examined condition. Both Sst2 and AMSH seem to unfold in a two-
state manner as indicated by the sigmoidal thermal denaturation curve (Figure 2.9). The 
midpoints of the transition of catalytic domain of Sst2 is 55.4°C which is less than that of 
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AMSH (61.1°C) as shown in Table 2.3; therfore, suggesting that Sst2 is less stable than 
AMSH.  
 
2.3.5 Model of Sst2 Bound to Lys63-linked Diubiquitin 
The model of Sst2cat bound to Lys63-linked diubiquitin (K63-Ub2) was generated 
by superimposing Sst2cat onto the previously determined X-ray structure of the catalytic 
domain of AMSH-LPE292A bound to Lys63-linked diubiquitin (PDB: 2ZNV) (Figure 
2.10A).24 In diubiquitin, the lysine residue of proximal ubiquitin is covalently attached to 
the carboxylate group of Gly26 of the distal ubiquitin. The overall fold is very similar to 
that of AMSH-LP bound to Lys63-linked diubiquitin with an rmsd of 0.68 of C-alpha 
atoms. The structural similarity suggests that the diubiquitin interaction as seen in the 
model would be preserved in the actual structure of Sst2cat bound to Lys63-linked 
diubiquitin. 
The model of Sst2cat- K63-Ub2 complex reveals that the residues from the loop of 
Ins-2 and the loop between helix α3 and strand β6 are involved in proximal ubiquitin 
recognition. The side chain of Lys63 in the proximal ubiquitin forms an isopeptide bond 
with the carboxylate group of the distal ubiquitin. Like in AMSH-LP, the model shows 
that the position and orientation of side chains of Gln62 and Glu64 of the proximal 
ubiquitin and the formation of aliphatic site by Phe349 and Phe403 of the JAMM core 
helps to align Lys63 in proper orientation for catalysis. The structural comparison of the 
residues involved in proximal ubiquitin recognition reveals that the residues are highly 
conserved between Sst2, AMSH and AMSH-LP (Figure 2.10C). The only difference seen 
from the modeling is the orientation of Ser352 which may adopt an orientation seen in 
AMSH-LP upon binding to ubiquitin.  
Likewise, the model reveals residues of Sst2 involved in distal ubiquitin 
recognition (Figure 2.10B). Asp324 of AMSH-LP involved in hydrogen bond and 
electrostatic interactions with side chain of Arg74 of the distal ubiquitin is replaced by 
Gly318 in Sst2, losing the interaction. Similarly, the residues Met325 and Val328 of 
AMSH-LP are replaced by Thr319 and Glu322 in Sst2. The structural comparison of the 
residues involved in distal ubiquitin recognition shows that except Gly318, all the other 
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residues are conserved between Sst2 and AMSH; thus, implying that the catalytic domain 




AMSH is an ESCRT-dependent DUB which consists of MIT domain and SH3 
motif that recruits to the ESCRT-III and ESCRT-0 components respectively during MVB 
formation. AMSH-LP, on the other hand is independent of ESCRT pathway.2,24 
However, Sst2 consists of a putative MIT domain and non-canonical SH3 motif. Despite 
the confirmation of MIT domain and SH3 motif, studies have shown the importance of 
Sst2 in the regulation of MVB formation and endocytosis. The structure of the catalytic 
domain of Sst2 in its apo form confirms that it is a JAMM metalloprotease which consists 
of two zinc ions: active site zinc responsible for catalysis, and structural zinc which 
stabilizes the enzyme, and supports the accommodation of isopeptide bond for catalysis. 
Furthermore, comparison of the structures of catalytic domains of Sst2, AMSH and 
AMSH-LP shows that all these three JAMM metalloprotease have nearly identical fold 
and overall architecture with superimposable zinc coordination sites. However, there are 
few residues that are unique to Sst2, and are not present in AMSH or AMSH-LP. Sst2cat 
consists of tripeptide segment in the flap as opposed to dipeptide segment in AMSH and 
AMSH-LP. The conserved residue Phe403 in Sst2 makes an interaction with the side 
chain of opposite residue Asp315 forming a close state of the enzyme when it is not 
bound to its substrate. Nevertheless, the flap needs to open to accommodate the scissile 
isopeptide bond at the active site, suggesting the mobility of backbone atoms and side 
chains of the flap residues. 
Another fascinating finding is the cis bond between Asp387-Pro388 in Sst2cat, 
which results in hydrogen bond formation between Pro388 and Gly256.  The importance 
of the cis peptide is not known currently. Since Pro388 is a starting residue for a helix 
holding Cys357 residue that contributes in coordinating structural zinc, it may be possible 
that such hydrogen bonding could provide extra stability to the helix.  
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Likewise, the other interesting observation was the presence of the cysteine pair 
with the potential for forming the disulfide bond, just as seen in AMSH. The importance 
of this disulfide bond is not clear at the moment. One possibility may be the requirement 
of the disulfide bond for the endosome-bound form. AMSH is recruited to ESCRT-III 
complex before formation of luminal vesicle in MVBs, which is then dissociated by 
Vps24 at the end of the MVB biogenesis so that the DUB and the ESCRT members can 
be reused for another around of endocytic sorting.7,13,37 The formation of disulfide bridge 
may help AMSH to maintain its stability and overall fold after it is dissociated from the 
ESCRT-III complex upon the action of Vps24. Additionally, Sst2 also showed specificity 
towards Lys63-linked diubiquitin with the similar efficiency as AMSH; further indicating 
that Sst2 is involved in ESCRT mediated endocytosis and Sst2 is the AMSH in yeast. 
Although the overall fold of Sst2 and AMSH are highly conserved, we noticed a 
difference between the two on the basis of thermal stability. The catalytic domain of Sst2 
was less stable than that of AMSH. It is possible that less stability or greater flexibility of 
Sst2 as compared to AMSH might have to do with its redudant activities as other DUBs 
in yeast that may impact endocytosis.18 
The structural comparison of model of Sst2 bound to Lys63-linked diubiquitin, 
AMSH and AMSH-LP suggests that most of the residues involved in diubiquitin 
recognition are conserved, suggesting that Sst2 also has specificity towards Lys63-linked 
ubiquitin chains. Moreover, subtitution of Sst2 residues involved in distal ubiquitin 
recognition shares more similarities to that of AMSH as far as ubiquitin binding is 
concerned; therefore, suggesting that Sst2 is indeed like AMSH, not AMSH-LP. The 
kinetic data also supports that Sst2 and AMSH are alike.2  
 The structure of the catalytic domain of Sst2 has revealed a nearly identical fold 
with catalytic zinc and structural zinc adopting similar orientation as observed in AMSH 
and AMSH-LP. The model of Sst2 bound to Lys63-linked diubiquitin was built to 
understand its diubiquitin recognition. Further studies are needed to validate the model 
with an emphasis on understanding the role of Sst2 at the ESCRT machinery. The 
catalytic activity, residues involved in distal ubiquitin recognition, a potential disulfide 
bridge between two cysteines at the periphery of the active site and involvement of Sst2 
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in MVB biogenesis suggests that Sst2 is indeed AMSH in fission yeast. Although 
structurally and kinetically Sst2 is similar to AMSH, the most significant difference 
between the two is their thermal stability. Sst2 is less stable than AMSH which may be 
due to its various roles within the yeast system. However, this study proves that fission 
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Figure 2.1: Sequence alignment of JAMM metalloproteases. The alignment consists of 
JAMM (catalytic) domains of AMSH, AMSH-LP (H. sapiens) and Sst2 (S. pombe). 
Residues involved in coordination of catalytic zinc (denoted by *) and structural zinc 




Figure 2.2: Comparison of Sst2, AMSH and AMSH-LP. A) Model of MIT domain of 
Sst2 from Swiss Homology Server based on MIT domain of AMSH (PDB: 2XZE). B) 
Alignment of residues of MIT domain of AMSH involved in contacting CHMP3 
(denoted by blue triangles) of ESCRT-III and predicted MIT domain of Sst2. C) 
Comparison of SH3 binding motif (SBM) of AMSH and Sst2. Three residues colored in 
red makes SBM of Sst2 a non-canonical motif. D) Domain diagram of AMSH, AMSH-





Figure 2.3: Purification of catalytic domain of Sst2 (residues 245-425): A) Superdex 75 
size exclusion chromatography chromatogram showing a clear separation between GST 
and Sst2 samples. The inset is the initial purification of Sst2 using GSH-sepharose resin 
(GE Life Sciences). The abbreviation represents cell lysate (L), supernatant (s), 
flowthrough (FT), was (W), elution (E), after dialysis (AD) and subtraction (sub). B) 





Figure 2.4: Crystallization and Data Collection of Sst2 (residues 245-435): A) Crystals of 
Sst2 which were optimized by additives. B) A single crystal of Sst2 looped and mounted 








Table 2.1: Crystallographic Data Table of catalytic domain of Sst2 in different space 
groups 
 
    
Data collection    
Space group P21  P21 P212121 
Cell dimensions    
    a, b, c (Å) 56.1, 69.4, 62.0 56.2, 69.4, 61.9 54.8, 58.1, 187.5 
    , ,  ()  90.0, 104.8, 90.0 90.0, 104.7, 90.0 90.0, 90.0, 90.0 
Wavelength (Å)    1.033 1.283 1.033 
Resolution (Å) 50.0- 1.45 (1.48-
1.45)           
50.0- 1.67 (1.70-
1.67)         
50.0-1.80 (1.83-
1.80) 
 Rmerge (%) 6.0 (68.5) 7.2 (51.4) 8.7 (62.8) 
I / I 19.3 (2.02) 20.8 (3.5)         17.8 (2.9) 
Completeness (%) 99.7 (99.2)        96.9 (90.9)        97.9 (96.6) 
Redundancy 3.8 (3.7)          7.7 (7.2)          6.0 (6.1) 
    
Refinement    
Resolution (Å) 1.45              1.67             1.80 
No. reflections 80642 51582 55256 
Rwork / Rfree 16.7/19.2 17.7/21.1         20.2/23.8 
No. atoms    
    Protein 3017 2981 4436 
    Ion 4 4 6 
    Water 212 268 217 
R.m.s. deviations    
    Bond lengths 
(Å) 
0.007 0.006 0.008 
    Bond angles () 1.260 1.120 1.143 
Ramachandran 
Plot 
   
Preferred (%) 97.7 98.6 97.3 
Allowed (%) 1.9 1.1 2.3 
Disallowed (%) 0.3 0.3 0.4 
Average B-factors 
(Å2) 
   
    Protein  26.1 25.8 35.7 
    Ion 21.7 25.4 31.5 
    Water 33.8 34.1 34.4 
    Ligand 38.3 34.7 54.3 
 
Values in parentheses are for the highest resolution shell.   
a Rsym = ∑∑|Ihkl − Ihkl(j)|/∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the final 
average intensity. 
b Rcrys = ∑||Fobs| − |Fcalc||/∑|Fobs| and Rfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys 
are calculated using a randomly selected test set of 5% of the data and all reflections 





Figure 2.5: Structure of catalytic domain of Sst2 (245-435, Sst2cat). A) Ribbon 
representation showing secondary structures of Sst2cat. The catalytic domain of Sst2 
consists of JAMM core shown in blue, Ins-1 and Ins-2 shown in yellow and green, 
respectively. B)  Expanded view of the active site zinc which is coordinated by His341, 
His 343, Asp354 and a water molecule (shown in red) in a tetrahedral coordination. C) 
Expanded view of the structural zinc, located 14Å away from the active site, and is 







Figure 2.6: Structural comparison of Sst2, AMSH and AMSH-LP. A) Superposition of 
the catalytic domains of Sst2 (blue), AMSH (pink) and AMSH-LP (gray). B) Stick 
representation of flap segment of Sst2, AMSH and AMSH-LP. Sst2 consists of three 
residues in its flap whereas AMSH and AMSH-LP consists of two residues. C) Sequence 









Figure 2.7: Different interactions formed within the catalytic domain of Sst2. A) Phe 403 
of the flap segment forms hydrophobic interaction with the side chain of opposite residue 
Asp315 resulting in a close conformation of the flap. B) Pro388 forms a cis peptide 
conformation in Sst2 resulting in hydrogen bond interaction with backbone NH groups of 
Gly256. C) A potential disulfide bond formation by one of the conformation of Cys288 
with Cys317. The residues forming disulfide bond are outlined by electron density from 










Figure 2.8: Representative plot of initial velocity divided by enzyme concentration as a 
function of substrate concentration for Sst2. Curve fit to Michaelis Menten parameters 
was generated in Kaliedograph.  
 
 
Table 2.2: Comparison of Kinetic parameters of Sst2, AMSH and AMSH-LP 
 
Sample KM (μM) kcat (s-1) kcat / KM x10-3 
(μM-1 s-1) 
Sst2 36.3 ± 8.4 1.1 ± 0.1 30.3 
*AMSH 32.0 ± 5.3 1.4 ± 0.1 43.7 
*AMSH-LP 66.2 ± 4.8 10.3 ± 0.3 155.6 
 






Figure 2.9: Thermal melting curves of the catalytic domain of Sst2 and AMSH indicate a 
slight variation between the midpoint temperatures (TM) as shown by circular dichroism 
(CD) spectroscopy data. Thermal denaturation of these proteins was irreversible under 
the examined condition. 
 
 
Table 2.3: Stability Parameters deduced from CD data. 
 








Figure 2.10: Model of Sst2 bound to Lys63-linked diubiquitin. A) Superposition of 
catalytic domain of Sst2 onto catalytic domain of AMSH-LPE292A-K63-Ub2 complex 
(PBD: 2ZNV). Sst2 is colored in blue, AMSH-LP in gray.  The proximal and distal 
ubiquitin are shown in orange and green, respectively. B) Stick representation of residues 
of Sst2 (blue), AMSH (pink) and AMSH-LP (gray) involved in distal ubiquitin (orange) 
recognition. C) Stick representation of residues of Sst2 (blue), AMSH (pink) and AMSH-






CHAPTER THREE: STRUCTURAL ANALYSIS OF SST2-UBIQUITIN AND SST2-
DIUBIQUITIN COMPLEXES 
3.1 Introduction 
AMSH has exclusive specificity towards Lys63-linked polyubiquitin chains, 
which act as a signal for ESCRT mediated endosomal-lysosomal degradation.1,2 On the 
basis of the structure of a catalytically inactive AMSH homologue, AMSH-LP, bound to 
Lys63-linked diubiquitin structure (PDB: 2ZNV), the specificity towards Lys63-linked 
ubiquitin chains may be due to the simultaneous binding of AMSH to both the proximal 
and distal ubiquitin in a diubiquitin substrate.3 Interestingly, AMSH shows a similar 
affinity for both ubiquitin and diubiquitin, suggesting that the catalytic domain of AMSH 
has one ubiquitin binding site.2 As a result, AMSH alone may not be able to discriminate 
between its Lys63-linked polyubiquitin substrate and ubiquitin product. AMSH is 
recruited to ESCRT-0 by binding SH3 domain of STAM component of ESCRT-0.4,5 The 
domain map of STAM shows a ubiquitin interacting motif (UIM) is present at its N-
terminal adjacent to SH3 domain which is separated by a short linker (Figure 3.1). 
Surprisingly, both UIM and SH3 binds to ubiquitin independently with KD of 273 ±16 
μM  and 62 ±7 μM , respectively, as shown by ITC experiments.2 Therefore, the 
diubiquitin may be held in tandem by AMSH and the UIM of STAM that helps in 
stabilizing the ubiquitin chain and in stimulating the enzyme’s activity. The complex of 
AMSH bound to ubiquitin and the ternary complex of catalytically inactive AMSH, 
UIM-SH3 and Lys63-linked diubiquitin would allow us to structurally characterize the 
underlying activation mechanism and also gain insights into the mode of recruitment of 
AMSH at ESCRT-0. 
Previously, it was shown that Sst2 is an AMSH orthologue in yeast.6-8 Its catalytic 





with differences in three residues.9  It can cleave Lys63-linked diubiquitin and the 
interactions of Sst2 with Lys63-linked diubiquitin as shown by the model (in chapter 2) 
were similar to that of AMSH. Moreover, the better expression of catalytic construct of 
Sst2 has been successful in yielding protein crystals from multiple conditions.  
This chapter presents three structures of Sst2 and its catalytic mutants bound to 
ubiquitin and a structure of catalytically inactive Sst2 bound to diubiquitin. Our structural 
analysis helps in understanding the mode of substrate recognition and also shows that the 
distal ubiquitin, one of the products of the diubiquitin substrate can remain tightly bound 
to the enzyme. The product specific interaction shows that the proximal ubiquitin has no 
contribution in diubiquitin (substrate) binding, thus explaining the similar affinity for the 
ubiquitin and Lys63-linked diubiquitin. 
 
3.2 Materials and Methods 
 
3.2.1 Cloning, Expression and Purification 
Different constructs of Sst2 (residues 245-435 and residues 221-435), DNA 
encoding UIM-SH3 domains of Hse1 and human ubiquitin were sub-cloned into pGEX-
6P1 vector and transformed into Escherichia coli Rosetta cells to be expressed as an 
recombinant protein fused with glutathione-S-transferase (GST) tag at the N-terminal . 
The proteins were purified following the methods as described in Shrestha et. al using 
standard GST affinity chromatography followed by size exclusion chromatography on a 
Superdex S75 column (GE Lifesciences).9 Glu286Ala and Asp354Ala mutations were 
introduced individually in Sst2 (residues 245-435), here referred as Sst2cat construct, by 
site-directed mutagenesis following the standard protocol. Likewise, five different 
mutations: Glu286Ala, Asp354Ala, Tyr234Val, Thr235Asp and GLu239Lys point 
mutations were introduced sequentially in Sst2 (residues 221-435), here referred as 
Sst2Δ220 construct. Each mutant was sequenced to confirm the presence of mutations. The 
resulting GST-tagged mutants were then expressed in Escherichia coli Rosetta cells and 





After the cleavage of GST tag using PreScission protease (GE Bioscience), the 
protein consists of an N-terminal pentapeptide (Gly-Pro-Leu-Gly-Ser, GPLGS) due to the 
cloning artifact in GST fusion proteins. To avoid the issue arising from this cloning 
artifact, Dr. Judith Ronau prepared ubiquitin from pRSETA plasmid (a kind gift from P. 
Loll, Drexel University, Philadelphia, PA) for isothermal titration calorimetry (ITC) as 
described here. The resultant construct were transformed into Escherichia coli BL21cells. 
The cells were grown overnight in a small scale culture of Luria Bertani (LB) 
supplemented with ampicillin. Six liters of LB media supplemented with ampicillin were 
inoculated using overnight small scale culture and grown until the optical density reached 
0.4-0.6 at 37°C. The protein expression was induced with 0.3 mM isopropyl-β-D- 
thiogalactoside (IPTG) and reducing the temperature to 18°C. After 16-18 hours, the cells 
were harvested, resuspended in 50 mM sodium acetate, lysed by French press and 
centrifuged at 100,000 x g for an hour. Lysate was loaded onto a column containing SP-
Sepharose Fast Flow resin (GE healthcare). The column was pre-equilibrated in 50 mM 
sodium acetate, pH 4.5 and ubiquitin was eluted by applying a step gradient with 50 mM 
sodium acetate, pH 4.5, 1 M NaCl.  Ubiquitin was further purified by size exclusion 
chromatography in a buffer consisting of 50 mM Tris pH 7.6, 50 mM NaCl, 1mM DTT 
using a Superdex S75 column (GE Biosciences). 2 ml fractions of eluent were collected 
and each sample was analyzed on SDS-PAGE gel for purity.  Pure fractions were 
concentrated down, flash frozen for future use.  
Two different Lys63-linked diubiquitin (K63-Ub2) were used for the 
crystallography experiments. One of the diubiquitin was synthesized artificially by E. 
Strieter’s lab, University of Wisconsin- Madison.10 The other diubiquitin was synthesized 
enzymatically using human E1 (Ubiquitin activating enzyme, Uba1), E2s (Ubiquitin 
conjugating enzymes, Uev1a and Ubc13) and two mouse ubiquitin mutants (Asp77 and 
K63R).3 All these proteins (E1, E2s and two ubiquitin mutants) were purified separately 
and then mixed in a reaction buffer containing 80 mM Tris-HCl, pH 7.4, 20 mM ATP 
MgCl2, and 1mM DTT. The reactions were incubated overnight at 37°C and quenched at 
room temperature using 10-fold excess of cation exchange buffer containing 50mM 





column (GE Healthcare) and eluted using a linear gradient of 0-300 mM NaCl with 
diubiquitin eluting at 200 mM NaCl. The purity of the samples was analyzed on SDS-
PAGE and the samples containing diubiquitin were pooled, concentrated and stored at -
80°C until use. 
 
3.2.2 Crystallization and Structure Determination of Catalytic Domain of Sst2 Bound to 
Ubiquitin 
The final concentration of Sst2cat and ubiquitin (Ub) used in crystallization was 19 
mg/ml and 29.9 mg/ml, respectively in 50 mM Tris-HCl, 7.6, 50 mM NaCl and 1 mM 
DTT. Sst2cat and Ub complex, here referred as Sst2cat-Ub, were mixed in a ratio of 1:1.6 
and crystallization was performed by sitting drop at room temperature. A crystal hit was 
identified in a week at room temperature in mother liquor containing 0.2 M sodium 
citrate tribasic dehydrate (pH 4.5). Sst2E286A and semi-synthetically obtained Lys63-
linked diubiquitin were mixed in a ratio of 1.5:1 with the hope of forming catalytic 
domain of Sst2 bound to diubiquitin complex. Crystals of the complex formed in room 
temperature in 3 days from the mother liquor containing 0.2 M ammonium phosphate 
dibasic (pH8.0), 20% (w/v) PEG 3,350. Likewise, Sst2D354A and ubiquitin were mixed in 
a ratio of 1.8:1 to form a complex, here referred as Sst2D354A-Ub. Crystals were grown in 
a week by sitting drop at room temperature from the mother liquor containing 1% (w/v) 
tryptone, 0.05 M HEPES sodium (pH7.0) and 20% (w/v) PEG 3,350. These crystals were 
looped, briefly soaked in 25% ethylene glycol and flash frozen in liquid nitrogen. Data 
for Sst2cat-Ub was collected at Argonne National Laboratory on beamline 23-ID-D using 
Mar300 CCD at 100°C; whereas data for Sst2E286A-Ub and Sst2D354A-Ub was collected at 
Argonne National Laboratory on beamline 23-ID-B using Mar300 CCD at 100°C. All 
data sets were indexed and processed with HKL2000 program.11 
The structures of the Sst2cat-Ub complex were obtained in two different space 
groups. The crystal obtained from 0.2 M Sodium citrate tribasic dehydrate (pH 8.3), 20% 
(w/v) PEG 3,350 diffracted to 1.97Å and crystallized in P21 space group. The structure 
was determined by Zn-SAD phasing using Autosol12,13 wizard from the PHENIX 





the final model yielded Rcrys and Rfree of 17.7% and 20.7%, respectively.  The other 
Sst2cat-Ub complex grown from 0.02 M zinc chloride, 20% (w/v) PEG mother liquor 
diffracted to 1.63Å resolution and crystallized in the P212121 space group. The structure 
was determined by molecular replacement (MR) with MolRep17 using the Zn-SAD 
determined Sst2cat-Ub structure as a search model. Initial refinements were carried out in 
Refmac518 using rigid body and restrained refinement. After that, rounds of model 
building and refinement were carried out in Coot16 and PHENIX14,15 which yielded an 
Rcrys and Rfree of 19.5% and 21.5%, respectively.  During refinement for both structures, 
TLS was also used, considering the entire asymmetric unit as one group.19,20  
Interestingly, the mixture of Sst2E286A and diubiquitin produced a cocrystal 
structure of the enzyme bound to ubiquitin due to the residual activity of the mutant. The 
structure of the complex, referred as Sst2E286A-Ub, diffracted to 1.74Å and crystallized in 
the P212121 space group. The structure of this complex was determined by molecular 
replacement using the solved structure of Sst2cat-Ub complex, which gave the final model 
with Rcrys and Rfree of 20.3% and 23.2% respectively after rounds of model building and 
refinement. Similarly, the structure of Sst2D354A-Ub was also solved by molecular 
replacement using the solved structure of Sst2cat-Ub complex. The crystal diffracted to 
2.05Å and crystallized in the P21 space group. Multiple rounds of refinement and model 
building yielded Rcrys and Rfree of 21.3% and 26.3% respectively. The molecular 
replacement, model building, multiple rounds of refinement were carried out as described 
above. All figures for the structures were rendered with PYMOL (version 1.7.0.0).21 
 
3.2.3 Crystallization and Structure Determination of Catalytic Domain of Sst2 Bound to 
Ly63-linked Diubiquitin  
 Dr, Judith Ronau, the former post-doctoral scholar determined the structure of 
catalytic domain of inactive Sst2 bound to Lys63-linked diubiquitin (Sst2Δ220-K63-Ub2). 
The three-protein complex of UIM-SH3, Sst2Δ220 and Lys63-linked diubiquitin was 
formed by initially mixing inactive Sst2Δ220 and the UIM-SH3 domain of Hse1 and was 
purified by size exclusion chromatography on a Superdex S75 column (GE Biosciences). 





and those containing pure samples were pooled, concentrated and complexed with 
enzymatically synthesized Lys63-linked diubiquitin. The three-protein complex was then 
again passed through Superdex S75 column and purity check of the fractions was 
performed by SDS-PAGE. The pure samples containing a stable complex of three 
proteins were pooled, and concentrated. Initial crystallization experiments were 
performed at 20°C using Genomics Solution Cartesion “Honeybee” 963 crystallization 
robot. The crystals of Sst2 bound to diubiquitin grew in a month from mother liquor 
containing 0.2M MgCl2, 0.1M Tris-HCl (pH8.5) and 25% (w/v) PEG 3350. These 
crystals were soaked in a 25% ethylene glycol and flash-frozen. X-ray diffraction data 
were collected at beamline 23-ID-D at the Advanced Photon Source at the Argonne 
National Laboratory and data were processed with HKL2000.11 
 The crystals of Sst2Δ220-K63-Ub2 complex diffracted to 2.3Å and crystallized in 
P212121 space group. The structure was determined by MR using MolRep17 of the ccp4 
suite16 using a model of Sst2cat bound to diubiquitin as a search model. The model of 
Sst2cat bound to diubiquitin was generated by superposition of Sst2cat onto the structure of 
AMSH-LP bound to diubiquitin (AMSHLP-K63-Ub2, PDB: 2ZNV).3 The model was 
built using Coot16 and refined using Refmac5.18 After rounds of refinement and model 
building, the final structure yielded an Rcrys and Rfree of 21.3% and 26.3%, respectively.  
During refinement, TLS19,20 considering one group for chain A (Sst2), five groups for 
chain B (distal ubiquitin) and three groups for chain C (proximal ubiquitin) and 
optimized weighting were used. 
 
3.2.4 Isothermal Titration Calorimetry 
Isothermal Titration Calorimetry (ITC) experiments were conducted at 25oC on a 
GE/MicroCal ITC200 Calorimeter to determine the binding of Sst2 with ubiquitin and 
diubiquitin. The protein solutions were dialyzed overnight using 50mM Tris-HCl (pH 
7.6) and 50mM NaCl. The dialysis buffer was exchanged three times. 0.4-1 mM of 
monoubiquitin or diubiquitin was titrated into 40-50 μM protein solution. A total of 28 
injections (1.4 µl/injection) were performed with a spacing of 180 seconds between 










3.3.1 Design of Sst2 Mutants 
In order to determine a ternary complex of Sst2, UIM-SH3 and diubiquitin, 
Sst2Δ220 was mutated at its SH3 binding motif (SBM) and its catalytic site. Sst2 contains 
three substitutions in its SBM compared to the canonical SBM sequence that are thought 
to render the SBM nonfunctional for binding to the SH3 domain of STAM (Hse1 in S. 
pombe). Therefore, three residues were mutated in this motif to restore a functional SBM 
(Figure 3.1). Likewise, catalytic residues were mutated to form a complex between Sst2 
and Lys63-linked diubiquitin. Initially, an inactive mutant of Sst2 was prepared by point 
mutation of the active-site residues Glu286 or Asp354 to Ala as performed in other 
thermolysin-like proteases. In contrast to our expectation, single mutation of the active 
site residues (Glu286Ala or Asp354Ala) was able to cleave the diubiquitin in an amount 
used for crystallization. Therefore, in order to have a completely inactive enzyme, double 
mutation was introduced by replacing both Glu286 and Asp354 with alanine.  
 
3.3.2 Crystallization of Sst2 in its Product Bound Form 
In order to improve our understanding of AMSH interaction with diubiquitin, 
Sst2E286A mutant was mixed with semi-synthetically prepared Lys63-linked diubiquitin.10 
This mutation was presumed to make the enzyme inactive because Glu286 is involved in 
holding the catalytic water in position; thus, serving as the fourth ligand in coordination 
of the active-site zinc and also as a nucleophile for hydrolysis.3,24 Therefore, the mutation 
leads to a loss of zinc and catalytic water. The glutamate also acts as both a general base 
and acid in the hydrolysis reaction, assuming that Sst2, like AMSH and AMSH-LP, also 
follow thermolysin-like hydrolysis mechanism. Moreover, mutation of Glu292 to alanine 





complex (PDB: 2ZNV).3 Unexpectedly, the crystals obtained from the mixture of 
Sst2E286A mutant and Lys63-linked diubiquitin were that of Sst2E286A mutant bound to 
ubiquitin. The structure provided a view of the enzyme bound to its product, which was 
generated from the reaction during crystallization trials. Since the mutant of Sst2 bound 
to its product was obtained, wild-type Sst2 was also crystallized with ubiquitin to form 
Sst2cat-Ub complex to get a better view of the product contacts to its wild-type enzyme.  
 
3.3.3 Structures of Catalytic Domain of Sst2 and Ubiquitin Complexes 
Wild-type Sst2 enzyme bound to ubiquitin, Sst2cat-Ub complex, crystallized in 
two different space groups, P21 and P212121. Both space groups have two subunits in the 
asymmetric unit. The structure of the P21 form was determined by zinc single-
wavelength anomalous dispersion (Zn-SAD) and P212121 form by molecular replacement 
using the refined model from Zn-SAD as a search model (refer to Table 3.1 and 3.2 for 
crystallographic data collection and refinement statistics). The different subunits in the 
asymmetric unit are the result of crystallographic packing. The crystals in P212121 space 
group grew from the mother liquor containing 0.02 M zinc chloride, 20% (w/v) PEG and 
interestingly, the crystal structure showed zinc-mediated packing at the interface. At the 
interface, two zinc ions are held in position by a tetrahedral coordination formed by two 
His residues from one subunit, a Glu from the other subunit of the asymmetric unit and a 
chloride ion (Figure 3.2). Both zinc and chloride ions might have been from ZnCl2 
present in the reservoir. Such coordination appears to provide substantial stabilization 
resulting in the formation of crystallographic dimer. Moreover, two hydrogen bonding 
interactions between two copies of Ser324 and Glu428 and van der Waals interaction of 
side chain of Phe328 also contribute to dimer formation.  
 Structures of Sst2cat-Ub, Sst2E286A-Ub and Sst2D324A-Ub help in understanding the 
product-bound state of the enzyme. Since these different product bound structures share 
many similarities, Sst2E286A-Ub structure will be used for analysis of Sst2 interaction with 
ubiquitin. Superposition of Sst2E286A-Ub onto AMSH-LPE280A bound to diubiquitin (PDB: 
2ZNV) reveals that the ubiquitin bound to the Sst2 interaction is similar to the distal 





ubiquitin interacts with Sst2 at three distinct areas: i) the extreme C-terminal hexapeptide 
ii) the Ile44 patch and iii) the hydrophobic patch opposite the Ile44 patch. Most of the 
interactions are contributed by the extreme C-terminal hexapeptide LRLRGG of the 
ubiquitin which is located nicely in the active site cleft (Figure 3.4B and C). This 
hexapeptide segment forms a β-strand that interacts with β5 strand of Ins-1 and α3 helix 
from the JAMM core. The main chain CO and NH atoms of Gly76 interact with Oγ atom 
of Ser 351 and Oδ atom of Asp354, respectively. Likewise, the main chain CO and NH 
atoms of Gly75 form hydrogen bonds with the main chain NH and CO atoms of Cys317, 
respectively. The main chain CO and NH atoms of Arg74, and the main chain CO atom 
of Arg72 in the distal ubiquitin also form hydrogen bonding with Oγ atom of Thr357, and 
Oη atom of Tyr 361, respectively. The Nη atoms of Arg74 interact with Oγ atom, and the 
main chain CO atom of Thr319. The main chain CO and NH of Leu73 also form 
hydrogen bonds with the main chain NH and Oγ atoms of Thr319. Apart from the 
hydrogen bonding, Leu73 forms hydrophobic interaction with side chains of Trp339, 
Cys288 and Ile290, and Leu71 with that of Tyr361 (Figure 3.4D).  
Apart from the extreme C-terminal interactions, all the other DUBs such as 
cysteine proteases and AMSH-LP have been shown to recognize the Ile44 patch of 
ubiquitin. Likewise, Sst2 also recognizes this hydrophobic patch in the ubiquitin which 
consists of Leu8, Ile44, Val70 and the Cβ atom of His68. Phe326 of Sst2 makes a number 
of van der Waals interactions with the residues of the Ile44 patch and Gln329 from Ins-1 
form van der Waals interaction with the side chain of Leu8 (Figure 3.5A and B). Lastly, 
the structure also reveals that Met364 from the JAMM core interacts with the 
hydrophobic pocket opposite the Ile44 patch. This hydrophobic pocket comprises of 
Ile36, Leu69, Leu71 and the Cγ atom of Thr7 of the ubiquitin (Figure 3.5C).  
 
3.3.4 Differences between Sst2cat-Ub, Sst2E286A-Ub and Sst2D354A-Ub Structures 
Despite many similarities, some interesting differences exist between atructures of 
wild-type Sst2cat-Ub complex and that represented by Sst2E286A and Sst2D354A bound to 
ubiquitin. The main difference can be seen in the interaction of ubiquitin at the active-site 





residues (His341 and His343), an aspartate (Asp354), and the catalytic water that is 
hydrogen bonded with glutamate (Glu286). In the wild-type Sst2cat-Ub complex, one of 
the oxygens from the carboxylate group of Gly76 of ubiquitin replaces the catalytic water 
and form a hydrogen bond with Glu286. The other oxygen coordinates the catalytic zinc 
to maintain its tetrahedral coordination (Figure 3.6A and D). Whereas, in the Sst2E286A-
Ub complex, the tetrahedral zinc coordination is maintained just as in apo form except 
that the water cannot hydrogen bond with Glu286. Surprisingly, the structure reveals that 
the carboxylate group of Gly76 of ubiquitin is displaced from zinc ion by the water, 
which forms hydrogen bond interaction with one of the oxygens of carboxylate group 
instead of Glu286 (Figure 3.6B and E) . This is remarkable because it seems that the 
structure of Sst2E286A-Ub complex provided a snapshot of a transient solution species in 
which the product is about to depart and the catalytic water is about to reestablish its 
contact with the active-site metal for its next catalytic activity. In Sst2D354A-Ub complex, 
the catalytic zinc is lost and is replaced by water. However, the catalytic water is replaced 
by one of the oxygens of the carboxylate group of Gly76 just like in wild-type Sst2cat-Ub 
complex (Figure 3.6C and F). All these structures clearly show that Sst2 and AMSH-
related family has one binding site for ubiquitin. 
 
3.3.5 Structure of Sst2cat Bound to Diubiquitin Complex 
 The crystals of catalytic domain of Sst2 bound to Lys63-linked diubiquitin (K63-
Ub2) were obtained from a mixture of Sst2Δ220, UIM-SH3 from Hse1 and K63-Ub2 
(Figure 3.7). The structure was solved by molecular replacement using the model of 
Sst2cat-K63-Ub2 generated by superposition of Sst2cat onto the structure of AMSH-LP 
bound to diubiquitin (PDB: 2ZNV). Refer to Table 3.2 for crystallographic data 
collection and refinement statistics. The final structure does not contain 27 residues at the 
N-terminal (residues 221-247) of Sst2 due to lack of electron density. Likewise, due to a 
lack of side-chain density, Phe248, Lys249, Gly297, Asn331, and Val434 were modeled 
as alanine in Sst2. Furthermore, residues 7-11, 28-42, 47, and 70-76 from chain C 
(proximal ubiquitin) were not modeled in the structure because of positional disorder. It 





measurement with a catalytically inactive mutant (KD: 1.1 ± 0.1 µM). On the other hand, 
UIM-SH3 may have somewhat weaker affinity for the binary complex resulting in the 
formation of Sst2Δ220-K63-Ub2 complex instead of ternary complex (UIM-SH3-Sst2Δ220-
K63-Ub2). 
 Superposition of the catalytic domain of AMSH-LP-K63-Ub2 complex and 
Sst2Δ220-K63-Ub2 shows that the overall three-dimensional fold of Sst2Δ220-K63-Ub2 is 
highly similar to that of AMSH-LP (Figure 3.8A). However, two mutations (E286A and 
D354A) were made instead of one, as seen in AMSH-LP to have an inactive enzyme. 
(Figure 3.8B and C). Like AMSH-LP, Lys63-linked diubiquitin binds to Sst2Δ220 in an 
extended conformation around the isopeptide linker and the majority of the protein 
contacts are contributed by the distal ubiquitin (Figure 3.9 A and C). Many of the 
interactions with the distal ubiquitin in the structure of Sst2Δ220-K63-Ub2 are preserved as 
observed in the product bound structure of Sst2 that was described previously. 
Interestingly, this structure also consists of a partially occupied disulfide bond between 
Cys288 and Cys317, as observed in the apo form of Sst2 (PDB: 4MS7) that was 
described in chapter 2. 
 The proximal ubiquitin interaction is also comparable to that observed in the 
structure of AMSH-LP-K63-Ub2.3 The residues from the loop of insertion-2 (Ins-2) and a 
loop that linked helix α3 to strand β6 in the JAMM core are engaged with the proximal 
ubiquitin. Phe403 from the loop of Ins-2 makes three van der Waals interactions with the 
isopeptide segment of diubiquitin. The Cζ and Cε2 atoms of Phe403 interacts with the Cδ 
atom of Lys63 from the proximal ubiquitin and the Cε2 atoms of Phe403  also makes an 
additional interaction with the backbone carbon atom of Gly76 from the distal ubiquitin. 
Likewise, the Cβ atom of Phe403 and the Cζ atom of Phe349 make hydrophobic 
interaction with the Cγ atom of Gln62 and the Cγ atom of Lys63 from proximal ubiquitin, 
respectively. Pro405 also forms a stacking interaction with Phe4 of proximal ubiquitin. 
Additionally, Thr347 and Ser352 of Sst2 make an important hydrogen bonding 
interaction with proximal ubiquitin. The Oγ atom and the main chain NH atom of Thr347 





main chain NH atom of Ser352 makes hydrogen bonds with the Oγ2 of Glu64 (Figure 
3.9B). 
 
3.3.6 Dynamics of the Active-Site Loop 
 Comparison of the structures of Sst2 in its apo form, ubiquitin and diubiquitin 
bound form show changes in a loop located in a structural element called Ins-2, which is 
near the proximal ubiquitin binding site (Figure 3.10A). The loop appears to fluctuate 
between open and close conformations. The key residues in the loop are Leu402 and 
Phe403 from Ins-2 segment, which are responsible for coordination of the structural zinc. 
In the apo form of Sst2cat, the closed conformation of the active-site cleft was maintained 
in absence of the substrate (Figure 3.10B). Leu402 and Phe403 maintained a contact with 
Thr316 and Asp315, respectively. Even in Sst2cat-Ub and Sst2cat-K63-Ub2 complexes, the 
closed conformation of the loop is maintained; however, the interactions between the 
residues are different (Figure 3.10C). In Sst2cat-Ub complex, both Leu402 and Phe403 
maintain a van der Waals contact with Thr316. Additionally, Phe403 also makes van der 
Waals interaction with Cα atom of Gly76. Interestingly, Sst2cat-K63-Ub2 complex also 
appears to have closed conformation (Figure 3.10E) with both Leu402 and Phe403 
forming van der Waals interaction with Thr316. However, both of these residues, Leu402 
and Phe403 need to move apart relative to Thr316 to accommodate diubiquitin substrate 
in the active-site. In Sst2E286A-Ub, Leu402 and Phe403 appears to have moved away from 
interaction with Thr316; thus, creating an opening likely to position the displaced 
carboxylate of Gly76 of ubiquitin (Figure 3.10D). Table 3.3 shows the interactions made 
in four different structures of Sst2. The mobility of the side chains of Asp315, Leu402 
and Phe403 may result in the dynamics of the β-turn resulting in a conformational change 
between the free form and ubiquitin bound form. 
 
3.3.7 Difference between Substrate-Bound and Product-Bound Forms 
 Comparison between structures of Sst2 bound to Lys63-linked diubiquitin and 
ubiquitin reveal that the interactions of Gln62-Lys63-Gly64 tripeptide segment and Phe4 





made inactive by the loss of catalytic water and zinc at the active site (Figure 3.8B and 
3.9B). However, in the product-bound form, these proximal ubiquitin interactions are 
replaced by interaction of zinc to the carboxylate group of ubiquitin. One of the 
carboxylate oxygens of Gly76 of ubiquitin occupies the position of the nucleophilic 
water, and the other oxygen act as a hydrogen bond donor and interacts with Glu286 
(Figure 3.6A and D). The interactions of the carboxylate group of ubiquitin’s Gly76 may 
contribute in tight binding of the product. Surprisingly, the mutation of Glu286 to Ala did 
not result in the loss of the ubiquitin affinity. In fact, the ITC study shows that the mutant 
binds ubiquitin stronger than the wild-type Sst2, which may be due to the change in the 
active-site structure (Figure 3.11). 
 
3.3.8 Comparison between Sst2cat-K63-Ub2, AMSH-LP-K63-Ub2 and AMSH 
The model that was built in the previous chapter provided some structural insight 
into how Sst2 might bind to diubiquitin. Comparing the model to that of the structure of 
Sst2cat-K63-Ub2 showed no difference. Like in the model, superposition of the catalytic 
domain of AMSH, AMSH-LP-K63-Ub2 and Sst2 reveals that all the residues involved in 
proximal ubiquitin recognition are highly conserved whereas, most of the residues mainly 
from α3 helix of JAMM core involved in the distal ubiquitin recognition are conserved 
(Figure 3.12A). There are three substitutions in Sst2 in the distal binding site compared to 
AMSH-LP and one substitution as compared to AMSH (Figure 3.12B). The two 
substitutions of Thr313 and Glu316 in AMSH and Thr329 and Glu322 in Sst2 in place of 
Met325 and Val328 of AMSH-LP imply that JAMM domain of Sst2 shares more 
similarities with AMSH than AMSH-LP regarding ubiquitin recognition. The substitution 
of Gly318 in Sst2 in place of Asn in AMSH and Asp in AMSH-LP leads to a loss of 
hydrogen bond interaction with Arg74 of ubiquitin; however, Arg74 reestablishes the 
interaction with Thr319 of Sst2, indicating that the substitutions do not alter the ubiquitin 









Different structures of Sst2 bound to Lys63-linked diubiquitin (substrate) and 
ubiquitin (product) not only provide the snapshots of mechanism of hydrolysis of Sst2 
and related enzymes based on a thermolysin-like mechanism (Figure 3.13), but also 
improve the understanding of how the enzyme recognizes and interacts with its substrate. 
AMSH and its closely related enzyme Sst2 were assumed to share mechanistic 
similarities with the well-studied metalloprotease thermolysin. In an attempt to crystallize 
Sst2 bound to diubiquitin, Glu286Ala mutation was generated in Sst2. The thermolysin-
like mechanism shows that Glu286 acts as a general base which activates the water bound 
to the zinc by abstracting a proton and making it a potent nucleophile; thus making it as 
an essential residue for catalysis. This nucleophilic water then attacks the carbonyl group 
of the scissile peptide bond, leading to a formation of a tetrahedral intermediate. The 
intermediate is stabilized by the interaction of the oxyanion with a nearby serine (Ser351 
in Sst2, Figure 3.4B and 3.9C) residue. The formation of the intermediate is followed by 
departure of the leaving group, the proximal ubiquitin, after the transfer of a proton to the 
amine group from the same glutamic acid (Glu286 in Sst2), which now acts as a proton 
donor. The tetrahedral intermediate gets collapsed and the carboxylate group of the 
product fragment, which corresponds to the distal ubiquitin in diubiquitin substrate, helps 
in coordinating the catalytic zinc. Finally, the distal ubiquitin dissociates, and the 
catalytic water gets replaced to reestablish its coordinating position adjacent to the active-
site zinc.  
Mutation of Glu to Ala in thermolysin-like enzymes leads to loss of zinc, making 
the enzyme inactive as seen in AMSH-LP structure.3 In contrast, the Glu286Ala mutant 
of Sst2 showed some residual activity as seen in matrilysin-like enzyme24,25 and yielded a 
cocrystal of the enzyme bound to the ubiquitin fragment from the reaction that occurred 
during crystallization. Thus, suggesting that Glu286 in Sst2 may not be playing the role 
of a general base in the hydrolysis reaction. This is supported by the pH values of the 
crystal conditions. The crystals were grown from solutions with pH values ranging from 
7-8; as a result, the pKa of Glu286 is relatively high and must remain protonated during 





as seen in thermolysin case.26,27 Moreover, the zinc-bound water may be ionized 
significantly to serve as the nucleophile itself as proposed for matrilysin.24,25 The role of 
Glu286 may be required for stabilization of the transition state via hydrogen bonding 
interaction with the carbonyl group of the scissile peptide bond and act as a proton donor 
to the leaving group. The crystal structures of Sst2 bound to ubiquitin also shows that 
Glu286 is involved in hydrogen bonding interaction with the carboxylate of Gly76 of 
ubiquitin. On the basis of these observation, Sst2 may behave more like matrilysin; 
however further studies should aim at providing insight into the mechanism of Sst2 and 
its related enzymes.  
Structures of Sst2 and its mutant bound to ubiquitin and diubiquitin also shows 
that the interactions with the distal ubiquitin of the substrate are still intact in the product-
bound form. This distal ubiquitin is also engaged in number of interactions with the 
catalytic domain of Sst2. This indicates that the substrate (diubiquitin) binding is 
predominantly due to the interactions of the distal ubiquitin, and also after hydrolysis, the 
distal ubiquitin (product) remains bound to the enzyme. The proximal ubiquitin plays a 
minimal role in substrate binding; however, it is important for the transition state of the 
catalytic reaction as shown by the kinetic analysis of mutants of proximal ubiquitin and 
AMSH.2 Additionally, ITC study shows that like that of AMSH, the affinity of Sst2 for 
ubiquitin is similar to the KM of diubiquitin hydrolysis (Table 3.4 and 3.5).   
Along with these structural observations, the other remarkable observation is that 
for both AMSH and Sst2, the affinity for the product (KD for ubiquitin) determined by 
ITC study matches with the KM value observed with the diubiquitin substrate as 
determined by kinetic analysis in the previous chapter. This may imply that the catalytic 
activity of AMSH and Sst2 may be regulated by binding to ubiquitin because the 
concentration of the free ubiquitin in cells (̴ 20µM) is close to the KD values that were 
measured.28  It is possible that AMSH and its related enzyme like Sst2, in the free 
cytosolic form, remain inhibited due to the higher concentration of ubiquitin than Lys63-
linked diubiquitin. However, upon assembly with other proteins such as ESCRT-0 in case 
of AMSH, which consists of ubiquitin binding domain such as UIM may shift the balance 





seen in other DUBs such as UCH37 when activated by Adrm1.29 The ability of UIM to 
bind ubiquitin provides additional strength in stabilizing the ubiquitin chain of the 
substrate since AMSH has only one binding site for ubiquitin.2 
All these different structures of Sst2 reveal structural features in the active-site 
that contributes both to substrate recognition and catalysis. One such feature is the open 
and close conformations of active-site flap near insertion-2, which may contribute to 
catalysis and also to the recognition of specific ubiquitin linkages. However, further 
studies are required to probe the contribution of the flap to linkage specificity and 
catalysis. Comparison of Sst2 bound to diubiquitin structure to that of AMSH and 
AMSH-LP shows that the distal site consisting of residues from Insertion-1 is 
evolutionarily less constrained than the proximal site consisting of JAMM core residues. 
Therefore, indicating that JAMM core residues are structurally important while the 
insertion residues, which evolved later, are more interchangeable. Overall, these studies 
show that the product specific interactions contribute in binding diubiquitin substrate for 
both Sst2 and AMSH. This explains the similar affinity for the product and that for the 
substrate. It is also likely that the cytosolic form of AMSH, and by extrapolation similar 
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Figure 3.1: Domain diagram of different constructs of Sst2 and STAM used for 
crystallization.  The JAMM domains, the SBM and MIT domains are indicated in blue, 
purple and green respectively.  Sst2cat and Sst2Δ220 were used to crystallize product and 
substrate bound structures, respectively.  The Sst2Δ220 contained mutations both in 
JAMM domain and SBM that inactivated the enzyme (for substrate binding) and 
introduced a functional SBM for recognition of the SH3 domain of STAM. The minimal 
construct of STAM contains UIM and SH3 domains indicated in orange and red and are 



















Table 3.1: Crystallographic refinement statistics for catalytic domain of Sst2 
bound to ubiquitin  
 
  Sst2cat-Ub Sst2cat-Ub 
Data collection   
Space group P21 P212121 
Cell dimensions   
    a, b, c (Å) 71.2, 57.0, 
81.2 
57.3, 74.6, 139.3 
    , ,  ()  90.0, 104.6, 
90.0 
90.0,90.0, 90.0 
Wavelength (Å)    1.281 1.033 
Resolution (Å) 50.0- 1.97 
(2.0-1.97)       
50.0- 1.63(1.66-
1.63)         
 Rmerge (%) 13.9 (90.0) 12.2 (92.6) 
I / I 20.9 (3.5) 17.1 (2.3)         
Completeness (%) 98.7 (97.6)      99.8 (96.1)        
Redundancy 7.5 (7.0)        7.3 (7.0)          
   
Refinement   
Resolution (Å) 1.97           1.63             
No. reflections 44008 74731 
Rwork / Rfree 17.7/20.7 19.5/21.5         
No. atoms   
    Protein 4108 4200 
    Ion 4 8 
    Water 304 227 
R.m.s. deviations   
    Bond lengths (Å) 0.007 0.006 
    Bond angles () 1.101 1.112 
Ramachandran Plot   
Preferred (%) 98.0 98.3 
Allowed (%) 1.8 1.7 




    Sst2 cat  26.5 18.2 
Distal Ubiquitin 40.9 26.4 
    Proximal Ubiquitin --- --- 
    Ion 25.6 14.9 
    Water 35.7 22.9 
 Ligand 40.8 27.5 
 
Values in parentheses are for the highest resolution shell.   
a Rsym = ∑∑|Ihkl − Ihkl(j)|/∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the final 
average intensity. 
b Rcrys = ∑||Fobs| − |Fcalc||/∑|Fobs| and Rfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys 
are calculated using a randomly selected test set of 5% of the data and all reflections 






Table 3.2: Crystallographic refinement statistics for catalytic mutants of Sst2 bound to 
ubiquitin or diubiquitin 
 
 E286A-Ub D354A-Ub Sst2Δ220-K63-
Ub2 
Data collection    
Space group P212121  P21 P212121 
Cell dimensions    
    a, b, c (Å) 57.0, 95.3, 112.9 42.4, 58.0, 56.2 49.5, 56.7, 135.1 
    , ,  ()  90.0, 90.0, 90.0 90,108.9, 90.0 90, 90, 90 
Wavelength (Å)    1.033 1.033 1.033 






 Rmerge (%) 11.6 (86.7)        8.6 (62.5) 11.2 (54.9) 
I / I 19.4 (2.7) 16.8 (2.6) 34.5 (4.1) 
Completeness (%) 100 (100)         100 (100) 100.0 (100.0) 
Redundancy 5.8 (5.5)          3.8 (3.7) 6.8 (6.7) 
    
Refinement    
Resolution (Å) 1.74             2.05 2.30 
No. reflections 63007 16420 16689 
Rwork / Rfree 20.3/23.2 20.5/25.3 21.3/26.3 
No. atoms    
    Protein 4130 2042 2396 
    Ion 4 1 1 
    Water 409 78 52 
R.m.s. deviations    
    Bond lengths (Å) 0.007 0.008 0.007 
    Bond angles () 1.164 1.213 1.183 
Ramachandran Plot    
Preferred (%) 97.9 95.72 98.7 
Allowed (%) 1.9 4.28 1.3 
Disallowed (%) 0.2 0.0 0.0 
Average B-factors 
(Å2) 
   
    Sst2 cat  22.6 31.1 19.1 
Distal Ubiquitin 25.5 29.7 18.3 
Proximal Ubiquitin 20.2 29.9 14.1 
    Ion 29.9 31.8 23.4 
    Water 33.6 33.8 29.4 
    Ligand   37.3 
 
Values in parentheses are for the highest resolution shell.   
a Rsym = ∑∑|Ihkl − Ihkl(j)|/∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the final 
average intensity. 
b Rcrys = ∑||Fobs| − |Fcalc||/∑|Fobs| and Rfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys 
are calculated using a randomly selected test set of 5% of the data and all reflections 









Figure 3.2: Crystal packing of Sst2cat construct bound to ubiquitin (Sst2cat-Ub). A) 
Dimeric formation of Sst2cat bound to Ub in crystals. Monomers are colored in limon and 
orange for Sst2cat and Ub, respectively from chain A and B, and in teal and orange for 
Sst2cat and Ub, respectively from chain C and D. The inset shows the zinc mediated 
packing at the interface. B) Expanded view of the zinc coordination at the interface. The 
coordinating residues are represented as sticks, with carbon in limon or teal, oxygen in 
red and, nitrogen in blue. Zinc is shown as a grey sphere and chloride as a green sphere. 



























Figure 3.3:  Crystal structure of  the catalytic domain of Sst2 bound to ubiquitin. A) 
Superposition of Sst2 (blue) bound to ubiquitin and  AMSH-LP (grey) bound to 
diubiquitin.  Proximal ubiquitin bound to AMSH-LP is shown as dark green.  Distal 
ubiquitin bound to both Sst2 and AMSH-LP is shown in orange. B) Ribbon 
representation of Sst2 (blue) bound to ubiquitin (orange). This mono-ubiquitin represents 



















Figure 3.4: Ubiquitin interactions with Sst2. A) Surface representation of the catalytic 
domain of Sst2 (blue) bound to ribbon representation of ubiquitin (orange). The red 
patches indicate residues involved in interactions with hydrophobic patches of ubiquitin. 
B) Residues of Sst2 involved in distal ubiquitin recognition. H-bond is shown in red 
dashes. C) Van der Waals interactions of Leu73 from ubiquitin with residues of Sst2 
































































































































































































































































































































































































































































































































































































































Figure 3.7: Purification of Sst2Δ220, UIM-SH3 domain of Hse1 and K63-Ub2: A) 
Superdex 75 size exclusion chromatography chromatogram showing a single peak for 3-
protein complex containing Sst2Δ220, UIM-SH3 domain of Hse1 and K63-Ub2. B) SDS-
PAGE gel of the samples obtained from the S-75 column to analyze the protein purity. 1, 






















Figure 3.8:  Crystal structure of Sst2 in complex with K63-Ub2. (A) Superposition of Sst2 
(blue) and AMSH-LP (grey) bound to diubiquitin.  Proximal ubiquitin is shown in dark 
green while distal ubiquitin is orange.  AMSH/Sst2 specific insertions 1 and 2 are shown 
in yellow and green, respectively.  B) Expanded view of catalytic site of Sst2 in its 
inactive form when bound to K63-linked diubiquitin. C)  Expanded view of catalytic site 











































































































































































































































































































































Figure 3.10:  Changes in the loop near the active site. A) Superposition of different Sst2 
structures showing conformational changes of a loop containing residues Leu402 and 
Phe403.  The free form of Sst2 is shown in limon, diubiquitin bound in purple, and two 
product bound forms are in blue-grey (wild type Sst2) and blue (E286A).  B-E) Surface 
representations of Sst2 comparing the opening of the loop in all structures. The loop area 




Table 3.3:  Comparison of van der Waals interactions between Phe403/Leu402 and 
Thr316, the residues near the active site flap which may result in open and close 
conformations of the flap 
 
Sample Sst2cat Sst2cat-Ub E286A-Ub Sst2Δ220-K63-
Ub2 
Phe403 Cζ - Cγ2 Thr316 6.0 Å 4.0 Å 5.9 Å 3.9 Å 
Phe403 Cζ - Cβ Asp315 3.7 Å 4.9 Å 6.1 Å 4.7 Å 
Leu402 Cδ2 - Cγ2 Thr316 4.4 Å 4.4 Å 6.2 Å 4.1 Å 
Phe403 Cζ – C Ub-Gly76 --- 4.3 Å 4.0 Å 4.2 Å 
Phe403 Cζ/Cε2 - Cδ Ub-
Lys63(proximal) 


















































































































































































































































Table 3.4: Thermodynamic parameters deduced from ITC Data 
 
Protein Titrant KD (μM) ΔH (kcal/mol) ΔS (cal 
mol−1 K−1) 
Sst2 Ub 10.2 ± 0.6 11.9 +/- 0.4 62.937 
Sst2E286A Ub 2.98 ±  0.56 8.0 +/- 0.7   52.207 








KD (μM) KM (μM) 
Sst2  Ub 10.2 ± 0.6 --- 
Sst2(D354A)* DiUb 1.1 ±  0.1 18.8  
AMSH# Ub 19 ± 3 --- 
AMSH# DiUb 19 ± 4 32 ± 5 
 
*KM value from Shrestha et al. Biochemistry (2014) 





























Figure 3.12:  Structural comparison of AMSH, AMSH-LP and Sst2 bound to diubiquitin. 
A) Superposition of catalytic domains of AMSH (light pink), AMSH-LP E292AK63-Ub2 
(grey) and Sst2Δ220-K63-Ub2 (blue). Proximal ubiquitin is shown in dark green and distal 
ubiquitin is shown in orange. B) Superposition of residues of AMSH (light pink), 












Figure 3.13:  Mechanism of deubiquitination by JAMM metalloprotease. A) Proposed 
mechanism of bond cleavage by thermolysin metalloprotease family members. UbP 
(green) denotes proximal ubiquitin while UbD (orange) indicates distal ubiquitin.  B) 






CHAPTER FOUR: STRUCTURAL ANALYSES OF SST2 ACTIVE-SITE FLAP 
MUTANTS IN ITS FREE FORM AND UBIQUITIN BOUND FORM 
4.1 Introduction 
The endosome-associated deubiquitinase (DUB) AMSH is a member of the 
JAMM family of zinc-dependent metallo-isopeptidases. It has high selectivity for Lys63-
linked polyubiquitin chains which play a key role in degradation of cell-surface receptors 
in the lysosomes via the ESCRT machinery.1-3 The structures of AMSH-LP bound to 
Lys63-linked diubiquitin and Sst2 bound to ubiquitin and Lys63-linked diubiquitin show 
features of the active-site that contributes to substrate recognition and catalysis.4,5  One 
such structural feature is a loop segment located at the top of the active site in a structural 
portion called insertion-2. Insertion-2 is a conserved feature between AMSH and its 
related enzymes, AMSH-LP and Sst2.6 The loop segment near the active site, referred 
here as the active-site flap, appears to open and close during the catalytic cycle (Figure 
4.1A-C). This active-site flap comprises of three key residues, Gly401, Leu402 and 
Phe403 in Sst2, while AMSH and AMSH-LP consists of two residues segment: Gly394-
Phe395 in AMSH and Gly406-Phe407 in AMSH-LP (Figure 4.1D).  
The structure of unbound form of Sst2 reveals the flap is in a closed state in which 
Phe403 residue makes van der Waals interaction (3.9Å) with the side chain of Asp 315 
on the opposite side of the flap (Figure 4.2A). This feature is conserved in AMSH and 
AMSH-LP.4,5,7 In Lys63-linked diubiquitin bound form of Sst2, Phe403 alone makes 
three van der Waals interactions with the isopeptide segment of diubiquitin (Figure 4.2B). 
Apart from Phe403 interactions, the proximal ubiquitin is also held by the interaction 
between Thr347, Phe349 and Ser352 from Sst2 and Gln62, Lys63 and Gly64 from 
proximal ubiquitin, respectively.5 A diubiquitin motif comprises of a distal ubiquitin 
which provides the Gly76 carboxylate group that is covalently attached to the -amino 
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group of a Lys residue from another ubiquitin, called the proximal ubiquitin. On the basis 
of the sequence alignment and structural analysis, it seems that a conserved Phe residue 
in the flap may be critical for the proper alignment of isopeptide segment for catalysis. 
Additionally, the interactions between the side chains of Phe residue and Asp residues 
across the active-site cleft, as observed in different structures of Sst2, both bound and 
unbound forms, suggests that Phe residue may contribute to the dynamics of the flap.  
This chapter presents the structural analyses of active site flap mutants 
(Phe403Ala and Phe403Trp) both in its free forms and ubiquitin-bound forms. The 
structures reveal no appreciable change that might impair substrate or alter product 
binding due to the mutations. However, the weak electron density enveloping the flap 
residues and higher B-factors of the flap in the crystal structure of the mutant 
(Phe403Trp) compared to internal residues indicates the flexibility of the flap residue 
even in the presence of its product (ubiquitin). Interestingly, Phe403Trp mutant shows 
greater flexibility despite the presence of a bulkier aromatic side chain. 
 
4.2 Materials and Methods 
 
4.2.1 Cloning, Protein Expression and Purification 
The catalytic domain of Sst2 (residues 245-435), here referred as Sst2cat, and 
human ubiquitin (Ub) were subcloned into pGEX-6P1 vector as described in the previous 
chapter. Phe403Ala and Phe403Trp point mutations were introduced individually into 
Sst2cat via site-directed mutagenesis following the standard protocol. Each mutant was 
sequenced to confirm the presence of mutations. The resulting GST-fusion proteins were 
expressed in Escherichia coli strain Rosetta cells and purified as described earlier using 
standard GST affinity chromatography followed by size exclusion chromatography on a 






4.2.2 Crystallization, Data Collection and Structure Determination of Sst2F403A  and 
Sst2F403W Mutants in its Free Form 
 
 Initial hits of crystals were obtained by screening using sitting-drop vapor 
diffusion method. Crystals of Sst2 Phe403Ala, here referred  as Sst2F403A, were grown 
from sitting drops containing 0.8:1 ratio volume of protein (37mg/ml) and mother liquor 
containing 0.2 M sodium citrate tribasic dehydrate (pH 8.3), 20% (w/v) polyethylene 
glycol (PEG) 3350. These crystals grew in 3-5 days. Likewise, Amy Bueno, one of the 
former lab members, obtained crystals of Phe403Trp, referred here as Sst2F403W. Crystals 
of Sst2F403W grew from sitting drops containing an equal volume of protein (6.7 mg/ml) 
and mother liquor containing 0.2 M ammonium tartrate dibasic (pH 7.0) and 20% (w/v) 
PEG 3350 which attained maximum size in 5-7 days. The crystals were soaked in 
cryoprotectant containing 25% (v/v) ethylene glycol in the mother liquor and flash frozen 
with liquid nitrogen. The data collections were done at Advanced Photon Source (APS) 
and 23 ID-B beamline, Argonne National Laboratory in Argonne, IL. The data was 
collected using a Mar300 CCD detector at 100K and processed with HKL2000 program.8 
 The crystals of Sst2F403A and Sst2F403W mutants diffracted to 2.1Å and 1.6Å, 
respectively and the structures were solved by molecular replacement using Sst2cat (PDB: 
4JXE) structure as the search model.9  The complete model of the interpretable density 
was built manually in Coot10 and initial refinements for each structure were carried out in 
Refmac511 using rigid body refinement followed by restrained refinement. Iterative 
rounds of model building and refinement for Sst2F403A were performed with Coot10 and 
Refmac511, whereas for Sst2F403W, model building and refinement were performed with 
Coot and PHENIX.12 The data collection and refinement statistics for both structures are 
shown in Table 4.1. All the figures were made using PYMOL (version 1.7.0.0).13 
 
  4.2.3 Crystallization, Data Collection and Determination of Sst2F403A-Ub and  
Sst2F403W-Ub Structures 
 Non-covalent complexes of each Sst2 mutant and ubiquitin were prepared by 
mixing each mutant (Sst2F403A and Sst2F403W) with ubiquitin (Ub) (40mg/ml) that 
contained GPLGS at its N-terminal as a remnant of GST-affinity purification at a ratio of 
1.5:1. Crystals of Sst2F403A-Ub grew in sitting drops from condition with 0.2 M sodium 
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citrate tribasic dihydrate, 0.1 M HEPES sodium (pH 7.5), 20% (v/v) 2-propanol in a 
week. Crystals of the complex of Sst2F403W-Ub were grown in 2-5 days from sitting drops 
with an equal volume of protein and mother liquor containing 0.04 M citric acid, 0.06 M 
Bis-TRIS propane (pH 6.4), 20% (w/v) PEG 3350.  To confirm the complex formation of 
both constructs, silver staining of an SDS-PAGE gel was run with dissolved crystals. 
Crystals were soaked in a cryoprotectant solution of 25% (v/v) ethylene glycol in the 
mother liquor and flash frozen with liquid nitrogen. The Sst2F403A-Ub and Sst2F403W-Ub 
crystals diffracted to 1.7Å and 2.3Å, respectively at 23 ID-B beamline, APS, IL. The data 
was processed using HKL2000 program8 and the structures of both the complexes was 
solved by molecular replacement using Sst2cat-Ub (PDB ID: 4K1R) as s search model.9 
The model building and refinement were carried out in the same format as the free form 
of Sst2F403A-Ub and Sst2F403W-Ub mutants using Coot10 and Refmac511 or PHENIX12 
respectively. TLS treatment of atomic displacement parameters was also performed, 
taking chain A of the asymmetric unit as one group.14 Amy Bueno also determined the 
structures of Sst2F403W-Ub. The final data collection and refinement statistics for both 
complexes are shown in Table 4.2.  
 
4.2.4 Generation of Models of Sst2 Flap Mutants Bound to Lys63-linked Diubiquitin 
Models of Sst2 active-site flap mutants in complex with Lys63-linked diubiquitin 
were generated.  The model of Sst2F403W bound to Lys63-linked diubiquitin (Sst2F403W-
K63-Ub2) was built by superimposing the ubiquitin bound form of Sst2F403W onto Sst2 
bound to Lys63-linked diubiquitin (PDB ID:4NQL).5 Likewise, model for Sst2F403A-K63-




4.3.1 Design of the Mutants 
 Different structures of catalytic domains of AMSH orthologue Sst2 in its free 
form and ubiquitin or diubiquitin bound forms revealed fluctuations in the active-site 
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flap5. In Lys63-linked diubiquitin bound form, the flap adopts a close conformation in 
which Phe403 residue made van der Waals interactions with the aliphatic portion of the 
side chain of Lys63 from the proximal ubiquitin and Gly76 from the distal ubiquitin. 
Similar interactions were also seen in the structure of AMSH-LP bound to diubiquitin 
(PDB ID: 2ZNV).4 In addition to the interactions with the scissile isopeptide bond, Phe 
403 was stabilized by a 3.9Å van der Waals contact with Thr316 and 4.1Å anion‐π 
interaction between the ring of Phe403 and the carboxylate group of Asp315 (Figure 
4.2C). In the free form of Sst2, AMSH, and AMSH-LP, the flap was still in the closed 
conformation; however the interactions were slightly different. The structure of Sst2 
showed that the interaction between Phe403 residue and Thr316 was lost and the 
aromatic group of Phe403 forms a 3.9Å anion‐π interaction with the carboxylate group of 
Asp315 (Figure 4.2A).  
For the substrate to fit in the catalytic groove near the active site, this active-site 
flap must be open. The flap must oscillate between open and closed conformations so that 
the enzyme can bind to the substrate in the open form and interacts with the isopeptide 
bond in the closed form. The crystallographic B-factors of residues in the flap are 
consistent with it being poorly ordered, and therefore flexible. Moreover, the mutation of 
the Phe residue to alanine in AMSH (Phe397Ala) and AMSH-LP (Phe407Ala) caused a 
significant loss in kcat with minor changes in KM, suggesting that van der Waals 
interactions between Phe403 and Lys63 side-chain of the proximal ubiquitin are 
important for the rate-limiting step rather than ground-state substrate binding.4,15 
Likewise, the similar affinity of AMSH for ubiquitin (bound to the distal site) and 
diubiquitin implies that the proximal ubiquitin contributes minimally to substrate 
affinity.15 
The mutation of Phe residue to Ala in AMSH-LP might have changed the 
dynamic nature of the flap to some extent leading to the loss of activity. Therefore, the 
Phe residue may be responsible for modulating the flap dynamics necessary for the 
catalysis. To understand the catalytic contribution of Phe403 in polyubiquitin processing 
and the role of the active-site flap, Phe403 of Sst2 was mutated to Ala and Trp. 
Phe403Ala mutant was expected to be in the open conformation as it loses the 
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interactions with the isopeptide bond of diubiquitin. The Phe403Trp mutant was expected 
to be in the closed conformation due to its bulkier aromatic side chain, thus providing a 
larger area for contact with the residues opposite the active-site cleft such as the γ-CH3 
group of Thr316. Although the Ala mutation was studied in both AMSH and AMSH-LP, 
these previous studies lacked structural characterization of this mutant.    
 
4.3.2 Structures of Catalytic Domain of Sst2F403A and Sst2F403A-Ub 
The crystals of Sst2F403A and Sst2F403A-Ub diffracted to 2.1Å and 1.7Å, 
respectively and both crystallized in the P21 space group. The structures were solved by 
molecular replacement using the previously solved wild-type structure of Sst2 catalytic 
domain (PDB ID: 4JXE) as the search model for Sst2F403A, and the previously solved 
structure of Sst2 bound to ubiquitin (PDB ID: 4K1R) as the search model for Sst2F403A-
Ub.9 The final structure of Sst2F403A yielded Rcrys and Rfree values of 20.04% and 24.18% 
respectively and Sst2F403A-Ub  yielded Rcrys and Rfree values of 20.07% and 23.81%, 
respectively.  
The overall fold of Sst2F403A mutant is identical to that of the wild-type Sst2 
(Figure 4.3A). The structure shows that the active-site flap of the mutant maintained the 
closed form, as seen in the wild-type enzyme. However, some changes occur between the 
structures. The absence of the aromatic side chain in the Sst2F403A mutant results in a 
narrow opening in the cavity of the active-site (Figure 4.4A). All the interactions 
associated with the side chain of Phe403 with its neighboring residues are lost in Ala 
mutant. As a result, the orientation of side chain of Asp315 in Sst2F403A mutant is slightly 
different as seen in wild-type enzyme, thus creating a different structural environment 
around the active-site metal (Figure 4.3B).   
Interestingly, the binding of ubiquitin to Sst2F403A led to more open form with a 
wider cavity instead of a narrow tunnel as seen in the wild-type Sst2-Ub structure (Figure 
4.4B and 4.5A). However, Sst2F403A-Ub shows that the ubiquitin binding interfaces 
utilizes the same three binding regions as seen in the Sst2-Ub: i) C-terminal tail of 
ubiquitin, ii) Ile44 path and the iii) the hydrophobic patch opposite to Ile44. All the 
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interactions with the ubiquitin were nearly identical as observed in wild-type Sst2-Ub 
(Figure 4.5A and C).  
One of the noteworthy observations is that the side chain of the Ala403 residue in 
the free form (both subunit A and B) show weak electron density in comparison to 
internal residues which have stronger electron density covering the side chain (Figure 6A 
and B). Additionally, the crystallographic B factor for Ala403 is higher than other 
internal residues (Table 4.3). Overall, this structural analysis of Sst2F403A and Sst2F403A-
Ub reveals no serious effect on the overall structure and the active-site area of the 
enzyme that could result from the mutation to alanine. 
 
4.3.3 Structures of Catalytic Domain of Sst2F403W and Sst2F403W-Ub 
The crystals of Sst2F403W and Sst2F403W-Ub diffracted to 1.6Å and 2.3Å, 
respectively and crystallized to P21 and P212121 space group, respectively. The structures 
were solved by molecular replacement using Sst2 catalytic doamin (PDB IDL 4JXE) as 
the search model for Sst2F403W and Sst2-Ub (PDB ID: 4K1R) as the search model for 
Sst2F403W-Ub, just like Sst2F403A mutants.9 The final structure of Sst2F403W yielded Rcrys 
and Rfree values of 17.0% and 19.9% respectively and Sst2F403A-Ub  yielded Rcrys and Rfree 
values of 19.2% and 23.5%, respectively (Table 4.1 and 4.2).  
Both Sst2F403W and Sst2F403W-Ub crystallized with two subunits in the asymmetric 
unit. The subunits of Sst2F403W can be superimposed with each other with C-alpha root-
mean-square deviations (RMSDs) of 0.198 and that of Sst2F403W-Ub with RMSDs of 
0.304 Å, indicating structural conservation between the two subunits. However, these 
subunits show a slight change around the flap region. Subunit A of Sst2F403W adopts a 
closed form of the flap with a completely occluded cavity resembling that of wild-type 
Sst2, whereas subunit B shows that the flap is closed, but has a narrow opening in the 
cavity of the active-site (Figure 4.4C and E). Sst2F403W-Ub structure reveals that the 
active site flap in subunits A and B formed a narrow channel around the C-terminal tail of 
ubiquitin which would be used to enable binding of the isopeptide linkage of diubiquitin. 
Surprisingly, the size of the tunnel in subunit B appears to be wider than subunit A 
(Figure 4.4D and 4.4F). Such changes near the active-site flap indicate the dynamic 
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nature of the flap in the Trp mutant. Additionally, the Trp403 in subunit B of both 
Sst2F403W and Sst2F403W-Ub shows a lack of strong electron density (Figure 4.4C and 
4.4D).  
Another difference between the two subunits of Sst2F403W and Sst2F403W-Ub is 
seen in the crystallographic contacts of the two subunits. In Sst2F403W, the Trp side chain 
of subunit A appears to be interacting with Thr345 of subunit B from its symmetry mates, 
whereas the Trp side chain of subunit B does not form any such interactions (Figure 4.7A 
and B). Likewise, the structure of Sst2F403W-Ub shows that the Trp side chain of subunit 
A is held in place by an additional interaction with the Lys48 side chain of the other 
ubiquitin-bound complex of the asymmetric unit (Figure 4.7C and D). Despite such 
crystallographic contacts, the crystallographic B factor for Trp403 in both free and 
ubiquitin bound form is elevated as compared to internal residues (Table 4.3).  Like 
Sst2F403A mutant, the ubiquitin binding interfaces were identical as in the wild-type 
enzyme (Figure 4.5B and C).  
 
4.3.4 Model of Sst2 Flap Mutants Bound to K63-linked Diubiquitin 
Due to the bulkier side chain of the tryptophan, the closed conformation of the 
flap was expected, which might inhibit or impair the catalysis of its substrate. 
Surprisingly, the model of Sst2F403W bound to diubiquitin shows no steric clashes 
between the side-chain of Trp and its neighboring residues or any part of the proximal 
ubiquitin. Superposition of the model onto the wild-type enzyme shows that the side-
chain of Trp403 maintained all the interactions with isopeptide linkage including the 
anion- π interaction with Asp315 as seen in the wild-type (Figure 4.8) suggesting the 
flexibility of the side chain of Trp403. On the other hand, Sst2F403A-K63-Ub2 model 
showed the open conformation of the flap as expected with Ala403 residues missing the 







Many enzymes bear flexible loops near the active-site that aid in catalysis.16-19 
These loops are highly disordered in absence of the substrate; however, upon substrate 
binding adopt specific conformations. Interestingly, AMSH and its related enzymes bear 
an active-site flap that oscillates between open and closed conformations independent of 
substrate binding. The structures of catalytic domains of AMSH-LP and Sst2 bound to 
diubiquitin showed that Phe403 (Phe407 in AMSH-LP) make three van der Waals 
interactions with Lys63. Additionally, the kinetic analysis of Phe407Ala mutant in 
AMSH-LP and Phe397Ala in AMSH indicated the Phe residue is important for the rate-
limiting step.4,15 In order to understand the structural changes arising from the mutation 
that could account for the loss of activity in the mutant, Phe403 in Sst2 was mutated to 
alanine and tryptophan. 
The overall fold of Sst2F403A and Sst2F403W were identical to that of wild-type 
Sst2. Both Sst2F403A-Ub and Sst2F403W-Ub also showed similar ubiquitin interactions as 
wild-type Sst2-Ub, suggesting that the mutations have no serious structural effect in 
substrate or product binding. However, the interesting finding was localized at the site of 
mutation. Both Ala403 and Trp403 appeared to be somewhat disordered as judged by the 
weak density and by the crystallographic B-factors. These observations indicated the 
higher disorder of the flap which is consistent with the dynamic nature of the flap.   
The structural study of the Ala mutant confirms that it losses three van der Waals 
interactions as shown by the model and also the anion‐π interaction with Asp315, a 
stabilizing interaction between the partially electropositive edge of the aromatic ring with 
the negatively charged Asp (or Glu) residue. A recent analysis of the PDB reveals a 
widespread presence of such contacts, indicating a role of anion-π interactions in protein 
stabilization and protein-protein interactions.20 Loss of such interaction in Ala mutant 
might make the flap more flexible and thus, impose a higher entropic penalty leading to a 
loss of activity as seen in AMSH and AMSH-LP. It would be interesting to study the 
activity of the Trp403 mutant. Although Trp has a bulkier side chain, the model shows 
that it could interact with diubiquitin substrate in the same way as the wild-type Sst2.  
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This chapter presents the structures of flap mutants which reveal no gross 
structural changes between the free and ubiquitin bound forms. However, the flap tends 
to be more flexible due to mutation. Moreover, structures show that the product binding 
is not altered by flap mutants; therefore, the flap may have an important role during 
catalysis. Even the bulkier side chain of Trp mutant is not predicted to prevent diubiquitin 
binding as shown by the model. Further studies are needed to validate the model and also 
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Figure 4.1: Flap residues in Sst2. A) Ribbon diagram representing secondary structures of 
catalytic domain of Sst2 (blue). Insertion 1 and insertion 2 are colored in yellow and 
green, respectively. The flap residue Phe403 is shown in red stick. B) Surface 
representation of active-site area of wild-type Sst2 in its free form (PDB ID: 4JXE) and 
C) ubiquitin bound form (PDB ID: 4K1R). Residues that constitute either side of the flap 
are Asp315, Thr316. Leu402 and Phe403 are shown in red. D) Sequence alignment of 











Figure 4.2: Interactions of flap residue Phe403 in Sst2 free form and ubiquitin bound 
form. A) In Sst2 free form, F403 forms 3.9 Å anion-π interactions (shown in blue dashes) 
between Cζ of F403 and the carboxylate of D315 and no interaction with T316 (shown in 
magenta). B) The scissile isopeptide is stabilized by the aromatic group of F403 through 
interactions with both K63 of the proximal ubiquitin (forest green) and G76 of the distal 
ubiquitin (orange). C) Upon binding of Lys63-linked diubiquitin (PDB entry 4NQL), 
F403 is stabilized by a 3.9 Å van der Waals contact between F403 and T316 and 4.1 Å 
anion-π interaction between the ring of F403 and the carboxylate of D315. Hydrophobic 














Table 4.1: Crystallographic refinement statistics for catalytic domain of Sst2 flap mutants 
 
 Sst2 F403A Sst2 F403W 
Data collection   
Space group P21 P21 
Cell dimensions   
    a, b, c (Å) 57.7, 74.9, 64.6 58.6, 73.7, 64.6 
α, β, γ (°)  90.0, 112.9, 90.0 90.0, 113.2, 90.0 
Wavelength (Å)    1.033 1.033 
Resolution (Å) 50.0-2.1 (2.14-
2.10) 50.0-1.6 (1.66-1.63) 
 Rmergeb (%) 10.5 (73.3) 9.5 (56.2) 
I / σI  11.6 (2.0)  18.1 (2.5) 
Completeness (%) 99.9 (99.9) 97.3 (96.2) 
Redundancy 3.8 (3.8) 3.9 (7.7) 
   
Refinement   
Resolution (Å) 2.1 1.6 
No. unique reflections 28834 60880 
Rworkc / Rfreed 20.0/24.2 17.0/19.9 
No. atoms   
    Protein 2926 2946 
    Ion 4 4 
    Water 93 151 
R.m.s. deviations   
    Bond lengths (Å) 0.018 0.007 
    Bond angles (Å) 1.935 1.111 
Ramachandran Plot   
Preferred (%) 97.1 98.3 
Allowed (%) 2.9 1.7 
Disallowed (%) 0.0 0 
Average B-factors (Å2)   
   Sst2  32.5 24.4 
    Ion 28.0 20.0 
    Water 31.0 30.0 
    Ligand 42.6 43.5 
 
a Values in parentheses are for the highest resolution shell.   
b Rmerge = ∑∑|Ihkl − Ihkl(j)|/∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the final 
average intensity. 
c Rcrys = ∑||Fobs| − |Fcalc||/∑|Fobs| and dRfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys 
are calculated using a randomly selected test set of 5% of the data and all reflections 




Table 4.2: Crystallographic refinement statistics for catalytic domain of Sst2 flap mutants 
bound to ubiquitin 
 
 F403A-Ub F403W-Ub 
Data collection   
Space group P21 P212121 
Cell dimensions   
    a, b, c (Å) 42.1, 58.2, 56.4 56.8, 89.4, 117.8 
α, β, γ (°)  90.0, 109.3, 90.0 90.0, 90.0, 90.0 
Wavelength (Å)    1.033 1.033 
Resolution (Å) 50.0-1.7 (1.75-1.72) 50.0 -2.3 (2.34-2.30)
 Rmergeb (%) 4.7 (56.1) 13.1 (84.8) 
I / σI  23.6 (2.3)  18.7 (2.3) 
Completeness (%) 99.9 (99.9) 100.0 (100.0) 
Redundancy 3.8 (3.6) 14.6 (13.8) 
   
Refinement   
Resolution (Å) 1.7 2.3 
No. unique reflections 26060 25792 
Rworkc / Rfreed 20.1/23.7 19.2/23.5 
No. atoms   
    Protein 2027 4059 
    Ion 2 4 
    Water 43 79 
R.m.s. deviations   
    Bond lengths (Å) 0.018 0.015 
    Bond angles (Å) 1.896 1.728 
Ramachandran Plot   
Preferred (%) 96.46 95.9 
Allowed (%) 3.2 3.7 
Disallowed (%) 0.39 0.39 
Average B-factors (Å2)   
   Sst2  18.9 42.8 
Ubiquitin 39.9 47.1 
    Ion 34.2 40.8 
    Water 38.0 41.1 
    Ligand 33.4 51.6 
 
a Values in parentheses are for the highest resolution shell.   
b Rmerge = ∑∑|Ihkl − Ihkl(j)|/∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the final 
average intensity. 
c Rcrys = ∑||Fobs| − |Fcalc||/∑|Fobs| and dRfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys 
are calculated using a randomly selected test set of 5% of the data and all reflections 




Figure 4.3: Structural comparison of Sst2 and its flap mutants. A) Superposition of 
catalytic domain of Sst2 (blue), Sst2F403A (limon), and Sst2F403W (skyblue). Insertion-1 
and insertion-2 are colored in yellow and green, respectively. The inset depicts 
superposition of the catalytic site along with flap residues. B) Expanded view of the 
superposition of Sst2 (blue), Sst2F403A (limon) and Sst2F403W (skyblue) highlighting the 
residues of active-site along with the residues of the active-site cleft. Active-site residues 
are colored in blue. Active-site zinc is shown in gray whereas the key flap residues F403 









Figure 4.4:  Changes in the active-site flap forming a closed cavity or a narrow tunnel in 
the cavity indicating the flexibility of the flap in Sst2 mutants. A), C), E) Surface 
representations of active-site area of Sst2F403A and Sst2F403W in their free form. Residues 
that constitute either side of the flap (D315, T316, L402 and F403) are marked red. B), 
D), F) Surface representations of flap mutants bound to ubiquitin comparing the opening 
of the flap (red) in all structures. Sst2F403A in shown limon, Sst2F403W subunit A in green 









Figure 4.5: Interaction of ubiquitin with Sst2 mutants. A) Surface representation of the 
catalytic domain of Sst2F403A (limon) bound to ubiquitin (orange). Residues of the flap 
region are highlighted in red. B) Surface representation of the catalytic domain of mutant 
Sst2F403W (skyblue) bound to ubiquitin (orange) highlighting the residues (red) in the flap 
region. C) Superposition of the wild-type Sst2 (blue), Sst2F403A (limon) and Sst2F403W 
(skyblue) mutants showing residues involved in distal ubiquitin recognition. Hydrogen 






Figure 4.6: Electron density map of catalytic domain of Sst2F403A and Sst2F403W mutants. 
A, B) Residues of active-site flap with an electron density enveloping the side chain of 
Ala403 in subunit A and subunit B (shown in limon) of free form of Sst2F403A mutant. C, 
D) Residues of active site flap showing a weak electron density enveloping the side chain 
of Trp403 in subunit A (shown in green) and subunit B (shown in skyblue) of free form 








Table 4.3: Comparison of B-factors (Å2) between internal residues and flap residues 
 
Enzyme Internal Residues Flap Residues 
 Phe301 Leu305 Leu402 Phe/Ala/Trp403 
Sst2Free form 20.2 15.7 52.5 49.1 
Sst2F403A 29.5 25.0 66.9 50.8 
Sst2F403W 20.4 16.5 33.9 38.4 
Sst2-K63-Ub2 18.2 14.9 22.7 21.1 
Sst2-Ub 16.6 13.5 28.3 24.6 
Sst2F403A-Ub 14.1 15.8 46.6 27.6 








Figure 4.7: Crystallographic contacts of subunits of Sst2F403W mutants. A) Dimeric 
structure of catalytic domain of Sst2F403W in its free form interacting with its symmetry 
mate. Monomers are colored green for subunit A and skyblue for subunit B. The inset 
shows the interaction between two asymmetric units.  B) Expanded view of the 
interaction between Trp403 with Asp315 of subunit A of one asymmetric unit and 
Thr345 of subunit B from another asymmetric unit. C) Dimeric structure of catalytic 
domain of Sst2F403W bound to Ub in crystals. Monomers are colored green and olive for 
Sst2F403W and Ub of chain A and B, respectively, and skyblue and orange for Sst2F403W 
and Ub of chain C and D, respectively. The inset portrays the packing of the crystal at the 
interface of the two subunits. D) Expanded view of the interaction between Trp403 
(subunit A) with Gly76 of subunit A and Lys48 of ubiquitin of subunit B at the interface. 
The electron density is rendered from a 2Fo-Fc map contoured at 1σ. The coordinating 





Figure 4.8: A model of Sst2F403W bound to Lys63-linked diubiquitin. A) Superposition of 
catalytic domain of Sst2F403W (skyblue) bound to ubiquitin and the catalytic domain of 
Sst2 (blue) bound to Lys63-linked diubiquitin (PDB ID: 4NQL). The proximal ubiquitin 
and distal ubiquitin are shown in forest green and orange respectively. B) Superposition 
of the active-site flap residues of Sst2F403W (skyblue) bound to ubiquitin and Sst2 (blue) 
bound to Lys63-linked diubiquitin. The electron density for Trp403 is rendered from the 
2Fo-Fc map contoured at 1σ (corresponding to the x-ray structure of Sst2F403W bound to 
ubiquitin) showing weak density enveloping the side chain of Trp403. C) Hydrophobic 
interaction of the aromatic group of Trp403 with Lys63 of the proximal ubiquitin (forest 
green) and Gly76 of the distal ubiquitin (orange), and anion- π interaction with opposite 






Figure 4.9: A model of Sst2F403A bound to Lys63-linked diubiquitin. A) Superposition of 
catalytic domain of Sst2F403A (limon) bound to ubiquitin and the catalytic domain of Sst2 
(blue) bound to Lys63-linked diubiquitin (PDB ID: 4NQL). The proximal ubiquitin and 
distal ubiquitin are shown in forest green and orange respectively. B) Superposition of the 
active-site flap residues of Sst2F403A (limon) bound to ubiquitin and Sst2 (blue) bound to 
Lys63-linked diubiquitin. The electron density for Trp403 is rendered from the 2Fo-Fc 
map contoured at 1σ (corresponding to the x-ray structure of Sst2F403A bound to 
ubiquitin) showing weak density enveloping the side chain of Ala403. C) Loss of 
interactions (shown in magenta dashes) between the 403 residue and isopeptide linkage 




 CHAPTER FIVE: BIOCHEMICAL AND BIOPHYSICAL ANALYSES OF SST2 
ACTIVE-SITE FLAP MUTANTS  
5.1 Introduction 
Crystal structures of Sst2 in free form, ubiquitin and diubiquitin bound forms 
reveal the dynamic nature of a loop located near the active-site.1 To understand the role 
of the active-site loop, here referred as flap, residue Phe403 in Sst2 was mutated to 
alanine and tryptophan. The structures of these mutants show the increased flexibility of 
the flap with no change in the overall fold. However, the biochemical and biophysical 
characterization of the flap mutants might provide insight into the flexibility of the flap in 
the mutants and its effect during catalysis. It is likely that the dynamics of the active-site 
flap may be a factor behind linkage specificity in addition to catalysis. 
This chapter presents analyses of kinetics, isothermal titration calorimetry (ITC), 
molecular dynamic simulation and circular dichroism (CD) spectroscopy for the active-
site flap mutants of Sst2 (Phe403Ala and Phe403Trp). Kinetic analysis shows that the 
Phe403 contributes key interactions during the rate-limiting step but not in substrate 
binding, and the mutations (Phe403Ala and Phe403Trp) also exhibit a defect in kcat and 
not in KM. Both CD and ITC analyses are consistent with the structural data shown in the 
previous chapter, indicating no difference in the structure and ubiquitin binding in 
comparison to the wild-type Sst2. Interestingly, molecular dynamic simulations indicate 
that the flap of Trp403 mutant is quite flexible as compared to wild-type enzyme, which 
might appear as a defect in interactions that facilitate the rate-limiting step. Overall, this 
chapter aims to provide further insight into the role of active-site flap in JAMM 





5.2 Materials and Methods 
 
5.2.1 Cloning, Protein Expression and Purification 
The catalytic domain of Sst2 (residues 245-435), here referred as Sst2cat and 
human ubiquitin (Ub) were subcloned into pGEX-6P1 vector as described in the previous 
chapter. Phe403Ala, Phe403Trp, Asp315Asn and Cys397Ala point mutations were 
introduced individually into Sst2cat via site-directed mutagenesis following the standard 
protocol. Each mutant was sequenced to confirm the presence of mutations. The resulting 
GST-fusion proteins were expressed in Escherichia coli Rosetta cells and purified as 
described earlier using standard GST affinity chromatography followed by size exclusion 
chromatography on a Superdex S75 column (GE Lifesciences).  
For ITC, Ub prepared from pRSETA plasmid was used to avoid issues caused by 
the addition of pentapeptide sequence (GPLGS) to the protein’s N-terminus from cloning 
artifact in GST fusion proteins. Ub from pRSETA plasmid was purified as described in 
the previous chapter and Shrestha et. al.1 Lys63-linked diubiquitin (K63-Ub2) was 
synthesized enzymatically using Ub AspD77 as the Ub acceptor and Ub Lys63Arg as the 
Ub donor.2 Human E1, two E2s (Uev1a, and Ubc13) and the two mouse ubiquitin 
mutants were purified separately, and mixed in a reaction buffer containing 80 mM Tris-
HCl, 20 mM ATP, 20 mM MgCl2, 1 mM DTT.  The synthesis reaction was carried out 
overnight at 37°C and was purified as described previously.  
  
5.2.2 Determination of Kinetic Parameters 
 Enzyme kinetics of Sst2F403A, Sst2F403W, Sst2C397A and Sst2D315N mutants in 
hydrolyzing Lys63-linked diubiquitin (K63-Ub2) were measured in reactions containing 
100 nM of the enzyme and  different concentrations (20, 49.5, 77, 99.5 µM) of K63-Ub2 
in a reaction mixture consisting of 50 mM Tris-HCl (pH 7.0), 20 mM KCl, 5 mM MgCl2, 
and 1 mM DTT at room temperature (25ºC). Reactions proceeded for 15 minutes and 
were quenched with 5x SDS-PAGE sample buffer. To convert the quantified intensity of 
the formed monoubiquitin to molar concentration, a standard curve of 6, 20 and 40µM 
ubiquitin was prepared. Samples including the standards were separated in 15% SDS-
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PAGE gel and the ubiquitin bands were quantified and integrated using ImageJ.3 A 
calibration curve of the previously mentioned standards were plotted to determine the 
amount of ubiquitin produced through the cleavage of K63-Ub2.The initial velocity 
values were then plotted against substrate concentration using Kaleidagraph and the data 
were fitted to the Michaelis-Menten equation: 
Vi ൌ Vmax	ሾSሿKM ൅ ሾSሿ ൌ
݇ܿܽݐ	ሾEሿሾSሿ
KM ൅ ሾSሿ  
Where Vi is the initial velocity, Vmax is the maximum velocity, [S] is the substrate 
concentration, KM is the Michaelis constant, and kcat is the turnover rate. 
 
5.2.3 Circular Dichroism 
 The circular dichroism (CD) spectra were recorded on a Jasco J-1500 
spectrophotometer at 20ºC. Protein samples were dissolved in 100 mM phosphate buffer 
(pH 7.4) to make a final concentration of 0.2 mg/ml. Native spectra were measured in the 
far-UV region (200-300 nm) in a cuvette with an optical path length of 0.1 cm. Each 
spectrum was composed of an average of four scans (speed scan of 100 nm/min) and 
corrected with a subtraction of a spectrum of the phosphate buffer alone. The mean 
residue molar ellipticity was calculated according to the following equation:  
[θ] = (θ x 100M)/(Cln)  
where θ is the ellipticity in degrees, l is the path length in centimeters, C is the 
concentration is mg/mL, M is molecular mass, and n is the total number of residues in the 
protein. Calculated mean residue molar ellipticity is given in degcm2dmol-1. The protein 
secondary structures from CD spectra were estimated using K2D24 and K2D35 analysis 
tool.  
 
5.2.4 Thermal Denaturation using CD Spectroscopy 
Thermal denaturation curves of the proteins were obtained by change in ellipticity 
at 222 nm as a function of increasing temperature (20ºC-86ºC) of 2ºC. The linear rate for 
temperature increase was 0.5ºC/min. data was recorded after every increase of 0.5ºC. The 
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proteins were dissolved in 100 mM phosphate buffer (pH 7.4) to make a final 
concentration of 0.2 mg/ml and a cuvette with path length of 0.1 cm was used. The 
thermal denaturation processes of all proteins examined were irreversible under this 
condition. The midpoint transition temperature (T1/2) at which 50% of the protein is 
denatured was determined from the stability curve.  
 
5.2.5 Isothermal Titration Calorimetry 
In order to quantify the binding affinity of the Sst2 mutants with ubiquitin, ITC 
experiments were carried out at 25oC using a GE/MicroCal ITC200 calorimeter. Protein 
samples were dialyzed overnight in a buffer of 50 mM Tris-HCl (pH 7.6) and 50 mM 
NaCl and the dialysis buffer was exchanged four times. A total of 22 injections with 1.4 
μL ubiquitin (500 μM) per injection were titrated into a 50 µM solution of protein. Each 
experiment has a spacing of 180 seconds between each injection to ensure that baseline 
was reached prior to the next injection. Baseline correction was performed by NITPIC 
and analyzed using a one-site model from SEDPHAT.6 
 
5.2.6 Deubiquitylation Assay 
A diubiquitin cleavage assay was performed in order to deduce whether the 
mutants were able to cleave Lys11-linked and Lys48-linked diubiquitin chains in addition 
to Lys63-linked diubiquitin.  Both wild-type and mutant DUBs were diluted in a reaction 
buffer (50 mM Tris-HCl (pH 7.0), 20 mM KCl, 5 mM MgCl2, and 1mM DTT). The DUB 
assay was carried out where 20μM of diubiquitin of different linkages (K63, K48 and 
K11) were incubated with 250 nM DUBs in the reaction volume of 15 µl. Reactions were 
incubated at room temperature for 5 hours and quenched with 5x SDS-PAGE sample 
buffer. Samples were loaded and run on 15% SDS-PAGE gel and ubiquitin bands were 
quantified and integrated using ImageJ.3 Ratios of monoubiquitin:diubiquitin were 





5.2.7 Molecular Dynamics Simulations 
Using the previously reported crystal structures of Sst2cat and recently determined 
structures of the Sst2F403A and Sst2F403W mutants as the starting configuration, Dr. Julian 
E. Fuchs  (Institute of General, Inorganic, and Theoretical Chemistry, University of 
Innsbruck, Innrain 82, 6020, Innsbruck, Austria) performed molecular dynamics 
simulations to investigate molecular motions in three apo Sst2 systems: native enzyme, 
Sst2F403A, and Sst2F403W mutant using Amber14 package and following the methods 
described in Bueno et. al, 2015.7 From the 1 microsecond, 50,000 snapshots per system 
(Sst2cat, Sst2F403A, Sst2F403W, AMSH and AMSH-LP) were analyzed. Global dynamics of 
the Cα of the conserved Phe residue (F403 in Sst2, F395 in AMSH, and F407 in AMSH-
LP) and local dynamics of the backbone atoms of this residue were characterized by 
alignment strategy.8 Additionally, dihedral entropies for all backbone torsions involving 
the conserved residue were also estimated.9  Simulation analysis was performed using 
cpptraj from Ambertools10 as well as in-house scripts. 
 
5.2.8 Generation of Models of Sst2 and its Mutants Bound to Lys48 and Lys11-linked 
Diubiquitin 
Models of Sst2 and its active-site flap mutants in complex with Lys11- and 
Lys48-linked diubiquitin were generated.  Initially, the model of Sst2F403W bound to 
Lys63-linked diubiquitin (Sst2F403-K63-Ub2) was built by superimposing the ubiquitin 
bound form of Sst2F403W onto Sst2 bound to Lys63-linked diubiquitin (PDB ID:4NQL). 
Then, using the Sst2F403W-K63-Ub2 model, another model of Sst2F403W bound to Lys11-
diubiquitin (Sst2F403-K11-Ub2) was generated by superimposing the LRLRGG motif of 
the distal ubiquitin of K11-Ub2  (PDB ID: 2XEW)11 onto K63-Ub2 so that the isopeptide 
segment of the K11-Ub2 was closer to the active site. Likewise, a model for Sst2F403W-
K48-Ub2 was built in a similar manner using PBD ID: 3NS812 for Lys48-linked 
diubiquitin. Models for Sst2F403A-K11-Ub2 and Sst2F403A-K48-Ub2 were also generated 







5.3.1 Kinetic Characterization of the Flap Mutants 
The previous chapter discusses the crystal structures of flap mutants Phe403Ala 
and Phe403Trp in its free and ubiquitin bound forms, which revealed the flexibility of the 
flap mutants. In order to understand if the increased flexibility of the flap has any effect 
in the enzyme’s catalytic activity, kinetic analyses were carried out and the mutants’ 
kinetic parameters were determined. Mutation of Phe to Ala shows a substantial loss of 
catalytic activity with an eighteen-fold decrease in kcat (Figure 5.1 and 5.2) and minimal 
effect (approximately two-fold decrease) on KM (Table 5.1) as compared to wild-type 
Sst2. Alanine mutations of Phe residue in both AMSH and AMSH-LP has a similar kcat 
and KM effects, suggesting the conserved role of aromatic side chain of Phe from human 
to yeast.2,13 Mutation of Phe403 to Trp also revealed a major effect on kcat (thirty-fold 
decrease) and minimal effect in KM just as Sst2F403A mutant (Figure 5.1, 5.2 and Table 
5.1). Taken together, these kinetic results implicate a role for Phe403 mainly in the rate-
limiting step, since both of these mutations leads to a loss in kcat and not in ground state 
substrate binding as shown by a relatively minor change in KM. The residue Asp315 was 
also mutated to Asn which resulted in a defective enzyme due to the reduction in kcat by 
nearly seven-fold.  
To further understand the role of Phe403, Aditya Babar, a former lab member, 
mutated Cys397 to Ala. Cys397 is one of the residues that coordinate the structural zinc. 
Mutation of Cys307 to Ala exhibits a significant defect in the deubiquitination reaction, 
with a reduction mainly in kcat (Table 1), consistent with the observations from the 
similar mutant in AMSH-LP (Cys402 to Ser).2  
 
5.3.2 Ubiquitin Binding with Flap Mutants 
To confirm that the loss of activity of Sst2F403A and Sst2F403AW mutant is not due 
to change in product (ubiquitin) release, we carried out ITC experiments (Figure 5.3). 
According to kinetic analysis, substrate binding is not affected by the mutations 
(indicated by minimal changes in KM for both the mutants). ITC experiment shows that 
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ubiquitin binds Sst2F403A mutant with a KD of 6.2 ± 0.5 µM (Table 2) which is 
comparable to that of wild-type enzyme. However, for Sst2F403W mutant, KD for ubiquitin 
binding is 3.6 ± 0.3 µM, which is three-fold lower than that of wild-type Sst2. This 
difference may indicate some level of interference in product release. However, the main 
reason behind the loss of activity of these mutants is due to the kcat ( ̴eighteen-fold lower) 
effect, not by substrate or product binding impairment.  
 
5.3.3 Secondary Structure Analysis and Thermal Stability of Flap Mutants 
The CD spectra of the flap mutants were also analyzed, indicating no major 
perturbation in secondary structure, and consistent with m crystal structures of mutants 
(Figure 4). Interestingly, the CD spectrum for Sst2C397A mutant is slightly different 
compared to wild-type enzyme. Deconvolution of the CD spectra of all mutants produced 
a similar α-helical and β-sheet content as in the wild-type protein (Table 5.3). 
 Melting temperatures of both Sst2F403A and Sst2F403W mutants did not change in 
comparison to the wild-type enzyme, indicating that the overall stability of the enzyme is 
unaffected by these mutations (Figure 5.5 and Table 5.4). Interestingly, the loss of 
structural zinc in Sst2C397A mutant leads to a significant loss of thermal stability, 
indicating a more flexible flap as compared to wild-type despite the comparable CD 
spectrum (Figure 5.5 and Table 5.4). 
 
5.3.4 Increased Dynamics of Phe403Trp Active-Site Flap 
In the previous chapter, the crystallographic B factors and weak density around 
the flap residues in Sst2F403A and Sst2F403W mutants suggested the increased flexibility of 
the flap in the mutants as compared to wild-type Sst2. To probe the dynamics nature of 
the flap, molecular dynamics simulations of wild-type Sst2, AMSH, AMSH-LP, Sst2F403A 
and Sst2F403W were performed by Dr. Julian E. Fuchs. The simulation results confirm that 
the active-site flap in AMSH, AMSH-LP and Sst2 are quite mobile and that the 
conserved Phe residue is highly mobile both at the backbone (Figure 5.6) and side-chain 
level (Figure 5.7A-E). Comparison of dimensional relative side-chain flexibilities14 
between Phe403 (0.92), Trp403 (0.83) and Ala403 (0.88) indicates free rotation for the 
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latter residue. Free rotation of the side chain for Phe403 and Trp403 is observed at this 
position which is paralleled by the loss of interactions with the residues (Asp315) 
opposite the active-site flap (interactions between Trp403 and Asp315 are observed only 
in 1% of the snapshots). However, hydrogen bonding interactions between Trp403 and 
Thr316 is observed in 3% of the snapshots. The residue at 403 position shows a broad 
conformational space, including an open conformation closely resembling the ubiquitin-
bound state. Among the wild-type Sst2, Sst2F403A and Sst2F403W, the Trp mutant shows 
the highest flexibilities both on global and local scale (Figure 5.7F-H), suggesting the 
loss of activity may be due to the increased dynamics of active site flap.  
 
5.3.5 Reduced Selectivity of Phe403Trp Mutant 
In order to understand the effect of the increased flexibilities in Sst2F403W mutant, 
an assay to measure the cleavage of Lys48 and Lys11-linked diubiquitin was performed. 
Sst2, like AMSH and AMSH-LP shows high selectivity towards Lys63-linked 
polyubiquitin chains due to interactions with proximal ubiquitin, and the dynamics of the 
flap may contribute to selectivity. However, the increased flexibility of the flap may 
result in loss of enzyme’s selectivity. According to the diubiquitin cleavage assay, 
Sst2F403W cleaves both Lys48 and Lys11-linked diubiquitin better than the wild-type and 
Sst2F403A mutant (Figure 5.8 and 5.9). The data indicates the Trp mutant has a more 
dynamic flap and hence a reduced selectivity. On the other hand, the reduced activity by 
Sst2F403A mutant with all three substrates (Lys63, Lys48, Lys11-linked diubiquitin) 
suggests the importance of the aromatic ring of the Phe residue in binding the Lys side-
chain of the proximal ubiquitin in all three linkage types.  
 
5.3.6 Models of Sst2 and Active-Site Flap Mutants Bound to Lys48 and Lys11-linked 
Diubiquitin 
To get better understanding of the role of Sst2 active-site in selectivity, models of 
Sst2 and its mutant bound to Lys48 and Lys11-linked diubiquitin were generated.  The 
model shows that the Trp403 clashes with Lys11 residue of the proximal ubiquitin of 
K11-Ub2, indicating that the Sst2F403W mutant cannot cleave K11-linked diubiquitin 
(Figure 5.10). Likewise, a model for Sst2F403W-K48-Ub2 was built in a similar manner 
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using PBD ID: 3NS8 for Lys48-linked diubiquitin which also shows clashes between the 
flap and the isopeptide segment (Figure 5.11). Due to the lack of an aromatic side chain 
in case of Sst2F403A models, the analysis was not very informative. The wild-type Sst2 
models also reveal similar clashes as observed with Sst2F403W models (Figure 5.10 and 
5.11). Overall, these models do show that the active-site flap can indeed interfere with the 
way these alternatives substrates dock into the active-site; therefore, its flexibility may 
relieve the unfavorable steric contacts and accommodate the scissile peptide bond of 
these non-cognate substrates for catalysis. Since, these models depict a static snapshot of 
binding; they do not take into account the flexibility of the substrates themselves. 
 
5.4 Discussion 
Crystal structures of the DUB domains of both AMSH-LP and Sst2 bound to 
diubiquitin shows that the substrate (Lys63-linked diubiquitin) is bound to Sst2 mainly by 
three different interactions from the distal moiety of the diubiquitin as seen in the product 
(ubiquitin) binding.1 The structures of the active site flap mutants in the previous chapter 
showed that the mutation of residue Phe403 did not affect product binding; however, the 
flap was able to retain its mobility. This is consistent with our observation that the residue 
has a minimal effect on KM, implying that the flap residues contribute little to substrate 
binding in the ground state. Furthermore, even the mutation of Cys397, a residue in 
Insertion-2 that stabilizes the structural zinc and contributes to catalysis by oscillating 
between open and closed conformation, did not affect its substrate binding significantly. 
However, this mutation resulted in an increased flexibility as indicated by the significant 
loss of thermal stability and defective kcat relative to other mutants. It is possible that the 
insertion might have lost its native structure due to mutation making the Phe residue less 
accessible for binding to the isopeptide moiety of the substrate during catalysis. 
Alternatively, the extreme conformational flexibility may mean a higher entropic penalty 
in organizing the flap into a productive orientation during the rate-determining step of the 
hydrolysis reaction. Thus, reflecting the significant loss in kcat as seen in the Sst2C397A 
mutant and also a similar mutant in AMSH-LP (Cys402 to Ser). Taken together, these 
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results indicate that the flexibility of the flap helps in catalysis as seen in many other 
enzymes such as asparaginase and dihydrofolate reductase.15,16 
Apart from the interactions with the isopeptide linkage, Phe403 forms anion-π 
interaction with Asp315, a conserved residue opposite the active-site flap. Such 
interactions are proposed to be involved in protein stabilization and protein-protein 
interactions.17 Mutation of Phe403 to Ala and Asp315 to Asn resulted in the loss of 
anion-π interaction and a decreased kcat. As discussed in the previous chapter, the loss of 
anion-π interaction in Sst2F403A might make the flap more flexible and thus, impose a 
higher entropic penalty leading to a loss of activity similar to AMSH and AMSH-LP. 
Likewise, a similar explanation could be made for Sst2D315N mutant for its reduced kcat.  
However, a closer inspection of the diubiquitin-bound crystal structure reveals that the 
Asp315 is 4 Å from amino-group of Met1 of the proximal ubiquitin of the diubiquitin 
substrate. Such a distance range could promote electrostatic attraction between the 
carboxylate and the amino group (likely protonated at the nearly neutral pH of the assay 
buffer). Therefore, to some extent, the loss of activity in the Sst2D315N mutant might also 
reflect a loss of the columbic attraction. 
 The crystal structures of Sst2F403W mutant in free and ubiquitin bound forms show 
elevated B factors of flap residues as compared to internal residues, indicating that the 
Trp mutant has increased flexibility. Moreover, despite the identical position of Trp side 
chain to interact with the substrate as Phe403 residue in the wild-type Sst2 (model from 
previous chapter), the reduction in kcat suggests an altered dynamics of the flap in the Trp 
mutant. Remarkably, the molecular dynamics simulations provide evidence that the 
Sst2F403W mutant has the highest mobility on three different flexibility metrics. 
Additionally, indirect evidence of higher flexibility is the cleavage of the alternate 
substrate Lys48 and Lys11-linked diubiquitin more readily by the mutants than the wild-
type enzyme.  Although the models show steric clashes with the alternative substrates, 
the increased flexibility of the flap may give rise to a more open active-site cleft, 
relieving the clashes and cleaving the non-cognate substrate. The wild-type enzyme, on 
the other hand, is more selective for Lys63-linkage due to a strict steric requirement 
imposed by the active-site flap. 
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 The structural and biochemical characterization of the active-site flap in Sst2 
reveals that the flap is not involved in substrate or product recognition, but its dynamic 
nature is tuned precisely to be in step with catalytic events. Since the flap is not involved 
in substrate binding, the increased flexibility of the flap might spend more time away 
from the active-site and forms a more exposed active-site cleft. As a result, a flexible flap 
poses less stringency on the precise nature of the substrate, thus reducing the selectivity. 
Overall, these results suggest the evolution of the flap in AMSH-like enzyme to increase 
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Figure 5.1: Representative plots of the initial velocity (divided by the total enzyme 




Table 5.1: Steady-state kinetic parameters of Sst2 flap mutants and its substrate, lysine63-
linked diubiquitin 
 
Sample KM (μM) kcat (s-1) kcat / KM x10-3 
(μM-1 s-1) 
Sst2 18.8 ± 8.4 1.5 ± 0.2 79.8 
Sst2F403A 33.6 ± 8.3 0.082± 0.007 2.4 
Sst2F403W 44.1 ± 8.2 0.085± 0.007 1.9 
Sst2C397A 32.8 ± 4.6 0.004± 0.0002 0.1 







Figure 5.2: SDS-PAGE gel of diubiquitin cleavage reactions with ubiquitin standards, 
different concentrations of the substrate and product after the reaction. Ubiquitin 
standards are used to quantitate ubiquitin produced from the reaction. Each reaction 
mixture contained 25 nM Sst2 catalytic domain or 100 nM Sst2F403A mutant or Sst2F403W 
mutant or 2µM Sst2C397A or 25 nM Sst2D315N mutant with different concentrations of 
Lys63-linked diubiquitin. The reaction proceeded for 15 min at 20°C and quenched with 









Figure 5.3: Determination of thermodynamic parameters for Sst2 flap mutants: (a) 
Isothermal titration calorimetry (ITC) thermogram for ubiquitin binding to the catalytic 
domain of Sst2F403A with a KD of 6.2 ± 0.5µM. (b) ITC thermogram of ubiquitin binding 
to the catalytic domain of Sst2F403W with a KD of 3.6 ± 0.3 µM.  
 
 
Table 5.2: Thermodynamic parameters of Sst2 flap mutants deduced from ITC Data 
 
Protein Titrant KD (μM) ΔH (kcal/mol) ΔS (cal 
mol−1 K−1) 
Sst2 Ub 10.2 ± 0.6 11.9 ± 0.4 62.9 
Sst2F403A Ub 6.2 ±  0.5 12.1 ± 0.4   64.3 
Sst2F403W Ub 3.6 ±  0.3 12.8 ± 0.4 67.9 
AMSH-LP Ub 17.3 ±  4.3 1.95 ±  0.4 28.3 




Figure 5.4: Native Circular Dichroism spectra of catalytic domain of Sst2, Sst2F403A, 
Sst2F403W and Sst2C397A showing the secondary structure of the enzyme in solution. The 




Table 5.3: Estimation of secondary structures of Sst2 flap mutants from CD spectra 
 
Protein               K2D3                K2D2 
   α helix (%)     β sheet (%)   α helix(%)       β sheet(%) 
Sst2     12.13     28.88     12.96 38.78 
Sst2F403A     9.41    30.24     9.89 38.33 
Sst2F403W     12.58    29.12     9.89 38.33 








Figure 5.5: Thermal melting curves showing the identical melting temperatures of the 
F403 mutants and wild-type Sst2. The thermal melting curve for the Sst2C397A mutant 




Table 5.4: Stability parameters for Sst2 flap mutants deduced from CD data 
 
Sample TM (°C) 222/209 ratio 
Sst2 56 0.87 
Sst2F403A 55 0.89 
Sst2F403W 56 0.91 






Figure 5.6: Conformational dynamics of the active site flap in Sst2, AMSH and AMSH-
LP: 20 equal-spaced snapshots were extracted from the molecular dynamics simulation 
and loop ensembles were superposed with their respective starting structures. The native 
protein conformation for Sst2, AMSH and AMSH-LP are shown in orange, blue and 
green cartoon representation respectively, with Zn2+ ions as gray spheres. All three 
enzymes Sst2 A), AMSH B), and AMSH-LP C) are highly flexible in the flap region and 
sample conformations resembling open and closed states. This data was generated by Dr. 









































































































































































































































































































































































































































































Figure 5.8: Cleavage of alternate substrates (Lys63-, Lys48- and Lys11-linked 
diubiquitin) by Sst2 wild-type and its flap mutants Sst2F403A and Sst2F403W. A) SDS-
PAGE gel comparing the activity of Sst2 wild-type and its mutants with different 
substrates. Each reaction mixture contained 250nM Sst2catalytic domain or Sst2F403A 
mutant or Sst2F403W mutant with 20µM concentrations of Lys63- or Lys48- or Lys11-
linked diubiquitin, and each reaction proceeded for 5 hrs at 20°C before quenching with 5 
X SDS-PAGE sample buffers. C) Chain morphologies of Lys63-, Lys48- and Lys11-








Figure 5.9: Representative plot of monoubiquitin:diubiquitin ratio as a function of 
different substrates (Lys63-, Lys48- and Lys11- linked diubiquitin) and different 
enzymes (Sst2 wild-type, Sst2F403A and Sst2F403W mutants). Bands corresponding to 
monoubiquitin and diubiquitin were integrated using ImageJ. This data was generated by 













Figure 5.10: Model of Sst2 wild-type and its mutants Sst2F403W and Sst2F403A bound to 
Lys11-linked diubiquitin. A) Superimposition of models of Sst2 wild-type and its 
mutants Sst2F403W and Sst2F403A bound to Lys11- linked diubiquitin (light pink). The inset 
with black margin shows the clash at proximal ubiquitin of Lys11-linked diubiquitin and 
the inset with red margin shows the clashes at distal ubiquitin. B) Expanded view of 
clashing between Sst2 wild-type (blue) and its mutants Sst2F403W (skyblue) and Sst2F403A 
limon) and distal ubiquitin of Lys11-linked diubiquitin (light pink). C) Expanded view of 
clashing between Sst2 wild-type (blue) and its mutants Sst2F403W (skyblue) and Sst2F403A 
(limon) and Lys11 of proximal ubiquitin of Lys11-linked diubiquitin (light pink). The 







Figure 5.11: Model of Sst2 wild-type and its mutants Sst2F403W and Sst2F403A bound to 
Lys48-linked diubiquitin. A) Superimposition of models of Sst2 wild-type and its 
mutants Sst2F403W and Sst2F403A bound to Lys48- linked diubiquitin (dark pink). The inset 
shows clashes that occur between Lys48-linked diubiquitin and Sst2 wild-type or its 
mutants. B) Expanded view of clashes showing that Leu50 of proximal ubiquitin clash 
with Phe403 or Trp403 side group of Sst2 wild-type and Sst2F403W, respectively. Some 
clashes also occur with the distal ubiquitin of Lys48-linked diubiquitin. The clashing 
residues and the isopeptide segment are shown in sticks with Phe403 in blue, Trp403 in 
skyblue, Ala403 in limon, Leu50 and isopeptide segment (Lys11 and Gly76) are shown 





CHAPTER SIX: STRUCTURAL CHARACTERIZATION OF THE EFFECTS OF 
MIC-CAP-ASSOCIATED MUTATIONS 
6.1 Introduction 
  AMSH, a Zn+ dependent deubiquitinase (DUB), regulates cell-surface receptor 
trafficking by cleaving Lys63-linked polyubiquitin chains from the internalized receptor, 
mediated by the members of the ESCRT machinery.1-4 The exact mechanism in which 
AMSH controls the trafficking remains elusive; however, the recent discovery of 
microcephaly capillary malformation (MIC-CAP) syndrome caused by mutations in 
AMSH gene highlights the involvement of AMSH in endosomal-lysosomal sorting. A 
whole-exome sequencing analysis discovered that a genetic defect due to recessive 
mutations in AMSH gene can lead to MIC-CAP syndrome.5 This disease is diagnosed at 
or shortly after birth, in which a child is born with smaller head (microcephaly), 
progressive cortical atrophy, intractable epilepsy, profound developmental delay and 
excessive small capillary malformation on the skin.6-9 Additionally, the phenotype of the 
disease is characterized by the accumulation of ubiquitinated proteins; thus suggesting 
the loss of enzymatic function of AMSH. Similar result of polyubiquitinated species 
buildup was also seen in AMSH knockout studies performed in mice.5,8,9 
 The study reported six missense mutations, two nonsense mutations, two 
translational frameshift mutations, and three intronic mutations in AMSH gene that could 
lead to MIC-CAP syndrome.5 Out of six missense mutations, five mutations occur within 
the MIT domain of AMSH, and the sixth, Thr313Ile, occurs within the JAMM domain of 
AMSH. Interestingly, one of the nonsense mutations Arg424X occurs within the C-
terminal of AMSH. To understand the disease basis of MIC-CAP syndrome, two 
mutations Thr313Ile and Arg424X were analyzed using Sst2. In Sst2, the corresponding 
residues are Thr319 and Arg433. 
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  Presented within this chapter are the crystal structure of catalytic domain of Sst2 
with Thr319Ile in its free form and its kinetic analysis, secondary structure and thermal 
stability analysis of Arg433Stop. Both Sst2 in its free form and ubiquitin bound forms 
were used to further understand how the two mutations could lead to the disease state.  
 
6.2 Materials and Methods 
 
6.2.1 Cloning, Protein Expression and Purification 
Full length Sst2 was amplified from a S. pombe cDNA preparation (a kind gift 
from K. Gould, Vanderbilt University). The catalytic domain of Sst2 (residues 245-435), 
here referred as Sst2cat, and human ubiquitin (Ub) were subcloned into pGEX-6P1 vector 
as described in the previous chapter. Thr319Ile and Arg433X mutations were introduced 
individually into Sst2cat via site-directed mutagenesis following the standard protocol. 
Each mutant was sequenced to confirm the presence of mutations. The resulting GST-
fusion proteins were expressed in Escherichia coli Rosetta cells and purified as described 
earlier using standard GST affinity chromatography followed by size exclusion 
chromatography on a Superdex S75 column (GE Lifesciences). GST tag was cleaved as 
part of the purification. Protein-containing fractions were concentrated, aliquoted and 
flash-frozen prior to storage at -80ºC. 
  
6.2.2 Crystallization, Data collection and Structure Determination of Sst2cat Thr319Ile 
Mutant in its Free Form 
 
 Initial hits of crystals were obtained using commercial screens in the sitting-drop 
vapor diffusion method. Thr319Ile mutant, here referred as Sst2T319I, was prepared in 50 
mM Tris-HCl, 50 mM Nacl, 1 mM DTT (pH 7.6) and mixed with Ub in a ratio of 1.5:1 
with the hope of forming Sst2T319I-Ub complex. The protein crystallized in 0.03 M citric 
acid, 0.07 M Bis-tris propane (pH 7.6), 20% PEG 3350, and 1.8% benzamidine 
hydrochloride as an additive. These crystals grew in a week. The crystals were soaked in 
cryoprotectant containing 20% (v/v) ethylene glycol in the mother liquor and flash frozen 
with liquid nitrogen. Diffraction data was collected at Advanced Photon Source (APS) 
144 
 
and 23 ID-B beamline, Argonne National Laboratory in Argonne, IL. The data was 
collected using a Mar300 CCD detector at 100K and processed with HKL2000 
program.10 
 Surprisingly, the mixture of Sst2T319I and ubiquitin produced a crystal structure of 
the mutant alone. Crystals of the MIC-CAP mutant, Sst2T319I diffracted to 1.9Å and the 
structure was solved by molecular replacement11 using Sst2cat (PDB: 4JXE) structure as 
the search model.12  The complete model of the interpretable density was built manually 
in Coot13 and initial refinements was  carried out in Refmac514 using rigid body 
refinement followed by restrained refinement. Iterative rounds of model building and 
refinement was performed with Coot13 and Refmac515.  The data collection and 
refinement statistics are shown in Table 6.2. All figures were generated using PYMOL 
(version 1.7.0.0). 
 
6.2.3 Kinetic Parameters Determination and Deubiquitylation Assay 
Enzyme kinetics of Sst2T319I mutant in hydrolyzing Lys63-linked diubiquitin 
(K63-Ub2) was determined by Dr. Judith Ronau. 1.25 µM of the enzyme was incubated 
in different concentrations (20, 49.5, 77, 99.5 µM) of K63-Ub2 consisting of 50 mM Tris-
HCl (pH 7.0), 20 mM KCl, 5 mM MgCl2, and 1 mM DTT reaction buffer at room 
temperature (22ºC). Reaction proceeded for 15 minutes and was quenched with 5x SDS-
PAGE sample buffer. To convert the quantified intensity of the formed monoubiquitin to 
molar concentration, a standard curve of 6, 20 and 40µM ubiquitin was prepared. 
Samples including the standards were separated in 15% SDS-PAGE gel and the ubiquitin 
bands were quantified and integrated using ImageJ.16 A calibration curve of the 
previously mentioned standards were plotted to determine the amount of ubiquitin 
produced through the cleavage of K63-Ub2.The initial velocity values were then plotted 
against substrate concentration using Kaleidagraph and the data were fitted to the 
Michaelis-Menten equation: 
Vi ൌ Vmax	ሾSሿKM ൅ ሾSሿ ൌ
݇ܿܽݐ	ሾEሿሾSሿ
KM ൅ ሾSሿ  
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Where Vi is the initial velocity, Vmax is the maximum velocity, [S] is the substrate 
concentration, KM is the Michaelis constant, and kcat is the turnover rate. 
Since Arg433 mutant, here referred as Sst2R433X, was very slow in cleaving K63-
linked diubiquitin, a diubiquitin cleavage assay was performed for this mutant.  Both 
wild-type and MIC-CAP mutant were diluted in a reaction buffer (50 mM Tris-HCl (pH 
7.0), 20 mM KCl, 5 mM MgCl2, and 1mM DTT). The DUB assay was carried out where 
20-40 μM of K63-linked diubiquitin was incubated with 10 µM DUBs in the reaction 
volume of 15 µl. Reactions were incubated at room temperature for indicated hours and 
quenched with 5x SDS-PAGE sample buffer. Samples were loaded and run on 15% SDS-
PAGE gel.  
 
6.2.4 Circular Dichroism 
Circular dichroism (CD) spectra were collected on a Jasco J-1500 
spectrophotometer at 20ºC in an 0.1 cm path length cuvette. Protein samples (wild-type 
Sst2cat and Sst2R433 mutant) were dissolved in 100 mM phosphate buffer (pH 7.4) to 
make a final concentration of 0.2 mg/ml. Native spectra were measured in the far-UV 
region (200-300 nm). Each CD spectrum represented an average of four accumulated 
scans at 100 nm/min) and corrected with a subtraction of a spectrum of the phosphate 
buffer alone. The mean residue molar ellipticity was calculated according to the 
following equation:  
[θ] = (θ x 100M)/(Cln)  
where θ is the ellipticity in degrees, l is the path length in centimeters, C is the 
concentration is mg/mL, M is molecular mass, and n is the total number of residues in the 
protein. Calculated mean residue molar ellipticity is given in degcm2dmol-1. The 








6.2.5 Thermal Denaturation using CD Spectroscopy 
Thermal denaturation curves of the proteins were obtained by change in ellipticity 
at 222 nm as a function of increasing temperature (20ºC-86ºC) of 2ºC. The linear rate for 
temperature increase was 0.5ºC/min. The proteins were dissolved in 100 mM phosphate 
buffer (pH 7.4) to make a final concentration of 0.2 mg/ml and a cuvette with path length 
of 0.1cm was used. The thermal denaturation processes of all proteins examined were 
irreversible under this condition. The midpoint transition temperature (T1/2) at which 





6.3.1 Kinetic Characterization of MIC-CAP Mutants Thr319Ile and Arg433Stop 
To understand the molecular basis of the MIC-CAP syndrome, Thr319Ile and 
Arg433Stop mutations were generated in Sst2. Previously, it was shown that AMSH 
orthologue Sst2 has the similar architecture to AMSH.12  Moreover, yeast could be used 
as a model to gain insight into how the mutation can lead to the disease.18  In Sst2, the 
corresponding residue for Thr313 and Arg424 are Thr319 and Arg433. Mutation of Thr 
to Ile in Sst2 shows a substantial loss of catalytic activity with a thirty-four-fold decrease 
in kcat and little change in KM (Table 6.1), consistent with results from a similar study 
with the Thr313Ile mutant in AMSH.9  
Similar studies of a non-sense mutation resulting in substitution of the extreme C-
terminal residue with a stop codon (Arg433Stop) in Sst2 shows more pronounced effect 
in the catalytic activity of the enzyme (Figure 6.1). Since the activity of Sst2R433X mutant 
is highly impaired, the kinetic parameters could not be deduced. During the protein 
purification, the enzyme mutant showed decreased solubility (data not shown). These 
results indicate that the reduced catalytic activity of the mutants could lead to a loss of 





6.3.2 Structural Effect of MIC-CAP Mutant, Sst2T319I 
To understand if the mutation reduced the enzyme’s catalytic efficiency by 
imposing either global changes to the protein’s overall structure or by imparting 
structural changes in the local environment affecting the ubiquitin interaction, the 
structure of  Sst2T319I was determined. The crystal obtained for Sst2T319I belonged to P21 
space group with 1.9Å diffraction resolution. The structure was solved by molecular 
replacement11 using the previously solved wild-type structure of catalytic domain of Sst2 
(PDB ID: 4JXE) as the search model.12 The final structure yielded Rcrys and Rfree values 
of 18.9% and 21.6% respectively (Table 6.2).  
Mutation to Ile did not cause any serious perturbation to its overall three-
dimensional structure (Figure 6.3A). However, mutation affected ubiquitin binding 
because only the free form of Sst2T319I crystals could be generated. The catalytic domain 
of Sst2 and other mutants  have formed a complex with ubiquitin.12 The structure of 
Sst2cat-Ub (and other ubiquitin and diubiquitin bound structures of Sst2) shows that the 
side-chain hydroxyl from Thr319 forms hydrogen bonding interaction with the backbone 
NH group of Leu73 of ubiquitin (Figure 6.3C). This observation is consistent with the 
model of AMSH-diubiquitin structure.5,9 Thus, the loss of hydrogen bonding may have 
weakened interactions with ubiquitin.  
The structure of Thr319Ile mutant of Sst2 in its free form reveals minimal 
changes in the protein structure localized around the site of mutation, and the global 
structure of the mutant remains largely unchanged to that of the wild-type Sst2. The most 
noticeable change is the orientation of the side-chain of Glu322, adjacent to Ile319. In the 
ubiquitin bound structure, Thr319 appears to orient Glu322 via hydrogen bonding in a 
position that enables it to engage in hydrogen-bonding with the side-chain of Arg42 of 
ubiquitin (Figure 6.3B). The altered positioning of Glu322 could result in the loss of 
interactions.  Collectively, it is possible that the substitution to Ile may lead to a loss of 






6.3.3 Secondary Structure Analysis and Thermal Stability of MIC-CAP Mutant, Sst2R433X 
 
The purity of Arg433Stop mutant was very poor (Figure 6.3); therefore, the 
crystal structure of this mutant could not be obtained. However, CD spectroscopy was 
used to study if the mutation caused any effect in the mutant’s secondary structure. 
Comparison of the far-UV CD spectra shows a pronounced secondary structural change 
induced by Arg433Stop mutation. Proteins with α-helical and coiled-coil regions have 
characteristic minima at 222 nm and 208 nm, the ratio of which (θ222/208) can be used to 
determine if a protein is coiled coil (θ222/208 = 1.02), versus purely α-helical (θ222/208 = 
0.85).19 The spectrum for wild type Sst2 has a molar ellipticity ratio (θ222/208) of 0.87 
(Table 6.4). Arg433Stop mutation altered spectra in such a way that the 222 nm minima 
is greater than the 208 nm (molar ellipticity ratios was 1.1; Figure 6.4 and Table 6.3), 
indicating a notable increase of random coil conformation in the secondary structure of 
Sst2. Overlay of the mutant spectra with that of wild-type highlights the differences 
which may be due to the local structural change caused by the mutation.  
To evaluate if the mutation affected the global stability of the enzyme, the 
transition from a fully folded native state to a fully denatured state as a function of 
temperature was determined by monitoring the change in circular dichroism (CD) 
spectroscopy at 222 nm as a function of increasing temperature. The wild-type AMSH 
seems to unfold in a two-state manner as indicated by the sigmoidal thermal denaturation 
curve. Interestingly, Arg433Stop mutant seems to have more complex denaturation with 
two distinct transitions (Figure 6.5). The first unfolding transition is at 52.4ºC and the 
second unfolding transition at 70.7ºC. Such behavior may be due to the presence of 
aggregation or accumulation of an unfolding intermediate. The midpoint of the inter-
phase plateau is 58.2°C (Table 6.4). The accumulation of the intermediate clearly 
suggests that a remarkable destabilization is associated with Arg433Stop mutation, which 







MIC-CAP syndrome is a severe developmental disorder caused by a congenitally 
defective DUB isopetidase AMSH, which functions in the endocytosis pathway.5 
Analysis of MIC-CAP patients’ lymphoblastoid cell lines showed increased ubiquitinated 
protein aggregation and apoptosis activation, which is consistent with brain imaging and 
human pathological analysis of MIC-CAP and AMSH knockout mouse model.20,21 Of the 
ten patients that were screened, different mutations in AMSH gene lead to the disease; 
however, the effects of the mutations are not known. To gain insight into the effects of 
mutations found in children with the MIC-CAP syndrome on the activity, structure and 
stability of AMSH, two of the mutations were studied using AMSH orthologue, Sst2.  
One of the mutants studied was Thr313; the corresponding residue is Thr319 in 
Sst2. X-ray crystal structure of DUB domain of Sst2 bound to ubiquitin and diubiquitin 
shows that Thr319 makes hydrogen bonding contact with the backbone NH group of the 
distal ubiquitin using its side chain hydroxyl group and its methyl group is engaged van 
der Waals contact with the aliphatic side chain of Leu73 of ubiquitin. Interestingly, the 
substitution of Thr with an Ile has a drastic effect in kcat and minimal change in KM, 
consistent with the result from a similar study with Thr313Ile mutant in AMSH.9 The 
structure of Sst2T319I shows a slight change in orientation of its neighboring residue, 
Glu322 caused by the mutation. This is interesting because in ubiquitin bound form of 
Sst2, Thr319 interacts with Glu322 via hydrogen bonding which is the only contact the 
latter residue makes with a protein atom. Such interaction appears to hold Glu322 in a 
position that could engage in hydrogen-bonding contact with Arg42 of ubiquitin.  
On the basis of the structure analysis, it can be expected that the loss of contacts 
with Leu73 and Arg42 of ubiquitin with T319I mutant may destabilize the Michaelis 
complex relative to the wild-type enzyme. However, the kinetic analysis indicates 
minimal effect on ubiquitin binding, but significant reduction in catalytic efficiency. It 
appears that the interactions of both Thr319 and Glu322 and by extrapolation, Thr313 
and Glu316 of AMSH, are important in aligning the peptide bond in the active site during 
formation of the transition state for the enzyme-catalyzed reaction. 
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Another disease mutant studied was Arg424, one of the nonsense mutations in the 
last residue of C-terminus of AMSH. The corresponding residue in Sst2 is Arg433. 
Arg433 is far away from the active site as well as the ubiquitin binding site, as seen in 
structures of catalytic domain of Sst2 (Figure 6.6A).12 However, this residue forms three 
hydrogen bond interactions with its neighboring residues Asp431 in Sst2. The main chain 
NH, NHδ and NHε atoms of Arg433 make hydrogen bond with main chain carbonyl 
group, Oγ1 and Oγ2 atoms of Asp431 (Figure 6.6B). Interestingly, the structural model of 
the disease mutation Arg433Stop shows that removal of Arg433 can result in the 
repulsion between the carboxylate group of Leu432 and side chain of Asp431, which may 
result in a subsequent change in protein conformation. The mutation however caused 
aggregation of the protein. The mutant also shows a profound effect on the catalytic 
activity of the enzyme. The activity of this mutant was highly impaired in compared to 
the wild-type enzyme further suggesting the loss of function as seen in Thr319Ile mutant.  
 Further structural analysis of Sst2 in its free form shows that along with hydrogen 
bonding with Asp431, the side chain NHε atoms of Arg433 forms water-mediated 
interaction with the main chain carbonyl oxygen of Val276 and carbonyl oxygen of 
Asn280 as shown in Figure 6.6B. Both residues are from α1 helix that holds a loop 
segment which contributes a critical glutamate residue (Glu286) involved in catalysis. 
Moreover, this nonsense mutation causes random coil formation as indicated by CD 
analysis which may be due to the local change around the site of mutation.  The mutant 
enzyme is also significantly less stable than the wild-type Sst2. Thus, Arg433Stop and by 
extrapolation Arg424Stop mutation as seen in children with MIC-CAP syndrome may 
perturb the secondary structure of AMSH in such a way that the enzyme loses all the 
above mentioned interactions affecting the integrity and stability of the protein; thereby, 
reducing its activity significantly enough to cause the disease.    
Thus, this chapter presents the structural insight into MIC-CAP mutants 
suggesting that the MIC-CAP mutations in AMSH gene result in minimal changes in the 
protein structure localized around the site of mutation. The mutations studied in this 
chapter, Thr319Ile and Arg433Stop in Sst2, do not affect the ubiquitin interaction. 
However, the structural change around the site of mutation is results in the loss of 
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function either by misaligning the substrate at the active site or affecting the integrity and 
stability of the enzyme. Further studies should focus on performing similar studies using 
Arg424 mutant in AMSH and also understanding if all the interactions of Arg424 is 
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Table 6.1: Steady-state kinetic parameters of Sst2, Sst2T319I and its substrate, lysine63-
linked diubiquitin 
 
Sample KM (μM) kcat (s-1) kcat / KM x10-3 
(μM-1 s-1) 
Sst2 18.8 ± 8.4 1.5 ± 0.2 79.8 
T319I 19.7 ± 4.0 0.043 ± 0.002 2.2 




Figure 6.1: Deubiquitylating assay testing activity of Sst2R433X mutant: SDS-PAGE gel 
comparing the activity of Sst2 wild-type and its R433X mutant at different time points. 
Each reaction mixture contained 10µM  Sst2 catalytic domain or Sst2R433XA mutant with 
20µM concentrations of Lys63-linked diubiquitin, and each reaction proceeded at 20°C at 













Data collection  
Space group P21 
Cell dimensions  
    a, b, c (Å) 58.1, 74.1, 64.8 
    , ,  ()  90.0, 113.4, 90.0 
Wavelength (Å)    1.033 
Resolution (Å) 50.0- 1.90(1.93-1.90       
 Rmerge (%) 7.0 (56.5) 
I / I 18.7 (2.9)               
Completeness (%) 100 (100)               
Redundancy 3.8 (3.8)                
  
Refinement  
Resolution (Å) 1.90                    
No. reflections 39791 
Rwork / Rfree 18.9/21.6               
No. atoms  
    Protein 2911 
    Ion 4 
    Water 164 
R.m.s. deviations  
    Bond lengths (Å) 0.006 
    Bond angles () 1.122 
Ramachandran Plot  
Preferred (%) 97.8 
Allowed (%) 1.9 
Disallowed (%) 0.3 
Average B-factors (Å2)  
    Sst2 cat  24.7 
    Ion 18.0 
    Water 27.8 
    Ligand 43.3 
 
Values in parentheses are for the highest resolution shell.   
a Rsym = ∑∑|Ihkl − Ihkl(j)|/∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the final 
average intensity. 
b Rcrys = ∑||Fobs| − |Fcalc||/∑|Fobs| and Rfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys 
are calculated using a randomly selected test set of 5% of the data and all reflections 








Figure 6.2: Structural comparison of MIC–CAP mutant T319I with wild-type Sst2: A) 
Superposition of catalytic doamin  of wild-type Sst2 (blue) and that of Sst2T319I (light 
yellow) mutant showing no change in the overall fold of the enzyme. B) Superposition of 
residue Thr319 of wild-type Sst2cat (blue) and Ile319 of mutant Sst2T319I (light yellow) 
showing the altered orientation of Glu322. The electron density for Ile319 is rendered 
from the 2Fo − Fc map contoured at 1.2σ. C) H-bond interactions of Thr319 of Sst2cat  
with Glu322 and Ub as seen in Sst2cat-Ub complex respectively. Residues of Sst2 and Ub 









Figure 6.3: SDS-PAGE gel analysis of Sst2R433X and Sst2cat protein after two step protein 
purification to determine the purity of the sample. About 100µM of wild-type Sst2cat and 
150µM of Sst2R433X proteins were applied to 15% polyacrylamide gel. The gel shows the 

















Figure 6.4: Native Circular dichroism (CD) spectra of catalytic domain of Sst2 and 
Sst2R433X show that the secondary structure of the enzyme is slightly perturbed in solution 
as a result of mutation. 
 
  
Table 6.3: Estimation of secondary structures of Sst2 and Sst2 R433X from CD spectra 
 
Protein                K2D2 
   α helix(%)       β sheet(%) 
Sst2 Wild-type 12.96 38.78 









Figure 6.5: Thermal melting curves comparing the stability of catalytic domain of Sst2 
and Sst2R433X determined by monitoring the change in circular dichroism (CD) 




Table 6.4: Stability parameters for Sst2 and Sst2 R433X deduced from CD data 
 
Sample TM (°C) 222/208 ratio 
Sst2 Wild-type 55.4 0.87 








Figure 6.6: Analysis of R433 residue using Sst2cat in its free form. A) R433 residue is 
away from the active site and also ubiquitin binding site (pointed by arrow). The residues 
in the active site are shown in sticks, and zinc ion and water are shown in gray and red 
sphere, respectively. The inset highlights the position of R433 in the structure of Sst2. B) 
H-bond interactions of R433  of Sst2cat  with its neighboring residues. Residues of Sst2 





CHAPTER SEVEN: BIOPHYSICAL ANALYSIS OF EXTREME C-TERMINAL 
TRIPEPTIDE RESIDUES OF AMSH  
7.1 Introduction 
Microcephaly-capillary malformation (MIC-CAP) syndrome is a rare, inherited 
disorder caused by mutations in AMSH gene.1-3 AMSH is involved in regulation of cell-
surface receptor signaling that controls protein homeostasis and various processes.1,4 
Studies have suggested that AMSH is also involved in signaling pathways responsible for 
growth and angiogenesis.5 Therefore, mutations in AMSH gene cause a newborn to have 
an abnormally small head (microcephaly) and malformations in capillaries along with 
abnormal movements, slow growth and short stature.1,3,6 Fourteen different mutations in 
AMSH related to MIC-CAP syndrome have been reported thus far.1,2 The structural 
analysis of MIC-CAP mutants in yeast orthologue Sst2 suggested localized changes 
around the site of mutation that might result in misalignment of the substrate at the active 
site or instability of the enzyme, causing a significant loss of the function.7 In the 
continuing effort to gain further insight into how one of the non-sense mutations, 
Arg424X, lead to the disease, two other conserved residues Asp422 and Leu423 at the C-
terminus along with Arg424 were identified among AMSH-related family.  
 In this chapter, a detailed analysis of the extreme C-terminal tripeptide residues, 
referred as DLR motif, is presented. Different mutations and truncation of the tripeptide 
residues in AMSH show a substantial reduction in the enzymatic activity with minimal 
effect on substrate binding. Additionally, secondary structure analysis indicates a 
perturbation and a loss of thermal stability. The microenvironment around the active-site 
of the enzyme is also affected by the mutations as exhibited by the tryptophan 
fluorescence spectroscopy. Overall, this study presents for the first time that the extreme 
162 
 
C-terminal residues (Asp422, Leu423 and Arg424) are important for stability and 
integrity of AMSH. 
 
7.2 Methods and Materials 
 
7.2.1 Cloning, Protein Expression and Purification 
The catalytic domain of AMSH (residues 219-424), here referred as AMSH, was 
subcloned into pGEX-6P1 vector using BamHI and XhoI restriction sites as described in 
previous chapter 6. Arg424X, Arg424Lys and Arg424Ala mutations were introduced 
individually into AMSH via site-directed mutagenesis following the standard protocol. 
For mutagenesis of Asp422Ala, Asp422Asn, Leu423Ala, and truncated construct (here 
referred as ΔDLR), the wild-type AMSH subcloned into pCold-GST vector was used as a 
template. Each mutant was then sequenced to confirm the presence of mutations. The 
resulting GST-fusion proteins were expressed in Escherichia coli Rosetta strain and 
purified as described earlier using standard GST affinity chromatography followed by 
size exclusion chromatography on a Superdex S75 column (GE Lifesciences). GST tag 
was cleaved as part of the purification. Protein-containing fractions were concentrated, 
aliquoted and flash-frozen prior to storage at -80ºC. The only difference between the 
protein purification between mutants obtained from pGEX-6P1and pCold-GST was that 
the mutants in pGEX-6P1 vector were expressed overnight at 18°C after inducing with 
300 µM IPTG, whereas, mutants in pCold-GST vector were expressed overnight at 15°C 
after inducing with 300 µM IPTG. pCold-GST expression system was used to improve 
the expression and purification yield of mutant proteins. 
Lys63-linked diubiquitin was synthesized enzymatically following published 
methods.  Human E1, two E2s (Uev1a, and Ubc13) and the two mouse ubiquitin mutants 
Lys63Arg and Asp77 ubiquitin mutants were purified separately. These E1, E2s and two 
different ubiquitin mutants were mixed in a reaction buffer containing 80 mM Tris-HCl, 
20 mM ATP, 20 mM MgCl2, 1 mM DTT, incubated overnight at 37oC, and quenched at 
room temperature with 10-fold excess Buffer A (50 mM sodium acetate pH 4.5).  The 
quenched reaction mixture was loaded onto a MonoS cation exchange column (GE 
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Healthcare) to separate synthesized diubiquitin from unreacted ubiquitin. Diubiquitin was 
eluted using a linear gradient with Buffer B (50 mM sodium acetate pH 4.5, 1 M NaCl).7 
 
7.2.2 Kinetic Parameters Determination and Deubiquitylation Assay 
Enzyme kinetics of AMSH mutants Arg424X, Arg424Lys and Arg424Ala in 
hydrolyzing Lys63-linked diubiquitin (K63-Ub2) was determined by Dr. Judith Ronau. 
The enzymes 50 nM  AMSH, 700 nm Arg424X, 200 nm Arg424Lys and 277 nm 
Arg424Ala, 1 µM Asp422Ala, 800 nm Leu423Ala, 500 nm Asp422Asn were incubated 
with different concentrations (20, 49.5, 77, 99.5 µM) of K63-Ub2 consisting of 50 mM 
Tris-HCl (pH 7.0), 20 mM KCl, 5 mM MgCl2, and 1mM DTT reaction buffer at room 
temperature (22ºC). Reaction proceeded for 15 minutes except Asp422Asn (8 mins on the 
basis of initial velocity measurement) and was quenched with 5x SDS-PAGE sample 
buffer. To convert the quantified intensity of the formed monoubiquitin to molar 
concentration, a standard curve of 6, 20 and 40 µM ubiquitin was prepared. Samples 
including the standards were separated in 15% SDS-PAGE gel and the ubiquitin bands 
were quantified and integrated using ImageJ.8 A calibration curve of the previously 
mentioned standards were plotted to determine the amount of ubiquitin produced through 
the cleavage of K63-Ub2.The initial velocity values were then plotted against substrate 
concentration using Kaleidagraph and the data were fitted to the Michaelis-Menten 
equation: 
Vi ൌ Vmax	ሾSሿKM ൅ ሾSሿ ൌ
݇ܿܽݐ	ሾEሿሾSሿ
KM ൅ ሾSሿ  
Where Vi is the initial velocity, Vmax is the maximum velocity, [S] is the substrate 
concentration, KM is the Michaelis constant, and kcat is the turnover rate. 
The in vitro DUB activity assay was carried out by incubating wild-type AMSH 
and its mutants Asp422Ala, Leu423Ala, Asp422Asn, Arg424X, Arg424Lys, Arg424Ala 
and ΔDLR at final concentration of 1 µM with 20 µM Lys63-linked diubiquitin. All 
reaction mixtures consisting of 50 mM Tris-HCl (pH 7.0), 20 mM KCl, 5 mM MgCl2, 
and 1mM DTT were proceeded for 4 hr at room temperature which was then quenched 
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by adding 5X SDS-PAGE sample buffer. Samples were loaded and run on 15% SDS-
PAGE gel. No activity was detected for ΔDLR under these conditions. 
 
7.2.3 Circular Dichroism 
Circular dichroism (CD) spectra were collected on a Jasco J-1500 
spectrophotometer at 20ºC in a 0.1 cm path length cuvette. Protein samples (wild-type 
AMSH and all the mutants) were dissolved in 100 mM phosphate buffer (pH 7.4) to make 
a final concentration of 0.2 mg/ml. Native spectra were measured in the far-UV region 
(200-300 nm). Each CD spectrum represented an average of four accumulated scans at 
100 nm/min) and corrected with a subtraction of a spectrum of the phosphate buffer 
alone. The mean residue molar ellipticity was calculated according to the following 
equation:  
[θ] = (θ x 100M)/(Cln)  
where θ is the ellipticity in degrees, l is the path length in centimeters, C is the 
concentration is mg/mL, M is molecular mass, and n is the total number of residues in the 
protein. Calculated mean residue molar ellipticity is given in degcm2dmol-1. The 
percentages of secondary structures were then calculated using K2D2 and K2D3 online 
software.9,10 
 
7.2.4 Thermal Denaturation using CD Spectroscopy 
Thermal denaturation curves of the proteins were obtained by change in ellipticity 
at 222 nm as a function of increasing temperature (20ºC-86ºC) of 2ºC. The linear rate for 
temperature increase was 0.5ºC/min. The proteins were dissolved in 100 mM phosphate 
buffer (pH 7.4) to make a final concentration of 0.2 mg/ml and a cuvette with path length 
of 0.1 cm was used. The thermal denaturation processes of all proteins examined were 
irreversible under this condition. The midpoint transition temperature (T1/2) at which 






7.2.5 Fluorescence Spectroscopy 
 Fluorescence data were collected on a Spectramax M5 spectroflorometer by using 
96 well-plate reader. Tryptophan emission spectra were recorded between 300-450 nm in 
2 nm steps with an excitation wavelength of 280 nm at room temperature. All samples 





7.3.1 Mutant Design 
Missense and nonsense mutations involved in the MIC-CAP syndrome are shown 
in the domain map of AMSH (Figure 7.1A). One of the nonsense mutations causing the 
disease is the last residue of C-terminus, Arg424 of AMSH.11 The corresponding residues 
in AMSH-LP and Sst2 are R436 and R433, respectively. Arg424 is far away from the 
active site as well as the ubiquitin binding site, as seen in structures of both the catalytic 
domain of AMSH-LP and Sst2 bound to their substrate Lys63-linked diubiquitin.7,12 
However, this residue is involved in three hydrogen bond interactions with its 
neighboring residue Asp422 (Asp434 and Asp431 in AMSH-LP and Sst2, respectively). 
The main chain NH, NHδ and NHε atoms of Arg424 form hydrogen bond with the main 
chain carbonyl group, Oγ1 and Oγ2 atoms of Asp422 (Figure 7.1B and C). Interestingly, 
the structural model of the disease mutation Arg424X showed that removal of Arg424 
can result in the repulsion between the carboxylate group of Leu423 and side chain of 
Asp422, which may result in a subsequent change in protein conformation (Figure 7.1D). 
Therefore, along with the disease mutation R424X, R424A and R424K mutants were 
generated to examine whether the side chain interactions, backbone interaction or both 
are required to maintain the integrity of the enzyme. 
 While analyzing Arg424 mutation in AMSH, a conserved tripeptide motif at the 
extreme C-terminus that included Arg424 residue was observed. Both the crystal 
structures and sequence analysis of AMSH and related enzymes confirms the presence of 
the tripeptide motif, which is referred here as DLR motif, along with catalytic residues 
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and second zinc coordinating residues (Figure 7.2A and B). A number of proteins are 
known to destabilize when termini are truncated.13-15 Since the importance of C-terminus 
DLR motif in AMSH related proteins is not known, AMSH with truncation of C-terminal 
residues (Asp422, Leu423 and Arg424), and referred to as ΔDLR was generated. In 
addition, point mutations Asp422Ala, Asp422Asn and Leu423Ala were also constructed 
in AMSH to examine the possible role of this DLR motif which may further help in 
understanding the cause of the MIC-CAP syndrome. 
 
7.3.2 Purity of AMSH Mutants 
 The purification of AMSH and its mutants were performed by following standard 
GST purification steps. Wild-type AMSH was both soluble and stable, whereas, most of 
the mutants were not very soluble. Therefore, the production levels of all the mutants are 
low compared to wild-type. All these proteins were purified to produce a single band on 
SDS-PAGE; however most of the mutants show multiple bands on the gel (Figure 7.3). 
The molecular weights of the proteins calculated from amino acid sequences are closer to 
23kD; however, the SDS-PAGE gel shows slight variation in the molecular weight. All 
these proteins exist in a monomeric state according to gel-filtration chromatography. 
These proteins were used for further biochemical characterization.  
 
7.3.3 Kinetic Characterization of AMSH Mutants 
 The disease mutation, Arg424X, shows a substantial loss of catalytic activity with 
five-fold decrease in kcat and a minimal effect on KM (Figure 7.4 and Table 7.1). Since 
this residue is not involved in substrate binding and is far away from the active site, the 
loss of activity is not very clear. Additionally, mutation of Arg424 to alanine has no 
change in kcat and KM; whereas, mutation to lysine shows an approximate two-fold 
decrease in both kcat and KM as compared to wild-type AMSH, suggesting that the 
backbone hydrogen interaction of Arg424 with its neighboring residue may be important 
in maintaining its structural integrity and function. 
 To further understand the basis of MIC-CAP syndrome, DLR mutants were also 
analyzed for activity towards Lys63-linked diubiquitin which reveals some interesting 
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results. Mutating Asp422 to alanine causes a six-fold decrease in kcat and two-fold 
decrease in KM similar to the observation in Arg424X mutant. This suggests that the 
hydrogen bonding between the main chain NH from Arg424 and Oγ1 atoms of Asp422 as 
shown in Figure 7.1C may play a role in stabilizing the C-terminus loop of AMSH. 
Interestingly, mutating Asp422 to asparagine has no change in the catalytic activity, 
however, yields an approximate three-fold reduction in KM ((Figure 7.4, 7.5 and Table 
7.1)). Surprisingly, a qualitative analysis of diubiquitin cleavage revealed that Leu423, 
when mutated to alanine was more active than the Asp422Asn mutant. However, the 
detailed kinetic analysis shows that Leu423Ala mutant suffered a four-fold decrease in 
kcat and two-fold decrease in KM as seen in both Arg424X and Asp422Ala mutants. 
Moreover, the truncated mutant AMSHΔDLR shows no activity towards Lys63-linked 
diubiquitin (Figure 7.6). Thus, it is possible that the truncation of DLR motif may lead to 
the loss of  interactions formed by Asp422, Leu423 and Arg424 which may be important 
in maintaining the structural integrity of AMSH; therefore, explaining the severe effect 
on the enzyme’s catalytic activity. 
 
7.3.4 Secondary Structure Analysis of AMSH and its Mutants 
 The CD spectra of all mutant proteins were analyzed to clarify whether the 
mutation induced any structural changes. Comparison of the far-UV CD spectra shows no 
pronounced secondary structural change induced by mutations except ΔDLR.  Most of 
the mutants have increased negative peak around 208 nm suggesting an increase in the 
fraction of helical content (Figure 7.7A). Estimation of protein secondary structure 
content from each CD spectra was performed by means of K2D2 and K2D3 software.9,10 
The results (Table 7.2) also suggest that Arg424Ala, Leu423Ala and Asp422Asn have no 
substantial conformational changes whereas Arg424X, Arg424Lys, Asp422Ala and 
ΔDLR induce a local structural change. The far-UV CD spectra of ΔDLR shows an 
increased absorbance suggesting that the spectra may include contributions from 
insoluble aggregate material as well as soluble protein. Likewise, all the mutants have 
similar profile to that of wild-type AMSH in the near-UV CD spectra except ΔDLR, 
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which may be due to the protein aggregation as shown in Figure7.7B, further confirming 
that ΔDLR may be misfolded and unstable.  
 
7.3.5 Thermal Stability of AMSH and its Mutants  
 To further explore the importance of DLR motif, the global stability of AMSH 
was analyzed using C-terminal mutants, the disease mutant (Arg424X) and the truncated 
construct. The stability was analyzed by monitoring the change in circular dichroism 
(CD) spectroscopy at 222 nm with the increase in temperature. Thermal denaturation of 
these proteins was irreversible under the examined condition. Wild-type AMSH and its 
DLR mutants except ΔDLR seems to unfold in a two-state manner as indicated by the 
sigmoidal thermal denaturation curve (Figure 7.8). The midpoints of the transition of 
these thermal denaturation curves (T1/2) are summarized in Table 7.3. The T1/2 values 
of Arg424 mutants: Arg424Ala, Arg424Lys and Arg424X are lower than the wild-type 
AMSH by 6.9, 7.8, and 5.5 respectively. Likewise, the mutants of DLR motif 
Asp422Ala, Asp422Asn, and Leu423Ala are lower than wild-type AMSH by 2.8, 2.0, 
and 1.6 respectively. Interestingly, ΔDLR appears to unfold through two distinct 
transitions as monitored by CD at 222nm which may be the result of the accumulation of 
unfolded intermediate.  The T1/2 values for the two transitions are 52.6°C and 70.1°C, 
respectively, and the midpoint of the inter-phase plateau is 56.5°C which is 2.6°C lower 
than the wild-type AMSH. These data (Table 7.3) clearly suggest that a remarkable 
destabilization is associated with the MIC-CAP mutant and DLR motif mutant. 
 
7.3.5 Fluorescence Spectroscopy 
 The active site of AMSH is in close vicinity to Trp333 making tryptophan 
excitation a valuable tool for examining local environmental change around the active 
site. At pH 7.4, the emission spectrum of AMSH has maximum intensity at 352 nm 
(λmax), similar to surface tryptophan, indicating a polar environment around Trp333.16 
The crystal structure of AMSH further confirms a polar configuration around Trp333 
with three trapped water molecules within 7Å (Figure 7.9), one of which is the catalytic 
water.11 The emission maximum of most of the mutants is blue-shifted (Table 7.4) except 
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Leu423Ala and Asp422Ala mutants, suggesting some changes around the 
microenvironment of the Trp333. Arg424Ala shows only 2 nm blue-shift of the emission 
maximum, whereas Arg424Lys and Arg424X are blue-shifted by approximately 8 nm 
and 6 nm, respectively.  Like Arg422Ala, Asp422Asn also has 2 nm changes in the 
emission maximum. The truncation of DLR motif exhibits further blue-shift of the 
emission maximum at 342 nm. The variation in the emission intensity as shown in Figure 
7.10 may be due to the lack of the pure sample, thus affecting the total concentration of 
the proteins used for the experiment. It is also possible that the observed quenching of the 
emission intensity may be attributed to the immediate environment of tryptophan. The 
crystal structure of AMSH shows that Trp333 is in close proximity with active site 
residues histidine and aspartate, which are the potential tryptophan fluorescence 
quenching residues.17 Overall, it appears that the mutations in the extreme C-terminal 
residues affect the structural integrity and compactness of the enzyme in such a way that 
the water molecules get removed from the environment of Trp333, which affects the 
active-site area of the enzyme.   
 
7.4 Discussion 
 Previously, it has been shown that one of the missense mutations Thr313Ile in 
AMSH (Thr319Ile in Sst2) results in the disease state of MIC-CAP syndrome due to the 
loss of hydrogen bonding contact with distal ubiquitin. As a result, it caused a significant 
reduction in its catalytic efficiency despite a minimal effect on protein folding and 
stability. Likewise, to further investigate the cause of the MIC-CAP syndrome, one of the 
nonsense mutations, Arg424 was characterized. The crystal structures of both AMSH-LP 
and Sst2 bound to Lys63-linked diubiquitin (PDB ID: 2ZNV and PDB ID: 4NQL, 
respectively) has revealed that this residue is not involved in substrate binding and 
catalysis. Therefore, as part of the continuing effort to understand the basis of MIC-CAP 
syndrome, the C-terminal tail of AMSH was examined in detail. Studies have shown that 
the C-terminal tail of an enzyme contributes in maintaining the integrity and stability of 
protein if it is anchored.13-15 Sequence alignment of AMSH-related family shows three 
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conserved residues at the extreme C-terminus among which the nonsense mutation of the 
last residue Arg424 lead to MIC-CAP syndrome.    
 According to the crystal structure of catalytic domain of AMSH, the extreme C-
terminal tail of AMSH is characterized by a short beta sheet and short loop. All three 
residues are part of the loop and are solvent exposed. However, these residues are 
anchored to the JAMM core through hydrogen bonds, electrostatic, and hydrophobic 
interactions (Figure 7.11). Along with hydrogen bonding with Asp422, the side chain 
NHε atoms of Arg424 forms electrostatic interactions with the main chain carbonyl 
oxygen of Leu270 and a water-mediated interaction with carbonyl oxygen of Asn274 as 
shown in Figure 7.11A, both residues are from the α1 helix that holds a loop segment 
which contributes a critical glutamate residue (Glu280) involved in catalysis.11 The 
kinetic analysis shows the disease mutant does not affect the KM implying that the 
terminal residue contributes little to substrate binding; however, the catalytic efficiency is 
reduced significantly. Moreover, this nonsense mutation may result in a local change 
around the site of mutation making the enzyme substantially less stable than the wild-
type AMSH as indicated by CD analysis and a loss of thermal stability. Additionally, the 
tryptophan fluorescence data also indicate changes in structural compactness compared to 
wild-type AMSH. Thus, the mutation of Arg424, as seen in children with MIC-CAP 
syndrome, is expected to lose all the above mentioned interactions which may perturb the 
secondary structure of AMSH affecting the integrity and stability of the protein 
conformation and thereby reducing its activity significantly enough to cause the disease.    
 Furthermore, Arg424 was mutated to alanine and lysine to understand if the 
backbone (main-chain) interactions, side-chain interactions, or both interactions are 
important for the structural integrity and function of the enzyme. Interestingly, the 
analyses show that the substitution of Arg424 with alanine, which maintains the 
backbone interaction (main chain NH group) with main chain carbonyl group and Oγ1 
atom of Asp422, is less stable as compared to the wild-type AMSH with no effect in its 
substrate binding and catalytic activity. On the other hand, Arg424 to lysine is also less 
stable and can still maintain the backbone interaction with Asp422; however, this 
mutation leads to a significant reduction in kcat. Despite the backbone interaction, the 
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significant instability, and substantial changes in structural compactness, as shown by 
thermal denaturation and tryptophan fluorescence induced by Arg424Lys mutation may 
have decreased its catalytic activity. Overall, it appears that the backbone interaction of 
Arg424 with Asp422 is important to uphold the integrity of the protein. 
 Likewise, the mutational analysis of Asp422 and Leu423 offer some interesting 
insights. The side-chain of Leu423 is involved in hydrophobic interactions with Leu319 
of Insertion-1 (Figure 7.11B). Mutation of Leu423 to alanine has a minimal effect on its 
secondary structure consistent with small blue-shift in tryptophan fluorescence and 
minimal loss in its thermal stability. However, the mutation shows a defective KM and kcat 
values compared to the wild-type AMSH, suggesting that the strong hydrophobic 
interaction between leucines may provide extra stability to the helix of insertion-1. This 
helix is involved in interactions with Ile44 hydrophobic patch of distal ubiquitin.11 The 
mutation may weaken this interaction resulting in a weak affinity with the substrate 
thereby, affecting the catalytic activity of the enzyme. Likewise, the mutation of Asp422 
to alanine loses hydrogen bonding between Oγ1 atom of Asp422 and main chain NH 
group of Arg424, and the mutation of Asp422 to asparagine may result in the repulsion 
between the side-chains of the two residues as shown in Figure 7.11B. Moreover, 
Asp424Ala mutation induces a significant conformational change with reduced stability, 
thus confirming the importance of the backbone interaction between Arg424 and Asp422. 
On the other hand, Asp422Asn results in a less stable enzyme with minimal blue-shift in 
the emission spectrum, which is consistent with CD result. Taken together, it is possible 
that the interaction between Arg424 and Asp422 is important in holding Leu423 in a 
correct position to maintain AMSH integrity for proper substrate binding and its catalytic 
activity.  
 Furthermore, the truncation of the extreme C-terminus tripeptide residues (DLR 
motif) resulted in an inactive enzyme. The protein obtained was of a very low purity. CD 
data also indicated a significant change in the secondary structure. It is possible that the 
loss of C-terminal tail may destabilize the protein and change the environment around 
active-site as shown by tryptophan fluorescence data, leading to a substantial loss of 
activity. Likewise, such misfolding may have resulted in a loss of thermal stability of the 
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enzyme. The crystal structures of AMSH, AMSH-LP and Sst2 shows that the extreme C-
terminal DLR motif anchors to JAMM core via different interactions. Along with the 
analyses presented in this chapter, it is possible that the DLR motif may be responsible in 
maintaining the entire structural integrity and stability of the enzymes for its proper 
function. Similar analyses can be performed in other families of AMSH to further 
confirm the role of the conserved C-terminus tripeptide motif. However, studying the 
effects of MIC-CAP mutants in the endocytosis pathway using a model system may 
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Figure 7.1: MIC-CAP mutations in AMSH. A) Domain diagram of AMSH indicating 
different missense and nonsense mutations that cause MIC-CAP syndrome. B) Ribbon 
representation of JAMM domain of AMSH shown in pink with insertion 1 and 2 in 
yellow. The inset highlights the tripeptide motif at the extreme C-terminus. C) Hydrogen 
bond interactions of the extreme C-terminus residue R424 with its neighboring residue 
D422. D) The possible repulsion between carboxyl group of backbone of L423 and side-





Figure 7.2: The conserved tripeptide motif DLR in AMSH-related family. A) 
Superposition of the catalytic domain of AMSH (PDB ID: 3RZU), AMSH-LP (PDB ID: 
2ZNR) and Sst2 (PBD ID: 4JXE). The inset in black highlights the extreme C-terminus 
conserved tripeptide residues. The insets in red highlight the conserved residues 
surrounding active-site zinc and structural zinc. D) Sequence alignment of AMSH from 












Figure 7.3: SDS-PAGE gel analysis of wild-type AMSH and DLR mutants after two 
steps protein purification to determine the purity of the sample. About 75µM of wild-type 
AMSH and mutant proteins were applied to 15% polyacrylamide gel. * indicates an 
unknown band in all the proteins. Multiple bands in the gel may be due to aggregation of 
protein misfolding. ΔDLR mutant shows the most aggregation followed by D422A, 











Figure 7.4: Representative plots of the initial velocity (divided by the total enzyme 
concentration) as a function of substrate concentration for wild-type AMSH and DLR 
mutants 
 
Table 7.1: Steady-state kinetic parameters of MIC-CAP mutants and its substrate, Lysine 
63-linked diubiquitin. 
 
Sample KM (μM) kcat (s-1) kcat / KM x10-3 
(μM-1 s-1) 
Wild-type AMSH 21.1 ± 0.8 0.059 ± 0.0007 2.7 
R424X 25.2 ± 1.2 0.014 ± 0.0003 0.6 
R424A 22.5 ± 3.5 0.06 ± 0.0027 2.6 
R424K 33.6 ± 7.9 0.043 ± 0.004 1.2 
L423A 45.1± 8.3 0.016 ± 0.001 0.4 
D422A 43.8 ± 13.1 0.011 ± 0.001 0.3 






Figure 7.5: SDS-PAGE gel of diubiquitin cleavage reactions with ubiquitin standards, 
different concentrations of the substrate and product after the reaction. Ubiquitin 
standards are used to quantitate ubiquitin produced from the reaction. Each reaction 
mixture contained 50nM AMSH, 700nm R424X, 200nm R424K and 277nm R424A, 
1µM D422A, 800nm L423A, 500nm D422N enzymes with different concentrations of 
Lys63-linked diubiquitin. The reaction proceeded for 15 min at 20°C except D422N 






Figure 7.6: Deubiquitylating assay testing activity of ΔDLR mutant: SDS-PAGE gel 
comparing the activity of wild-type AMSH and different DLR mutants. Each reaction 
mixture contained 1µM enzymes except R424A enzyme (235nm) with 20µM 
concentrations of Lys63-linked diubiquitin, and each reaction proceeded at 20°C for 4 hrs 


















Figure 7.7: Native Circular Dichroism spectra of AMSH and DLR mutants. A) A far-UV 
CD spectra of AMSH and its mutants showing conformational change in the secondary 
structure due to mutation. B). A near-Uv CD profile of AMSH and DLR mutants 




Table 7.2: Estimation of secondary structures of MIC-CAP mutants from CD spectra 
 
Sample K2D2 K2D3 
 α helix(%)          β sheet(%) α helix(%)         β sheet(%) 
Wild-type AMSH 21.98 23.67 25.08 22.2 
R424X 25.36 22.48 27.8 17.15 
R424A 23.21 24.55 25.08 22.2 
R424K 28.07 20.31 39.07 10.4 
L423A 23.77 23.79 25.08 22.2 
D422A 26.4 27.26 31.47 11.99 
D422N 22.76 25.23 23.76 23.78 





Figure 7.8: Thermal melting curves showing the variation in melting temperatures of the 
DLR mutants and wild-type AMSH. The thermal melting curve for the ΔDLR mutant 




Table 7.3: Stability parameters of MIC-CAP mutants deduced from CD data 
 
Sample TM (°C) ΔT1/2(°C) 
Wild-type AMSH 59.1 - 
R424X 53.6 5.5 
R424A 52.2 6.9 
R424K 51.3 7.8 
L423A 57.5 1.6 
D422A 56.3 2.8 
D422N 57.1 2 







Figure 7.9: Local environment around W333 with three trapped water molecules within 
7Å and two potential tryptophan fluorescence quenching residues (histidine and 












Figure 7.10: Comparison of fluorescence spectra of AMSH and DLR mutants. The 
enzymes were excited at 280 nm and emission spectra were recorded at room 




Table 7.4: Emission Maxima (λmax) deduced from Tryptophan Fluorescence Data 
 
Sample Emission λmax (nm) 













Figure 7.11: Interactions of DLR motif with JAMM core. A) Hydrogen bond and salt 
bridge formation by DLR residues with residues from α1 helix that holds a loop segment 
leading to glutamate residue (Glu280) involved in catalysis. B) Hydrophobic interactions 
formed by DLR motif with its neighboring residues. L423 interacts with residues of 






CHAPTER EIGHT: CRYSTALLOGRAPHIC AND BIOCHEMICAL STUDIES OF 
PROKARYOTIC DEQUITIQUITINASE, SSEL 
 
8.1 Introduction 
Ubiquitination is involved in various eukaryotic cellular processes such as 
endocytic trafficking of receptors, regulation of homeostasis, inflammatory responses and 
defense system.1-4 The importance of this modification within a host cell makes it an 
ideal target for microbial manipulation. Bacteria produce effector proteins that mimic 
enzymes of the host ubiquitin system and hijack the host signaling pathway for their own 
benefit.5  Many bacteria synthesize effectors that interfere with the host ubiquitin system 
by mimicking host deubiquitinases (DUBs).5 A number of bacterial DUBs have been 
discovered a decade ago; however, recently the structures of bacterial DUBs have been 
reported. The structures of the SdeA DUB from Legionella pneumophila in its apo and 
ubiquitin bound forms are the first structures of a prokaryotic DUB.6 Bacterial DUBs are 
usually modelled after eukaryotic cysteine proteases.5 Interestingly, the structure of DUB 
domain of SdeA and ubiquitin complex revealed that the Ile44 patch of ubiquitin, which 
is involved in interactions with eukaryotic DUBs, is not engaged in binding with SdeA.6  
 Like SdeA, Salmonella-secreted factor L, or Ssel, is also a bacterial effector 
protein that exhibits DUB activity. Ssel was first described by Holden lab (Imperial 
College, London), who demonstrated the ability of Ssel to remove ubiquitin.7 Salmonella 
typhimurium is a gram negative facultative bacterium that can cause diseases of the 
Salmonella spectrum.8,9 After entering the host cell, the bacterium resides within a 
membrane-bound compartment called a Salmonella-containing vacuole (SCV) (Figure 
8.1).10-12 Salmonella pathogenicity island (SPI)-2 type 3 secretion system (T3SS) is then 
inserted into the SCV membrane which translocates effector molecules including Ssel 
and other proteins to the cytosol.9  This connection with the cytosol causes the bacteria to 
be recognized by the host ubiquitin and defense cell system. As a result, either SCV gets 
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ubiquitinated or aggresome-like induced structures (ALIS) are formed which upregulates 
the autophagy receptor and autophagic flux, leading to SCV degradation.10,13 In order to 
counteract this mechanism, S. typhimurium translocates Ssel which removes ubiquitin 
from SCV and ALIS.14 As a result, the autophagy receptor p62 cannot recognize SCV 
and ALIX, lowering the autophagic flux and helping the Salmonella to proliferate.14,15 
 This chapter presents the structural and biochemical characterization of different 
constructs of Ssel. The crystal structure of the shortest construct of Ssel (SselΔ157) 
revealed a flexible catalytic residues and a pronounced defect in the catalytic activity of 
the enzyme. SselΔ122 construct also showed impaired activity compared to full-length Ssel 
despite the presence of all three variable regions and the constant region for ubiquitin 
binding as suggested by Pruneda et al.  The full-length construct of Ssel, on the other 
hand, showed strong preference for Lys63-linked diubiquitin over Lys48- and Lys11-
linked diubiquitin substrate. The kinetic analysis using Lys63-linked diubiquitin in which 
Gln40 of the substrate was mutated to alanine indicated that Ssel binds to substrate via 
Gln40 patch of ubiquitin, similar to SdeA DUB from Legionella Pneumophila. ITC 
experiments further suggest that N-terminal residues of Ssel may be involved in ubiquitin 
binding. Overall, this study suggests that Ssel may bind its substrate in two steps. 
Initially, the N-terminus of Ssel, also known as VHS domain may be used to capture the 
ubiquitin of the substrate and the, would present the ubiquitin to the catalytic domain for 
catalysis via the flexible linker between the two domains. .  
 
 
8.2 Methods and Materials 
 
8.2.1 Cloning, Protein Expression and Purification 
Different constructs of Ssel (Full-length, residues 122-340 and residues 158-340) 
were subcloned into pGEX-6P1 vector using BamHI and XhoI restriction sites as 
described in previous chapters. The DNA was a kind gift from David Holden, Imperial 
College, London). The resulting GST-fusion proteins were expressed in Escherichia coli 
Rosetta cells which was used to inoculate a starter culture in LB media supplemented 
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with ampicillin and was grown overnight at 37°C. The next day, 6L of LB media 
supplemented with ampicillin was inoculated with the starter culture and grown until the 
optical density reached 0.4-0.6 and then induced with 0.1-0.3 mM IPTG to overexpress 
the protein at 18°C overnight. The cells were harvested, resuspended using 1X PBS 
buffer, lysed by French press and centrifuged at 100,000 x g for an hour. The supernatant 
was applied to Glutathione-Sepharose column from GE Biosciences. The GST beads was 
washed with 5 column volumes of GST purification buffer and eluted using GSH elution 
buffer (250 mM Tris pH 8, 500 mM KCl and10 mM reduced glutathione) followed by the 
removal of the tag by PreScission protease (GE Biosciences) via overnight dialysis at 
4°C. The GST tag was then removed by passing the eluent through the GST beads again 
(Figure 8.3A). The solution collected from the column was  further purified by  size-
exclusion Superdex S75 column (GE Biosciences) using a buffer containing 50 mM Tris-
HCl, pH 7.6,  50 mM NaCl and 1 mM DTT. 2 ml fractions of eluent were collected and 
each sample was analyzed on SDS-PAGE gel for purity (Figure 8.3B). Pure fractions 
were concentrated down, flash frozen and stored at -80°C. 
 
8.2.2 Crystallization, Data collection and Structure Determination of SselΔ157 
Initial hits of crystals were obtained by screening using sitting-drop vapor 
diffusion method. Crystals of Ssel (residues 158-340), here referred  as SselΔ157 
(11mg/ml), were grown from sitting drops in a mother liquor containing 0.1 M HEPES 
sodium pH 7.5 and 1.5 M lithium sulfate monohydrate. These crystals grew in 2 weeks 
and were soaked in cryoprotectant containing 20% (v/v) ethylene glycol in the mother 
liquor and flash frozen with liquid nitrogen. The data collections were done at Advanced 
Photon Source (APS) and 23 ID-B beamline, Argonne National Laboratory in Argonne, 
IL. The data was collected using a Mar300 CCD detector at 100K and processed with 
HKL2000 program.16 
 The crystals of SselΔ157mutants diffracted to 2.4Å and the structure was solved by 
molecular replacement using full-length Ssel (PDB: 5HAF) structure as the search 
model.17  The complete model of the interpretable density was built manually in Coot18 
and initial refinements for the structure was carried out in Refmac519 using rigid body 
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refinement followed by restrained refinement. Multiple rounds of model building and 
refinement were performed with Coot18 and PHENIX.20 Optimized weighting was also 
applied during the structure refinement. The data collection and refinement statistics for 
both structures are shown in Table 8.1. All the figures were made using PYMOL (version 
1.7.0.0).21 
 
8.2.3 Diubiquitin Synthesis and Purification 
 Lys63-linked diubiquitin (K63-Ub2) was synthesized enzymatically using Ub 
AspD77 as the Ub acceptor and Ub Lys63Arg as the Ub donor.22 Human E1, two E2s 
(Uev1a, and Ubc13) and the two mouse ubiquitin mutants were purified separately, and 
mixed in a reaction buffer containing 80 mM Tris-HCl, 20 mM ATP, 20 mM MgCl2, 1 
mM DTT.  The synthesis reaction was carried out overnight at 37°C and was purified as 
described previously in chapter 3. Lys48-linked diubqiutin was also synthesized 
enzymatically using human E1, E2 (CDC34), Ub AspD77 as the Ub acceptor and Ub 
Lys48Arg as the Ub donar and purified like Lys63-linked diubiquitin chains. Whereas, 
for Lys11-linked diubiquitin, E1, E2 (Ube2S) and wild-type ubiquitin were incubated at 
37°C in reaction buffer until an appreciable amount of diubiquitin was formed as 
determined by SDS-PAGE. The sample was then quenched and further purified as 
Lys63-linked diubiquitin chains.  
Lys63-linked diubiquitin substrate with Gln40 mutated to alanine was designed to 
probe the binding of ubiquitin by Gln40 patch. Initially, Gln40 was mutated to alanine 
using the Ub Lys63Arg mutant as a template following standard site directed mutagenesis 
protocols. This new mutant construct was then confirmed by DNA sequencing. The 
ubiquitin double mutant was then purified in a similar manner as wild type ubiquitin as 
described in chapter 3. The synthesis of this new diubiquitin substrate was then 
accomplished following a typical Lys63-linked diubiquitin synthesis protocols. Lys63-
linked diubiquitin with Gln40 mutated to alanine was purified by a former lab member, 





8.2.4 Synthesis of Ubiquitin-Propargyl and Reactivity 
 Initially, Ubiquitin-MESNA was purified using intein-mediated semisynthetic 
chemistry following the previously described protocol.23-25 The plasmid DNA with 
ubiquitin (residues 1-75) subcloned into a pTXB1 vector containing an intein fused chitin 
binding domain at the C-terminus was used. The resulting fusion protein was expressed 
in Escherichia coli BL21 cells which was used to inoculate a starter culture in LB media 
supplemented with ampicillin and was grown overnight at 37°C. The next day, 6L of LB 
media supplemented with ampicillin was inoculated with the starter culture and grown 
until the optical density reached 0.4-0.6 and then induced with 0.3 mM IPTG to 
overexpress the protein at 18°C for 16-18°C. The cells were harvested, resuspended using 
purification buffer (50mM MES, 300 mM NaOAc, pH 6.0), lysed by French press and 
centrifuged at 100,000 x g for an hour. The supernatant was then applied to chitin resin 
for purification (New England Biolabs). The resin was then washed with 5 column 
volumes of MESNa purification buffer. About 2 column volumes of purification buffer 
supplemented with 250 μM MESNa was passed through the resin until the buffer was just 
above the resin. The column was then capped and incubated overnight at 37 °C, allowing 
for the trans-thiolation reaction and subsequent attachement of the MESNa moiety to the 
ubiquitin. The next day, the protein (ubiquitin-MESNa) was eluted using purification 
buffer supplemented with MESNa, concentrated down to 1.5 ml, and flash frozen in 
liquid nitrogen for further use. 
The reactive propargylamine moiety was attached to the C-terminus of ubiquitin 
to form ubiquitin-propargyl (Ub-prg) by incubating 500 μl of 98% (v/v) propargylamine 
(Sigma Aldrich) with 1.5 ml of ubiquitin-MESNa in 1 M sodium carbonate at pH 8, 
overnight at room temperature. The reaction was then quenched by adding10 X cation 
exchange purification buffer (50 mM sodium acetate pH 4.5) and then was passed 
through MonoS cation exchange resin (GE Life Sciences) using a linear gradient of 0-300 
mM NaCl. 0.5 ml fractions of eluent were collected and each sample was analyzed on 
SDS-PAGE gel for purity. Pure fractions were concentrated down, flash frozen and 
stored at -80°C.  
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The reactivity of different constructs of Ssel constructs (Full-length, residues 122-
340, here referred as SselΔ121 and SselΔ157) with Ub-PRG was demonstrated by incubating 
8 µM of Ssel constructs with excess Ub-PRG at room temperature, overnight. The 
reactions were then quenched using 5 X SDS-PAGE buffers and the reactivity was 
assessed by running on a 15% SDS-PAGE gel which indicated 8 kDa shifts in molecular 
weight. 
 
8.2.5 Kinetic Parameters Determination 
To determine the kinetic parameters, full-length Ssel (0.2-1µM) was incubated 
with different concentrations (20, 49.5, 77, 99.5 µM) of substrate (Lys63, Lys48, Lys11 
and Lys63Gln40A-linked diubiquitin) in a reaction buffer (50 mM Tris-HCl pH 7.4, 20 
mM KCl, 5 mM MgCl2, and 1 mM DTT) at room temperature (25ºC). Reactions 
proceeded for 15 minutes except with Lys11-linked diubiquitin (45 mins on the basis of 
initial velocity of the reaction) and were quenched with 5x SDS-PAGE sample buffer. To 
convert the quantified intensity of the formed monoubiquitin to molar concentration, a 
standard curve of 6, 20 and 40µM ubiquitin was prepared. Samples including the 
standards were separated in 15% SDS-PAGE gel and densitometric analysis in ImageJ26 
was performed to determine the amount of ubiquitin produced through the cleavage of 
diubiquitin. The initial velocity values were then plotted against substrate concentration 
using Kaleidagraph and the data were fitted to the Michaelis-Menten equation: 
Vi ൌ Vmax	ሾSሿKM ൅ ሾSሿ ൌ
݇ܿܽݐ	ሾEሿሾSሿ
KM ൅ ሾSሿ  
Where Vi is the initial velocity, Vmax is the maximum velocity, [S] is the substrate 
concentration, KM is the Michaelis constant, and kcat is the turnover rate. 
 Likewise, kinetic parameter for GST tagged full-length Ssel was also performed 
to determine if the GST-tag affects the activity of the enzyme as described above. 
Diubiquitin cleavage assay was also carried out using different constructs of Ssel (Full-
length, residues 122-340 and residues 158-340).  All reaction mixtures consisting of 5 
µM enzyme, 20 µM Lys63-linked diubiquitin and a reaction buffer (50 mM Tris-HCl (pH 
7.0), 20 mM KCl, 5 mM MgCl2, and 1mM DTT) were proceeded overnight at room 
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temperature which was then quenched by adding 5X SDS-PAGE sample buffer. Samples 
were loaded and run on 15% SDS-PAGE gel.  
 
8.2.6 Isothermal Titration Calorimetry 
In order to quantify the binding affinity of different constructs of Ssel (Full-
length, SselΔ121 and SselΔ157) with ubiquitin ITC experiments were carried out at 25oC 
using a GE/MicroCal ITC200 calorimeter. Protein samples were dialyzed overnight in a 
buffer of 50 mM Tris-HCl (pH 7.6) and 50 mM NaCl by exchanging the dialysis buffer 
three times. A total of 27 injections with 1.5 μL ubiquitin (1.1 mM) per injection were 
titrated into  ̴ 110 µM solution of protein. Each experiment has a spacing of 150 seconds 
between each injection to ensure that baseline was reached prior to the next injection. 
Baseline correction was performed by NITPIC and analyzed using a one-site model from 
SEDPHAT.27 
 
8.2.7 Polyubiquitinated PY-GFP Deubiquitination Assay 
In order to determine the ability of Ssel to cleave ubiquitin from a 
polyubiquitinated substrate, a polyubiquitinated PY-GFP which consists of mostly 
Lys63-linked ubiquitin chains and small population of Lys48 and Lys11-linked ubiquitin 
chains, purified by a former lab member Dr. Michael Sheedlo was used. Different 
constructs of  200 nm Ssel (full-length, residues 122-340 and residues 158-340) were 
incubated with 2µM polyubiquitinated PY-GFP (as determined by the concentration of 
GFP, not polyubiquitinated GFP)  in a reaction buffer (50 mM Tris-HCl pH 7.4, 20 mM 
KCl, 5 mM MgCl2, and 1 mM DTT) at room temperature (25ºC) for 15 minutes. The 
reactions were quenched with 5x SDS-PAGE sample buffer and were analyzed by 15% 
SDS-PAGE gel. The reaction of polyubiquitinated GFP with SdeA DUB domain was 
also run as a positive control. The loss of higher molecular weight band corresponding to 
polyubiquitinated GFP band was analyzed using ImageJ. Likewise, similar reaction was 
performed for only Ssel full-length at different time points (0, 5, 15, 30, 60, 180 secs). 
The low molecular weight bands corresponding to ubiquitin linkages of varying length 
193 
 
(ubiquitin, diubiquitin, triubiquitin and tetraubiquitin) were also then analyzed using 




8.3.1 Design of Ssel Constructs 
 The DUB domain of the Ssel was designed on the basis of sequence alignment 
with different prokaryotic DUBs and the secondary structure prediction program from 
ExPASy (Figure 8.2). With the help of sequence alignment, all three catalytic residues 
were assigned. Then, the secondary structure prediction program helped in finalizing the 
two possible DUB domain of Ssel: Ssel 158-340, here referred as SselΔ157, and Ssel 122-
340, here referred as SselΔ121. Additionally, the Ub-AMC cleavage assay by Ssel 
(residues 179-341) further confirmed the constructs of Ssel.28 
 
8.3.2 Structure of SselΔ157 Construct 
 The crystal of SselΔ157 diffracted to 2.4Å and crystallized in C2 space 
group. The structure was solved by molecular replacement using the full-length Ssel 
structure (PDB ID: 5HAF) as the search model. The final structure yielded Rcrys and Rfree 
values of 24.8% and 30.4% respectively (refer to Table 8.1 for crystallographic statistics). 
The asymmetric unit consists of two subunits of SselΔ157 with discernible electron density 
for residues 173-179, 265-268 in chain A and 174-177, 265-268, 298-301 in chain B 
(Figure 8.4A and B). Ssel consists of five stranded beta sheets ( β1 is disordered) with the 
middle strand β3 arranged antiparallel to the other four, similar to NEDP1 structure.29 
The beta sheets are sandwiched between five helices, α2 and α3 on the top, and α2, α4 
and α5 on the bottom. The α5 helix is followed by α6 helix with its axis aligned almost 
90° to the direction of β-strands.   
The catalytic core of Ssel consists of three beta strands (β2, β3 and β4) and the 
central helix α4, similar to other members of protease superfamily.29 The catalytic residue 
Cys285 is located at the N-terminus of α4 with His 223 at the N-terminus of β3 and 
Asn242 at the C-terminus of β4. A conserved glutamine (Gln278) residue at the N-
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terminus of catalytic Cys residue may stabilizes the oxyanion species. Comparison of two 
subunits in the asymmetric unit reveals different orientations of Cys285 and His223 
residues. In subunit A, the catalytic site is in unproductive formation with His223 rotated 
out of electrostatic interaction distance (> 4Å) from the catalytic Cys285 (Figure 8.4C). 
Whereas, in subunit B, all the three catalytic residues are within hydrogen bond/ 
electrostatic interaction distances; thus, suggesting the flexibility in the catalytic residue 
(Figure 8.5).    
 
8.3.3 Diubiquitin Cleavage by Ssel Constructs with Preference for Lys63-linked Chains 
 The ability of Ssel to cleave polyubiquitin chains has been shown previously 
using GST-tagged Ssel.7 The study showed that GST-Ssel prefers Lys63-linked 
polyubiquitin chains over Lys48-linked chains. Moreover, the kinetic parameters for Ssel 
have been determined using ubiquitin-7-amino-4-methylcoumarin (Ub-AMC), a synthetic 
monoubiquitin fluorogenic substrate.7,28 However, to determine the kinetic parameters of 
untagged Ssel using a natural substrate such as diubiquitin, a gel based diubiquitin 
cleavage assay was performed. All three constructs of Ssel, full-length, SselΔ157, and 
SselΔ121, were used for the Lys63-linked diubiquitin cleavage assay (Figure 8.6A). 
Surprisingly, the shorter constructs of Ssel shows a pronounced effect on its activity, in 
contrast to the study performed with Ub-AMC using Ssel (179-341 residues).28 Despite 
performing the overnight cleavage assay, Figure 8.6B shows that the shortest construct 
SselΔ157 barely cleaves the substrate followed by SselΔ121 construct.  
Full-length Ssel was then used to determine the Michaelis-Menten parameters of 
the reaction. These assays yield KM and kcat values of 17.1 μM and 0.08 s-1, respectively 
for Lys63-linked diubiquitin substrate. Likewise, the kinetic parameters for Lys48- and 
Lys11-linked diubiquitin substrate were also determined (Table 8.2). Although a minimal 
effect is seen in KM, Ssel cleaves both Lys48- and Lys11-linked diubiquitin poorly. 
Lys11-linked diubiquitin is the worst substrate of all three as the kcat showed forty-four-
fold reduction as compared to Lys63-linked diubiquitin. Overall, the kinetic data 
indicates that the preferred chain type of Ssel is indeed Lys63-linked ubiquitin chains, 
consistent with previous studies (Figure 8.7 and 8.8A-C).7 Furthermore, kinetic 
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parameters were also calculated using GST-Ssel to confirm that the GST-tag does not 
interfere with the substrate binding and catalysis. GST-Ssel shows similar binding 
constant (KM) and kcat values using Lys63-linked diubiquitin substrate (Figure 8.8E, 8.9 
and Table 8.3).  
Furthermore, to probe the Gln40 binding site as seen in SdeA DUB, a Lys63-
linked diubiquitin substrate was designed with Gln40 mutated to alanine. Kinetic 
parameters were calculated and showed that the KM value is 2.6 fold lower than the 
wildtype Lys63-linked diubiquitin substrate and kcat is twenty-two- fold lower (Figure 
8.7, 8.8D and Table 8.2). These results suggest that Ssel recognizes this unique patch 
(Gln40) of ubiquitin, similar to SdeA DUB. 
 
8.3.4 Formation of Covalently-linked Adduct 
 To determine the ability of Ssel to bind ubiquitin, a suicide inhibitor ubiquitin-
propargyl (Ub-prg) was synthesized and reacted with different constructs of Ssel. Due to 
the inability of shorter constructs of Ssel (SselΔ157 and SselΔ121) to cleave diubiquitin 
substrate, molecular weight shift due to formation of covalent adduct was not expected. 
However, all the constructs of Ssel (Full-length, SselΔ157, and SselΔ121) shows an 8.5 kD 
shift in SDS-PAGE gel (Figure 8.6C). Moreover, the shorter constructs left no unreacted 
DUB compared to full-length Ssel. These results suggest that the shorter constructs may 
have been able to bind to ubiquitin due to the stronger covalent interaction between the 
catalytic Cys285 residue and reactive propargyl moiety linked to the C-terminus of 
ubiquitin. 
  
8.3.5 Ubiquitin Binding by Ssel 
 To understand the ability of different constructs of Ssel to bind to monoubiquitin, 
ITC experiments were performed. In these experiments, Ssel binds monoubiquitin with 
KD of 5.261 ± 0.025 µM (Table 8.4); whereas, the other two constructs lacking the N-
terminal domain show no binding with ubiquitin (Figure 8.10). These ITC data suggest 
that the entire affinity for ubiquitin must have come from N-terminal VHS (Vps27, Hrs 
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and STAM) domain of Ssel, suggesting that VHS domain is involved in ubiquitin 
binding. 
 
8.3.6 Deubiquitination of Polyubiquitinated GFP Substrate 
 Comparison of different constructs of  Ssel (full-length, SselΔ157, and SselΔ121) 
with SdeA DUB domain shows that like SdeA DUB, full-length Ssel cleaves 
polyubiquitin chains from PY-GFP substrate as shown by the loss of higher molecular 
weight corresponding to polyubiqutinated PY-GFP (Figure 8.11A). The shorter 
constructs, SselΔ157, and SselΔ121, show no cleavage with the polyubiquitinated substrate, 
which is consistent with other diubiquitin cleavage assay data (Figure 8.11A and B). 
Interestingly, the full-length Ssel yields a banding pattern that included ubiquitin chains 
of varying length (mono, di, tri, tetra and penta) over the course of reaction. The banding 
pattern shows a higher accumulation of diubiquitin compared to any other ubiquitin 
chains (Figure 8.11C). Additionally, no free PY-GFP is seen in the reaction, suggesting 
that the GFP is not completely deubiquitinated.  
    In order to confirm that Ssel cannot completely deubiquitinate polyubiquitinated 
substrate, a time course assay was performed. Within three hours, the banding pattern 
seemed to disappear, and a band corresponding to GFP and a higher accumulation of 
monoubiquitin was seen (Figure 8.12 A and B). These observations indicate that the 
cleavage preference of Ssel is controlled compared to SdeA DUB. 
 
8.3.7 Model of Ssel Bound to Ubiquitin 
 The model of Ssel bound to ubiquitin was generated by aligning catalytic residues 
of SselΔ157 construct onto catalytic residues of SdeA DUB bound to ubiquitin (PDB: 
5CRA) because SdeA DUB was the first DUB to show a novel mode of ubiquitin 
recognition via Gln40 (Figure 8.13). The model showed some clashes between ubiquitin 
and the loop of Ssel; therefore, the ubiquitin was moved to prevent the clash such that 
Gln40 was accessible for binding. The full-length Ssel (PDB: 5HAF) was then 
superimposed onto the SselΔ157.  
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 Pruneda et al. has shown that bacterial DUBs bind ubiquitin at four different sites: 
variable region 1, 2, 3 (VR-1, VR-2 and VR-3) and a conserved helix (also known as 
constant region, CR).30 The model of SselΔ157 bound to ubiquitin consists of VR-2, VR-3 
and CR, but not VR-1 which may be the reason for the loss of ubiquitin binding, 
consistent with ITC data. The potential VR-1 is shown in dash line in the model (Figure 
8.10). The inability of the shortest construct (SselΔ157) to bind to its substrate due to the 
lack of VR-1 may also have resulted in poor catalytic activity. Interestingly, the structure 
of full-length Ssel (PDB:5HAF) also lacked VR-1 region suggesting that the VR-1 
consists of loop which is highly disordered and unable to be captured in the crystal 
structure (Figure 8.14A), thus the presence of substrate (ubiquitin) may help in forming 
the well-ordered conformation of the loop.  
 
8.4 Discussion 
Ssel is a bacterial DUB from Salmonella typhimurium that mimics eukaryotic 
DUBs and manipulates the host ubiquitin system.5 Upon infection, Ssel is injected by the 
Salmonella–containing vacuole (SCV) into the host cytosol along with other effector 
proteins which causes the bacteria to be recognized by the host ubiquitin. As a result, 
SCV gets ubiquitinated and autophagosomes surrounding the intracellular proteins 
aggregate in the host’s cytoplasm.9 The ubiquitinated species are then recognized by p62 
(ubiquitin binding protein) and are transported to the lysosome for destruction via an 
autophagy-mediated pathway.14 Ssel, through its DUB activity, removes ubiquitin from 
SCV and protein aggregates, thus delaying the lysosomal degradation and facilitating 
bacterial propagation.14,15 Interestingly, these aggregates are assumed to be Lys63-linked 
polyubiquitinated,14 and the preference of Ssel for Lys63-linked chains over other chain 
types, as seen by kinetic analysis, is consistent with this assumption. Moreover, Ssel also 
recognizes its substrate (diubiquitin) via Gln40 as shown by low kcat when a Lys63-linked 
diubiquitin mutant (Gln40Ala) was used as a substrate. Therefore, it is possible that when 
ubiquitin binds to Ssel, the ubiquitin is oriented in a similar manner as seen in SdeA DUB 
such that Gln40 of ubiquitin is accessible for interaction.  
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Ssel shows an interesting result while cleaving a polyubiquitinated PY-GFP 
substrate. The enzyme removes the polyubiquitin chains from the substrate only after a 
longer incubation period. Initially, the cleavage shows a banding pattern of different 
ubiquitin chain lengths. The slow activity and the banding pattern may be due to the 
presence of different linkages within the polyubiquitin chain. It is possible that Ssel starts 
cleaving Lys63-linked chains first followed by Lys48- and Lys11-linked chains. As a 
result, it takes longer to cleave off the polyubiquitin from PY-GFP substrate compared to 
SdeA DUB.  On the other hand, the accumulation of diubiquitin in the initial time points 
suggests that Ssel may prefer ubiquitin chains longer than diubiquitin. Once the ubiquitin 
chains of higher lengths get depleted, the enzyme cleaves diubiquitin and generates 
monoubiquitin. It is unclear why Ssel would prefer longer chain length. Further 
experiments should be performed to determine the minimal chain length necessary for the 
efficient cleavage by Ssel.   
 The structure of Ssel (residues 158-340, SselΔ157) reveals a core Ulp fold and 
catalytic triad, consistent with other bacterial DUBs of CE clan.30 Comparison of this 
structure of Ssel to full-length Ssel shows that one of the subunits in the asymmetric unit 
of SselΔ157 construct was in unproductive form, indicating the flexibility of the catalytic 
residues and that the N-terminal domain of Ssel may be required to make the catalytic 
residues rigid. Although all the catalytic residues were present, the activity was highly 
impaired which may be due to the flexible catalytic residues or its inability to bind to the 
substrate. Surprisingly, the construct forms a covalently-linked adduct with Ub-prg 
similar to full-length Ssel, suggesting that the ubiquitin binding may not be impaired, in 
contrast to the ITC experiment. To further understand the ubiquitin binding, a model of 
SselΔ157-Ub was generated. According to the model, one of the regions (VR-1) which 
binds to ubiquitin is missing; as a result, this construct of Ssel could not bind the 
substrate tightly enough for catalysis. It is possible that the stronger covalent interaction 
between propargyl moiety of ubiquitin and the catalytic cysteine may have resulted in a 
covalent complex, as shown by 8.5kD shift (Figure 8.6C). A weaker non-covalent 
interaction is formed between the carboxylate group of Gly76 of ubiquitin and catalytic 
cysteine, suggesting more interactions may be required to hold the ubiquitin in place. To 
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further determine the minimal construct of catalytic domain of Ssel, SselΔ121 (residues 
122-340) was designed and cleavage assays, Ub-prg assays and ITC experiments were 
performed. On the basis of the full-length Ssel structure, SselΔ121 construct contains a 
potential VR-1 region that may be involved in ubiquitin recognition. Just like the SselΔ157 
construct, SselΔ121 is unable to bind its substrate despite having the residues that may be 
involved in ubiquitin binding.  
 The model of the SselΔ157-Ub complex shows that SselΔ157 construct contains three 
regions out of four regions that may be required for binding ubiquitin. However, the 
construct could not bind, suggesting that the N-terminal VHS domain of Ssel may be 
involved in ubiquitin binding. In eukaryotes, VHS domains are involved in vesicular 
trafficking by binding to the ubiquitin of the receptor or phosphorylated receptor.31,32 
Pruneda et al. showed that VHS domain of Ssel has high affinity for ubiquitin; however, 
this domain has no contribution to ubiquitin recognition or hydrolysis of ubiquitin 
chains.30 It was shown to be involved in subcellular localization of the effector.30 
Interestingly, Pruneda et al. showed by NMR titration experiment that the isolated VHS 
domain of Ssel and full-length Ssel (24-340) have identical ubiquitin binding affinity.30 
The ITC data presented here showed that the shorter constructs of Ssel (SselΔ157 and 
SselΔ122) cannot bind to the ubiquitin at all; therefore the entire ubiquitin binding affinity  
(KD: 5.26 µM) for full-length must be from VHS domain alone. Taken together, it can be 
suggested that the Ssel binds to ubiquitin with the help of VHS domain.  
 The structure of full-length of Ssel shows that the potential VR-1 site is the loop 
region which was highly dynamic; as a result, it was not captured in the crystal structure. 
This flexible loop links VHS domain to the catalytic domain of Ssel. Due to the dynamic 
nature of the loop, it is possible that VHS domain of Ssel not only binds to ubiquitin, but 
also facilitates catalysis. Thus, it can be said that Ssel may bind to its substrate in at least 
two steps. Initially, VHS domain of Ssel which has high affinity for ubiquitin may be 
used to capture the substrate. Then, with the help of the flexible loop that links the VHS 
domain and the catalytic domain of Ssel, VHS domain would present ubiquitin to the 
catalytic domain for catalysis. 
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The model of the SselΔ157-Ub complex also shows that the Ile44 patch of ubiquitin 
is solvent exposed and is accessible for interaction (Figure 8.13). Inspection of the Ssel 
loop (residues 137-157) revealed a surface exposed hydrophobic patch centered on 
Trp154 as a potential Ub-interacting surface (Figure 8.14). Further studies should be 
performed to determine if Trp154 is involved in ubiquitin binding. It is possible that the 
VHS domain of Ssel may play a role in capturing the substrate initially and then present it 
to the catalytic domain such that the loop is turned next to Ile44 patch for interaction 
(Figure 8.14B). In order to validate the model and confirm the observations, determining 
the crystal structure of full-length Ssel and ubiquitin complex would be beneficial. 
Moreover, extending the study by using different bacterial DUBs, especially ElaD, which 
shares 38% sequence identity with Ssel, may provide some insight into ubiquitin binding 
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Figure 8.1: Role of Ssel in Salmonella Typhimurium. The bacterium shown in yellow is 
taken up by a normal macrophage via phagocytotic mechanism, which then resides in a 
Salmonella-containing vacuole (SCV). With the help of type-III secretion system, 
Salmonella inject effector proteins along with Ssel into the host cytoplasm that causes the 
bacterium to be recognized by the host ubiquitin. As a result, SCV gets ubiquitinated and 
autophagosomes surrounding intracellular protein aggregates in the host’s cytoplasm. 
These ubiquitinated species are then destroyed in lysosome via autophagy-mediated 
pathway. However, in presence of Ssel, ubiquitin from SCV and protein aggregates are 















Figure 8.2: Sequence alignment of prokaryotic DUBs highlighting the conserved residues 
in red. The alignment consists of Dubs from from Legionella pneumophila (SdeA), 
Salmonella typhimurium (Ssel), Escherichia coli (ElaD) and Chlamydia trachomatis 
(Chladub1 and Chladub2). NEDP1, an eukaryotic deNeddylating enzyme, is included as 





















Figure 8.3: Purification of Ssel (residues 158-340) construct. A) Superdex 75 size 
exclusion chromatography chromatogram showing a clear separation between GST and 
Ssel samples. The inset is the initial purification of Ssel using GSH-sepharose resin (GE 
Life Sciences). The abbreviation represents cell lysate (L), supernatant (S), flowthrough 
(FT), was (W), elution (E), after dialysis (AD) and subtraction (Sub). B) SDS-PAGE gel 
of the samples obtained from the S-75 column to analyze the protein purity. The samples 












Figure 8.4: Structures of Ssel (residues 158-340, SselΔ157). A) Diffraction pattern of Ssel 
crystals. B) Ribbon representation showing secondary structures of SselΔ157. C) Expanded 
view of catalytic triad (C285, H223 and N242) including a residue Q278 that stabilizes an 
oxyanion species. One of the subunits of Ssel was in unproductive form with 7.3Å 















Table 8.1: Crystallographic Data Table of Ssel (residues 158-340) 
 
 Ssel (158-340) 
Data collection  
Space group C2  
Cell dimensions  
    a, b, c (Å) 109.8, 65.0, 56.9 
    , ,  ()  90.0, 113.6, 90.0 
Wavelength (Å)   1.033 
Resolution (Å) 54.6- 2.4 (2.44-
2.40)           
 Rmerge (%) 9.3 (81.0) 
I / I 11.4 (2.05) 
Completeness (%) 99.9 (100)         
Redundancy 3.8 (3.8)          
  
Refinement  
Resolution (Å) 2.4               
No. reflections 14424 
Rwork / Rfree 24.8/30.4 
No. atoms  
    Protein 1004 
    Ion 0 
    Water 34 
R.m.s. deviations  
    Bond lengths 
(Å) 
0.004 




Preferred (%) 93.33 
Allowed (%) 5.76 




    Protein  53.5 
    Ion 0 
    Water 47.5 
    Ligand 54.7 
 
Values in parentheses are for the highest resolution shell.   
a Rsym = ∑∑|Ihkl − Ihkl(j)|/∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the final 
average intensity. 
b Rcrys = ∑||Fobs| − |Fcalc||/∑|Fobs| and Rfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys 
are calculated using a randomly selected test set of 5% of the data and all reflections 





Figure 8.5: Comparison of Ssel structures. A) Superposition of SselΔ157 (purple) onto full-
length Ssel (green). B) Stick representation of catalytic residues of Ssel from two 
subunits of SselΔ157 and full-length Ssel. His223 and C285 show a slight variation in its 





















                      
 
Figure 8.6: Different constructs of Ssel used in this study. A) Domain diagram of 
different constructs of Ssel. Full-length Ssel consists of VHS (orange) and DUB (purple) 
domain. The shortest construct (residues 158-340) consist of only DUB domain. Ssel 
(residues 122-340) is slightly longer and include part of a VHS domain. B) SDS-PAGE 
gel comparing the activity of different Ssel constructs. Each reaction mixture contained 
5µM enzymes with 20µM concentrations of Lys63-linked diubiquitin, and each reaction 
proceeded at 20°C overnight before quenching with 5 X SDS-PAGE sample buffers. C) 
SDS-PAGE gel showing ubiquitin-propargyl (Ub-prg) reactivity with different Ssel 
constructs. Each constructs was incubated with excess Ub-prg overnight at room 




Figure 8.7: Kinetic Plots of Ssel diubiquitin cleavage. The kinetic parameters were 
determined for Ssel using different diubiquitin substrate: Lys63- (black), Lys48- (green), 
Lys11- (red) and Gln40-Ala, Lys63- (blue) linked diubiquitin. Each plot was fit with the 
Michaelis-Menten equation.  
 
 




KM (μM) kcat (s-1) kcat / KM x10-3 
(μM-1 s-1) 
Lys63-linked 17.1 ± 2.97 0.08 ± 0.0035 4.7 
Lys48-linked 61.7 ± 11.5 0.018 ± 0.0016 0.3 
Lys11-linked 38.9 ± 5.65 0.0018 ± 0.0001 0.05 
Gln40Ala, Lys63-
linked 















Figure 8.8: SDS-PAGE gel of diubiquitin cleavage reactions with ubiquitin standards, different 
concentrations of the substrate and product after the reaction. Ubiquitin standards are used to 
quantitate ubiquitin produced from the reaction. Each reaction mixture contained A) 200 nM 
B)800 nM, C)800 nM , D) 1µM of full-length Ssel and E) 200 nM of GST-SSel with different 
concentrations of diubiquitin substrate (Lys63-, Lys48-, Lys11, Gln40Ala Lys63-linked 
diubiquitin). The reaction proceeded for A, B, D, E) 15 mins and C) 45 mins at 20°C and 






Figure 8.9: Comparison of kinetic plots of Ssel (black) and GST-Ssel (green) using 





Table 8.3: Comparison of Kinetic parameters of Ssel and GST-Ssel 
 
Sample KM (μM) kcat (s-1) kcat / KM x10-3 
(μM-1 s-1) 
Ssel 17.1 ± 2.97 0.08 ± 0.0035 4.7 





















































































































































































































Table 8.4: Thermodynamic parameters of Ssel constructs deduced from ITC data 
 
Protein Titrant KD (μM) ΔH (kcal/mol) ΔS (cal 
mol−1 K−1) 
Ssel Ub 5.26 ± 0.03 -17.63 ± 0.18 -35.052 
SselΔ121 Ub N/A N/A N/A 





















Figure 8.11: Comparison of cleavage of polyubiquitinated PY-GFP substrate. A)  SDS-
PAGE gel of polyubiquitinated PY-GFP cleavage reactions using SdeA DUB and different 
constructs of Ssel (full-length, residues 122-340 and residues 158-340). B) Graphical 
representation of cleavage efficiency of SdeA DUB and different constructs of Ssel. C) 
Graphical representation of comparison between SdeA DUB and full-length Ssel banding 





Figure 8.12: Deubiquitination of polyubiquitinated PY-GFP by full-length Ssel. A) SDS-
PAGE gel of cleavage of polyubiquitinated PY-GFP substrate at different time points 
showing a banding pattern of ubiquitin chains of varying length. B) Graphical 
representation of the amount of different ubiquitin chain length accumulated during the 




Figure 8.13: Model of Ssel (residues 158-340) bound to ubiquitin. Ssel is shown in purple 
and ubiquitin in red. The model was generated by superimposing Ssel into SdeADUB 
bound to ubiquitin (PDB: 5CRA). The model shows three different variable regions (VR-
1, VR-2, VR-3) and constant region (CR) that are responsible for ubiquitin binding. VR-1 
is shown in black dash line which is missing from Ssel (residues 158-340) construct. The 






















Figure 8.14: Model of full-length Ssel bound to ubiquitin. A) Superposition of Ssel 
(residues 158-340) shown in purple onto full-length Ssel shown in green to generate the 
model of full-length Ssel –Ub complex. The black dash line represents the loop region 
that is missing from the structure. B) A model of Ssel showing the movement of VHS 
domain (compared to Figure 8.14A) to bring the loop (potential VR-1 region) closer to 
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ABSTRACT: AMSH, a conserved zinc metallo deubiquiti-
nase, controls downregulation and degradation of cell-surface
receptors mediated by the endosomal sorting complexes
required for transport (ESCRT) machinery. It displays high
specificity toward the Lys63-linked polyubiquitin chain, which
is used as a signal for ESCRT-mediated endosomal−lysosomal
sorting of receptors. Herein, we report the crystal structures of
the catalytic domain of AMSH orthologue Sst2 from fission
yeast, its ubiquitin (product)-bound form, and its Lys63-linked
diubiquitin (substrate)-bound form at 1.45, 1.7, and 2.3 Å, respectively. The structures reveal that the P-side product fragment
maintains nearly all the contacts with the enzyme as seen with the P portion (distal ubiquitin) of the Lys63-linked diubiquitin
substrate, with additional coordination of the Gly76 carboxylate group of the product with the active-site Zn2+. One of the
product-bound structures described herein is the result of an attempt to cocrystallize the diubiquitin substrate bound to an active
site mutant presumed to render the enzyme inactive, instead yielding a cocrystal structure of the enzyme bound to the P-side
ubiquitin fragment of the substrate (distal ubiquitin). This fragment was generated in situ from the residual activity of the mutant
enzyme. In this structure, the catalytic water is seen placed between the active-site Zn2+ and the carboxylate group of Gly76 of
ubiquitin, providing what appears to be a snapshot of the active site when the product is about to depart. Comparison of this
structure with that of the substrate-bound form suggests the importance of dynamics of a flexible flap near the active site in
catalysis. The crystal structure of the Thr319Ile mutant of the catalytic domain of Sst2 provides insight into structural basis of
microcephaly capillary malformation syndrome. Isothermal titration calorimetry yields a dissociation constant (KD) of 10.2 ± 0.6
μM for the binding of ubiquitin to the enzyme, a value comparable to the KM of the enzyme catalyzing hydrolysis of the Lys63-
linked diubiquitin substrate (∼20 μM). These results, together with the previously reported observation that the intracellular
concentration of free ubiquitin (∼20 μM) exceeds that of Lys63-linked polyubiquitin chains, imply that the free, cytosolic form of
the enzyme remains inhibited by being tightly bound to free ubiquitin. We propose that when AMSH associates with endosomes,
inhibition would be relieved because of ubiquitin binding domains present on its endosomal binding partners that would shift the
balance toward better recognition of polyubiquitin chains via the avidity effect.
Ubiquitination, covalent attachment of the 76-amino acidprotein ubiquitin to target proteins, controls a wide array
of cellular functions, including protein quality control, cell cycle
progression, transcription, endocytosis, DNA repair, and
cellular signaling.1−5 Ubiquitin is attached to target proteins
via an isopeptide bond linking the side-chain amino group of
lysine residues of the target to the terminal carboxylate group of
ubiquitin (Gly76). This modification is allowed by the
sequential catalytic activity of three enzymatic systems: E1
(ubiquitin-activating enzyme), E2 (ubiquitin-conjugating en-
zyme), and E3 (ubiquitin ligase).6,7 The more widely
understood form of ubiquitination involves the attachment of
a polyubiquitin chain in which successive ubiquitin groups are
linked to one of the seven lysines, or the N-terminal amino
group of the preceding monomer, to generate homopolymeric
structures of one of eight linkage types. Polyubiquitin chains of
distinct three-dimensional architecture are thus generated
depending on which amino group of ubiquitin is used for
chain extension (lysine 6, 11, 27, 29, 33, 48, or 63 or the amino
group of Met1). A polyubiquitin chain of a given linkage type
signifies a specific type of functional outcome.5,8−10 For
example, Lys48 (K48)-linked chains and, to some extent,
K11-linked chains usually serve as the signal for proteasomal
degradation, whereas K63 chains signal other types of
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functions, such as DNA repair, endosomal−lysosomal sorting,
and NF-κB signaling.5,11
Ubiquitination is a reversible post-translational modification
like phosphorylation. Deubiquitinating enzymes, or DUBs, can
hydrolytically remove ubiquitin from protein adducts to
counteract ubiquitination. Accordingly, DUBs are known to
play key regulatory roles in numerous cellular processes that
rely on ubiquitination.12,13 The human genome encodes
approximately 100 DUBs, and most of their biological functions
are yet to be determined. They can be grouped into five major
families based on the structure of their catalytic domain:
ubiquitin specific proteases (USPs), ubiquitin C-terminal
hydrolases (UCHs), ovarian tumor proteases (OTUs), JAB1/
MPN/MOV34 metalloenzymes (JAMMs), and Machado-
Josephin domain proteases (MJDs).14,15 Mechanistically,
these enzymes can be divided into two main groups: cysteine
proteases and zinc metalloproteases. The zinc metalloproteases
consist of only one family, the JAMMs, whereas the other four
families are cysteine proteases.14,16,17
The JAMM family of metallo DUBs is mechanistically related
to the well-known metalloprotease thermolysin, despite having
sequences substantially different from that of thermolysin.
Generally, the active sites of thermolysin-like metalloproteases
contain a Zn2+ ion coordinated by two histidines, an aspartate
(or a glutamate), and a water molecule. The water molecule is
held in place by hydrogen bonding with a different glutamate
residue from the second coordination sphere, in addition to the
metal ion, and acts as the nucleophile during the hydrolysis
reaction.16,18−20 Of the 14 JAMM proteins in the human
genome, only seven contain a complete set of conserved
residues needed for Zn2+ coordination in the active site, six of
which, AMSH, AMSH-LP (AMSH-like protein), BRCC36,
RPN11 (POH1), MYSM1, and CSN5, are known to have
isopeptidase activity toward proteins conjugated to ubiquitin or
ubiquitin-like modifiers.14,16,17,20−27
Endocytic sorting of cell-surface receptors to lysosomes for
their degradation is executed by the ESCRT (endosomal
sorting complexes required for transport) machinery, which
consists of four different macromolecular assemblies, ESCRT-0,
-I, -II, and -III.28,29 Internalized receptors (cargo) are
ubiquitinated in their cytosolic parts by attachment of Lys63-
linked polyubiquitin chains, which then serve as a signal for
subsequent sorting and delivery of cargo to lysosomes via the
multivesicular bodies (MVB) pathway.30,31 Lys63-linked
polyubiquitin chains attached to receptors are required for
their binding to the ESCRT machinery, whose members shuttle
the cargo and package it into intraluminal vesicles (ILVs) in
MVBs (endosomes carrying ILVs are known as MVBs). The
ESCRT members appear to play distinct roles in this sorting
process. ESCRT-0 clusters ubiquitinated cargo on early
endosomes and subsequently passes it to the next member,
ESCRT-I, which is responsible for recruiting ESCRT-II.
ESCRT-I and -II work in tandem to bend the membrane,
creating membrane buds, while ensuring that the cargo is
confined to these newly formed buds. In the final step of cargo
sorting, components of ESCRT-III assemble at bud necks to
catalyze the scission process, whereby the newly formed vesicles
carrying cargo are released into the lumen of the endo-
some.29,31−33 Subsequently, these newly formed ILVs fuse with
the lysosome, delivering the cargo for its destruction. It is
important to note that the cargo is deubiquitinated prior to its
sequestration into ILVs to spare ubiquitin from being destroyed
in the process. Accordingly, certain members of ESCRT-III
feature binding domains for recruiting AMSH and USP8 (also
known as UBPY), the two mammalian DUBs known to
regulate endocytic sorting.30,31,34−36 It is not clear why two
DUBs, one exquisitely specific for the Lys63-linked poly-
ubiquitin chain (AMSH) and the other with no specificity
(USP8), are chosen for this task. Interestingly, in mammals, the
initial complex, ESCRT-0, can also recruit both DUBs, the
functional significance of which remains to be elucidated.37 One
possibility is that recruitment of AMSH might be required for
shortening polyubiquitin chains, so that the cargo can be passed
easily from ESCRT-0 to ESCRT-I and -II, a necessity arising
because the latter two complexes manifest affinity for the
polyubiquitin chain weaker than that of ESCRT-0. The chain
shortening action of AMSH is consistent with its high
selectivity for Lys63-linked chains; it can disassemble Lys63-
linked chains but perhaps cannot remove ubiquitin completely
from the cargo. In contrast, the recruitment of USP8 at the
ESCRT-0 stage might lead to complete deubiquitination of the
cargo, resulting in its falling off from the ESCRT complexes.
This would likely facilitate its recycling back to the plasma
membrane.37,38
Our laboratory has been interested in understanding the role
AMSH plays at the ESCRT-0 stage in regulating endocytic
sorting. So far, we have determined the structure of AMSH and
established a mechanism of its activation upon binding to the
STAM component of ESCRT-0. Specifically, using site-directed
mutants, we have shown recently that the UIM domain of
STAM, abutting its SH3 domain that it uses to bind to AMSH,
could facilitate catalysis by binding to the proximal ubiquitin of
a diubiquitin substrate.38 (In diubiquitin, a lysine residue of one
ubiquitin, called the proximal ubiquitin, is covalently attached
to the last carboxylate group, Gly76, of the other ubiquitin,
called the distal ubiquitin.) Such a mode of binding could lead
to catalytic activation of the DUB upon its association with
ESCRT-0. We wish to provide structural data in support of the
biochemical evidence with the hopes of clearly establishing the
mechanism underlying the recruitment and activation of AMSH
at ESCRT-0. For this reason, we purified a ternary complex
consisting of a catalytically inactive construct of Sst2, the
Schizosaccharomyces pombe orthologue of AMSH, the UIM-SH3
construct representing STAM, and the Lys63-linked diubiquitin
substrate with the aim of crystallizing it. Although we are yet to
crystallize the ternary complex, our efforts in this direction so
far have yielded cocrystal structures of the enzyme bound to
diubiquitin, its substrate, and bound to ubiquitin, its product.
Our structural analysis provides important insights into the
mode of substrate recognition and shows that one of the
products of the diubiquitin substrate, that is the distal ubiquitin,
can remain tightly bound to the enzyme after the hydrolysis
reaction, as the carboxylate group of ubiquitin’s Gly76 is
coordinated to the active-site metal and is also hydrogen-
bonded with the conserved glutamate that is used for holding
the nucleophilic water. These product specific interactions
appear to offset the contribution of the proximal ubiquitin in a
diubiquitin substrate, thus explaining the close correspondence
between the affinity for the product and that for the substrate
(the dissociation constant with ubiquitin rivals the Michaelis
constant, KM, for the Lys63-linked diubiquitin substrate). It is
thus likely that the cytosolic form of AMSH, and by
extrapolation similar JAMM DUBs, would be bound to
ubiquitin and exist in an inhibited state.
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■ METHODS
Cloning, Expression, and Purification. Full length Sst2
and the UIM-SH3 domains of HseI (STAM orthologue of S.
pombe) were amplified by polymerase chain reaction using the
S. pombe cDNA library (a kind gift from K. Gould, Vanderbilt
University, Nashville, TN). The catalytic domain of Sst2
(residues 245−435), here termed Sst2cat, and a longer construct
of Sst2 (residues 221−435) containing the putative SH3
binding motif (SBM), here termed Sst2Δ220, were both
subcloned into pGEX-6P1 vectors using standard cloning
protocols. The DNA encoding the UIM-SH3 domains of HseI
was subcloned into the pGEX-6P1 vector. Human ubiquitin
was also subcloned into a pGEX-6P1 vector. The resulting
recombinant DNA constructs were transformed into Escherichia
coli Rosetta cells to be expressed as a recombinant protein fused
with a glutathione S-transferase (GST) tag at their N-termini
and purified as described. Six liters of Luria-Bertani cultures was
grown at 37 °C until the optical density at 600 nm reached
0.4−0.6 and then induced with 0.1−0.3 mM isopropyl β-D-
thiogalactoside (IPTG) to allow overexpression of the protein
at 18 °C overnight. The next day, the cells were centrifuged at
8630g for 10 min at 4 °C and the pellets were resuspended in
phosphate-buffered saline (PBS) containing 400 mM KCl.
Lysozyme was added to the suspension, which was then lysed
via a French press. The lysate was centrifuged at 22000g for 45
min at 4 °C to remove the cellular debris. The supernatant was
further clarified by centrifugation again at 100000g for 30 min
at 4 °C. The GST-tagged protein was purified using a
glutathione-Sepharose column (GE Biosciences) according to
the manufacturer’s protocol. After removal of the GST tag with
PreScission protease (GE Biosciences), the protein was further
purified by size exclusion chromatography (SEC) in a buffer
consisting of 50 mM Tris-HCl, 50 mM NaCl, and 1 mM DTT
(pH 7.6) using a Superdex S75 column (GE Biosciences). All
protein samples were concentrated, and the final concentrations
were measured spectrophotometrically at 280 nm. Samples
were flash-frozen and stored at −80 °C until they were used.
Glu286Ala, Asp354Ala, and Thr319Ile mutations were
introduced individually into the Sst2cat construct by site-
directed mutagenesis following the standard protocol. Addi-
tionally, the Glu286Ala, Asp354Ala, Tyr234Val, Thr235Asp,
and Glu239Lys point mutations were all introduced sequen-
tially into the Sst2Δ220 construct (this construct therefore
contains five mutations). The presence of these mutations was
confirmed by DNA sequencing. The resulting GST-tagged
mutants were expressed in E. coli and purified following the
purification methods described above.
To avoid issues that may arise as a result of an N-terminal
pentapeptide cloning artifact from ubiquitin prepared via GST
affinity chromatography, ubiquitin was prepared from a
pRSETA plasmid (gift from P. Loll, Drexel University,
Philadelphia, PA) for isothermal titration calorimetry experi-
ments. After cells had been induced with 300 μM IPTG at an
OD600 ranging from 0.4 to 0.6, expression was conducted
overnight at 18 °C. Cells were harvested at 3570g, and pellets
were resuspended in 50 mM sodium acetate (pH 4.5). The
suspension was lysed via two rounds of a French press, and the
lysate was heated to 80 °C for 5 min before centrifugation at
100000g for 1 h. The lysate was loaded onto a column
containing SP-Sepharose Fast Flow resin (GE Healthcare), pre-
equilibrated in 50 mM sodium acetate (pH 4.5), and ubiquitin
was eluted by applying a step gradient with 50 mM sodium
acetate (pH 4.5) and 1 M NaCl. Ubiquitin was further purified
by size exclusion chromatography in a buffer consisting of 50
mM Tris (pH 7.6), 50 mM NaCl, and 1 mM DTT using a
Superdex S75 column (GE Biosciences).
Lys63-linked diubiquitin was synthesized enzymatically
according to published methods23 using Lys63Arg and Asp77
ubiquitin mutants, with some modifications. Human E1, Uev1a,
and Ubc13 and the two mouse ubiquitin mutants were purified
separately and then mixed in a reaction buffer containing 80
mM Tris-HCl (pH 7.4), 20 mM ATP, 20 mM MgCl2, and 1
mM DTT. The reactions were conducted overnight at 37 °C
and quenched at room temperature with a 10-fold excess of
buffer A [50 mM sodium acetate (pH 4.5)]. To separate
synthesized diubiquitin from unreacted ubiquitin, the quenched
reactions were loaded onto a MonoS cation exchange column
(GE Healthcare) pre-equilibrated with buffer A and eluted
using a linear gradient with buffer B [50 mM sodium acetate
(pH 4.5) and 1 M NaCl]. Diubiquitin was concentrated and
stored at −80 °C until it was used. For one of our
crystallography experiments, we also used a form of Lys63-
linked diubiquitin that was obtained by semisynthesis.39
Crystallization and Data Collection. Crystallization was
performed by sitting drop vapor diffusion at room temperature.
Crystals of Sst2cat were grown from the mother liquor
containing 0.2 M ammonium phosphate dibasic (pH 8.0) and
20% (w/v) poly(ethylene glycol) 3350, with either 2.7% (w/v)
1,6-hexanediol or 91 mM glycine included as an additive. With
the help of one of these additives, the crystals attain their
maximal size in 1−5 days. Crystals of Sst2catT319I grew in 1
week in 0.03 M citric acid, 0.07 M bis-tris propane (pH 7.6),
20% PEG 3350, and 1.8% benzamidine hydrochloride
(additive).
To prepare a complex of Sst2 and ubiquitin, Sst2cat and
ubiquitin were mixed in a ratio of 1:1.6. Crystals of the
complex, here termed Sst2cat−Ub, formed at room temperature
in 1 week in 0.2 M sodium citrate tribasic dehydrate (pH 8.3)
and 20% (w/v) PEG 3350. Sst2cat−Ub also crystallized in 60
days in 0.02 M zinc chloride and 20% (w/v) PEG 3350 (pH
4.5). With the goal of forming a complex between Sst2 and
diubiquitin, Sst2catE286A and Lys63-linked diubiquitin (synthe-
sized artificially by E. Strieter, University of Wisconsin
Madison) were mixed in a ratio of 1.5:1 to form the complex.
Crystallization was performed by sitting drop vapor diffusion at
room temperature, and crystals grew in 3 days from the mother
liquor containing 0.2 M ammonium phosphate dibasic (pH
8.0) and 20% (w/v) PEG 3350. Sst2catD354A and ubiquitin
were also mixed in a ratio of 1.8:1 to make the complex.
Crystals of the complex, here termed Sst2catD354A−Ub, also
formed at room temperature in 1 week in 1% (w/v) tryptone,
0.05 M HEPES sodium (pH 7.0), and 20% (w/v) PEG 3350.
The three-protein complex consisting of Sst2Δ220, the UIM-
SH3 domain of HseI, and Lys63-linked diubiquitin (K63-Ub2)
was buffer exchanged into 50 mM Tris (pH 7.6), 50 mM NaCl,
and 1 mM DTT. The three-protein complex was formed by
first mixing Sst2Δ220 and the UIM-SH3 domain from HseI to
form an initial complex, which was purified by size exclusion
chromatography on a Superdex S75 column (GE Biosciences).
Fractions from the sodium dodecyl sulfate−polyacrylamide gel
electrophoresis (SDS−PAGE) gel corresponding to the Sst2−
UIM-SH3 complex were pooled, concentrated, and complexed
with enzymatically synthesized K63-Ub2. This three-protein
complex was then purified by size exclusion chromatography,
again on a Superdex S75 column (GE Biosciences). SDS−
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PAGE fractions corresponding to the three-protein complex
were pooled and concentrated for crystallography. Initial
crystallization experiments were performed at 20 °C. A
Genomics Solutions Cartesian “Honeybee” 963 crystallization
robot was used to set up approximately 700 conditions in a
sitting drop format. Large crystals of Sst2 in complex with
enzymatically synthesized diubiquitin (Sst2Δ220−K63-Ub2)
grew after 1 month at 20 °C from the MCSG-1 crystal screen
(Microlytic) mother liquor containing 0.2 M MgCl2, 0.1 M
Tris-HCl (pH 8.5), and 25% (w/v) PEG 3350.
Crystals were briefly soaked in a cryoprotectant solution
(20−25% ethylene glycol) and flash-frozen by being plunged
into liquid nitrogen. Crystals of Sst2cat formed from additive
2.7% (w/v) 1,6-hexanediol were soaked in 2.5 mM zinc
chloride for 45 min and washed with 25% ethylene glycol,
which was also used as the cryoprotectant. Finally, the crystals
were flash-frozen in liquid nitrogen. X-ray diffraction data for
Sst2cat, Sst2cat−Ub, and Sst2Δ220−K63-Ub2 were collected at
100 K using a Mar300 CCD detector at beamline 23-ID-D, and
diffraction data for Sst2catT319I and Sst2catE286A−Ub were
collected at 100 K using a Mar300 CCD detector at beamline
23-ID-B at the Advanced Photon Source at Argonne National
Laboratory (Argonne, IL). All data were processed with
HKL3000.40
Structure Determination and Refinement for Sst2cat in
Its Free Form. Three crystal structures were obtained for
Sst2cat in two space groups. The difference in space groups
resulted from crystals that formed from different additives in
the same mother liquor. Crystals of Sst2cat grown using glycine
as an additive crystallized in the P212121 space group and
diffracted to 1.8 Å. Data were collected, and the structure was
determined by molecular replacement with MolRep41 of the
ccp4 suite42 using the catalytic domain of AMSH-LP23 as a
search model. A homology model for the catalytic domain of
Sst2 was generated on the basis of the crystal structure of the
catalytic domain of AMSH-LP using the SWISS-MODEL
homology modeling server.43 Crystals of Sst2cat grown using
1,6-hexanediol as an additive crystallized in the P21 space group
and diffracted to 1.45 Å. This structure was also determined by
molecular replacement (MR) with MolRep41 using the Sst2cat
structure as a search model. Initial refinements of both
structures were conducted in Refmac544 using rigid body
refinement followed by restrained refinement. The model was
built using Coot,45 and subsequent rounds of refinement were
conducted in PHENIX,46,47 yielding Rcrys and Rfree values of
20.2 and 23.8%, respectively, for the P212121 crystal and 16.7
and 19.2%, respectively, for the P21 crystal. During refinement,
TLS48,49 was also used, with the entire asymmetric unit taken as
one group.
Native Sst2 coordinates two metals, one in the active site and
one serving a structural role away from the active site. Using
crystals of Sst2cat belonging to the P21 space group, a
fluorescence edge scan was run to detect zinc in the crystal,
and data were collected at a wavelength of 1.283 Å. The crystal
diffracted to 1.67 Å, and the structure was determined using
zinc single-wavelength anomalous dispersion (Zn-SAD).
Experimental phasing was performed with AutoSol50 in the
PHENIX suite,45,46 using Phaser51 to calculate experimental
phases and RESOLVE52 for density modification and initial
model building, yielding interpretable density in the exper-
imental map. Subsequent rounds of model building and
refinement were conducted in Coot45 and PHENIX,46,47
respectively, yielding Rcrys and Rfree values of 17.7 and 21.1%,
respectively. TLS Motion47,48 was used during refinement,
using one group.
Crystals of the MIC-CAP mutant, Sst2catT319I, belong to the
P21 space group and diffracted to 1.9 Å resolution. Data were
collected, and the structure was determined by MR with
MolRep41 using the structure of Sst2cat as the search model.
After initial rigid body and restrained refinement with
Refmac5,43 additional rounds of refinement and model building
were conducted as described above, yielding Rcrys and Rfree
values of 18.9 and 21.6%, respectively.
Structure Determination and Refinement of Sst2cat−
Ub-Bound Structures. Sst2cat bound to ubiquitin (Sst2cat−
Ub) crystallized in two different space groups, arising from
different crystallization conditions. The crystal obtained from
0.2 M sodium citrate tribasic dihydrate and 20% (w/v) PEG
3350 (pH 8.3) crystallized in the P21 space group and diffracted
to 1.97 Å resolution. After detection of zinc by running a
fluorescence edge scan, data were collected at a wavelength of
1.281 Å using Zn-SAD. The structure was determined as
described above, using AutoSol50 to generate an experimental
map with interpretable density, allowing cycles of model
building and refinement using Coot45 and PHENIX,46,47
respectively. The final model yielded Rcrys and Rfree values of
17.7 and 20.7%, respectively. Crystals of Sst2cat−Ub grown in
0.02 M zinc chloride and 20% (w/v) PEG crystallized in the
P212121 space group and diffracted to 1.63 Å resolution. Data
were collected, and this structure was determined by MR with
MolRep41 using the Zn-SAD-determined Sst2cat−Ub structure
as a search model. The model was initially refined in Refmac543
using rigid body followed by restrained refinement. Rounds of
model building and refinement in Coot45 and PHENIX46,47
gave Rcrys and Rfree values of 19.5 and 21.5%, respectively.
TLS48,49 was used, with one group, during refinement of both
structures.
Crystals of Sst2catE286A−Ub, which crystallized in the
P212121 space group, and Sst2
catD354A−Ub, which crystallized
in the P21 space group, diffracted to 1.74 and 2.05 Å resolution,
respectively. These structures were also determined by MR
using the previously described Zn-SAD-determined Sst2cat−Ub
structure as a search model. MR, followed by rounds of
refinement and model building, was conducted as described
above. The final models yielded Rcrys and Rfree values for the
E286A mutant bound to ubiquitin of 20.3 and 23.2%,
respectively, while the Rcrys and Rfree values for the D354A
mutant bound to ubiquitin were 20.5 and 25.3%, respectively.
Structure Determination and Refinement of Sst2Δ220−
K63-Ub2. Crystals of Sst2
Δ220−K63-Ub2, which crystallized in
the P212121 space group, diffracted to 2.3 Å resolution, and the
structure was determined by MR using MolRep41 of the ccp4
suite42 using a model generated by superposition of Sst2cat with
the structure of AMSH-LP bound to diubiquitin (PDB entry
2ZNV23) as the search model. After superposition of the
structures, AMSH-LP atoms were removed, leaving a model of
Sst2 bound to diubiquitin. The model was built using Coot45
and refined using Refmac5,44 yielding Rcrys and Rfree values of
21.3 and 26.3%, respectively. TLS48,49 was used during
structure refinement in which one group was selected for
chain A (Sst2), five groups were selected for chain B (distal
ubiquitin), and three groups (proximal ubiquitin) were selected
for chain C. Optimized weighting was also applied during
structure refinement. All figures for all structures described
were rendered with PYMOL (version 1.7.0.0).53
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Determination of Kinetic Parameters. The kinetic
parameters were determined as described previously.20 Briefly,
the enzyme (25 nM Sst2cat or 1.25 μM T319I mutant) was
incubated in reaction buffer [50 mM Tris-HCl (pH 7.0), 20
mM KCl, 5 mM MgCl2, and 1 mM DTT] with four
concentrations of diubiquitin, ranging from 20 to 100 μM.
To elucidate initial rate measurements, these reactions were
conducted at 20 °C for 7.5 min (wild type) or 15 min (T319I
mutant). We attempted to obtain initial velocity measurements
for the E286A mutant, but no activity was detected under these
conditions. The reactions were quenched by the addition of 5×
SDS−PAGE sample buffer. Because of ubiquitin aggregation
upon boiling, samples were not boiled prior to being loaded on
an SDS−PAGE gel. Bands corresponding to monoubiquitin
were integrated using ImageJ.54 Ubiquitin standards ranging
from 6 to 40 μM were used to draw calibration plots, which
were used to quantify the amount of ubiquitin produced via the
cleavage of diubiquitin. All kinetic data were analyzed using
Kaleidagraph and fit to the Michaelis−Menten equation Vi =
(Vmax[S])/(KM + [S]).
Isothermal Titration Calorimetry. Isothermal titration
calorimetry (ITC) experiments were conducted at 25 °C to
determine the binding affinity of Sst2 with ubiquitin and
diubiquitin using a GE/MicroCal ITC200 calorimeter. The
protein solutions were dialyzed overnight in 50 mM Tris-HCl
(pH 7.6) and 50 mM NaCl, exchanging the buffer three times.
A typical experiment consisted of titrating 0.4−1 mM ubiquitin
(mono or di) into a 40−50 μM protein solution. A total of 28
injections (1.4 μL/injection) were performed over the course
of an experiment. Each experiment had a spacing of 180 s
between injections that allows for a return to baseline before
the subsequent injection. The data were baseline corrected by
NITPIC55 and analyzed using a one-site model from
SEDPHAT.56
■ RESULTS
Isolation of a Sst2−UIM-SH3 Domain−Lys63-Linked
Diubiquitin Ternary Complex. We have previously shown
that an AMSH construct spanning its DUB domain and its N-
terminally adjacent SH3 binding motif (SBM) can be activated
by the UIM-SH3 construct of the ESCRT-0 member STAM.38
To characterize the underlying activation mechanism structur-
ally and to gain insights into the mode of recruitment of AMSH
to ESCRT-0, we aimed to crystallize the ternary complex
consisting of a catalytically inactive DUB domain construct of
AMSH (bearing the active-site Glu to Ala mutation), UIM-
SH3, and Lys63-linked diubiquitin. However, we were unable
to crystallize this ternary complex, or even the binary complex
of AMSH with diubiquitin. We then turned to Sst2, the S.
pombe orthologue of AMSH. Catalytic constructs of Sst2
(Figure 1), including many of its mutants, showed better
expression and appeared to be suitable for crystallization (the
construct alone and its mutants readily yielded crystals from
multiple conditions). To generate the corresponding ternary
complex with the S. pombe constructs, we prepared a similar
inactivating mutant of the enzyme by replacing the active-site
Glu with Ala and prepared a complex with Lys63-linked
diubiquitin. Crystallization trials of this binary complex yielded
crystals, but surprisingly, these crystals happened to be those of
Sst2 bound to ubiquitin, a product fragment of diubiquitin.
Thus, in contrast to our expectation that the active-site Glu to
Ala mutant would be inactive, as has been seen in other
thermolysin-like proteases,57,58 there was enough hydrolytic
activity under the crystallization conditions to cleave
diubiquitin, leading to cocrystallization with the product (see
below). To completely inactivate the enzyme so that it could
form a stable complex with the diubiquitin substrate and the
UIM-SH3 construct, we had to introduce an additional
mutation by changing an active-site zinc-coordinating Asp to
Ala. Furthermore, Sst2, while sharing a high level of sequence
similarity with AMSH in both its catalytic and MIT
(microtubule interacting and trafficking) domain (for binding
to ESCRT-III members), bears three substitutions in its
corresponding SBM that are presumed to render the SBM
nonfunctional for binding to the SH3 domain of STAM (Hse1
in S. pombe). We therefore engineered three mutations in this
domain (Figure 1) to restore a functional SBM as found in the
human counterpart (see below), with the hope of creating a
construct of Sst2 that would bind to the UIM-SH3 domain of
Hse1. Indeed, a ternary complex consisting of the catalytically
inactive Sst2 DUB construct, Lys63-linked diubiquitin, and the
UIM-SH3 domain could be purified via size exclusion
chromatography, indicating that a stable complex was formed
among the three proteins (Figure 1 of the Supporting
Information). Despite several attempts to conduct crystalliza-
tion trials, the complex so far has yielded crystals of only the
enzyme bound to Lys63-linked diubiquitin. The crystal
structures of these two complexes allow comparison of Sst2
bound to the product, generated, as described previously, in situ
from a mixture of enzyme (catalytically impaired because of the
Glu to Ala mutation, yet with some residual activity) and its
substrate. Additionally, we decided to take advantage of Sst2’s
Figure 1. Comparison of AMSH, AMSH-LP, and Sst2. (a) Domain
structures of AMSH, AMSH-LP, and Sst2. The JAMM domain is
colored blue, while the SBM and MIT domains are colored purple and
green, respectively. Sst2cat and Sst2Δ220 were used to crystallize
product- and substrate-bound structures, respectively. Sst2Δ220
contains mutations that both inactivated the enzyme (for substrate
binding) and knocked in a functional SBM for recognition of the SH3
domain of STAM. (b) Comparison of the SBM of AMSH, AMSH-LP,
and Sst2. Mutations made in the SBM of Sst2 to make it functional for
SH3 binding are colored red. (c) The isopeptide bond of diubiquitin is
formed between proximal ubiquitin (UbP), which donates its lysine,
and distal ubiquitin (UbD), which donates its C-terminal carboxylate
group. In other protease systems, UbD and UbP are equivalent to the
P and P′ fragments, respectively, of a peptide bond.
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crystallizability to understand the basis of the MIC-CAP
mutation59 at the atomic level by generating the Thr319Ile
mutant in the DUB domain of Sst2.
Structure of the Catalytic Domain of Sst2 in Its Free
Form. Structure Determination. To gain structural insights
into Sst2, we have crystallized a construct spanning the catalytic
domain of the protein, here termed Sst2cat (residues 245−435).
Sst2cat crystallized in two different space groups, P21 and
P212121. The P21 form has two subunits in the asymmetric unit,
whereas the P212121 form has three subunits. The structure of
Sst2cat was determined by zinc single-wavelength anomalous
dispersion (SAD) and also by molecular replacement (MR)
using the structure of the catalytic domain of AMSH-LP as the
search model23 (see Table 1 for crystallographic data collection
and refinement statistics). The structures were refined yielding
satisfactory crystallographic and free R factors with good
stereochemistry.
Like the DUB domain of AMSH-LP and AMSH,20,23 its two
most closely related homologues, the structure of Sst2cat
features a JAMM core with two characteristic insertions,
insertion 1 (Ins-1, residues 308−333) and insertion 2 (Ins-2,
residues 388−413). These insertions play an important role in
ubiquitin recognition and contribute key functional groups for
catalysis performed by these enzymes. The JAMM core consists
of a mixed β-sheet, which adopts the shape of a partially open
β-barrel sandwiched by two α-helices, one on top (α1) and one
on the bottom (α3) (Figure 2a), an architectural feature shared
among the members of JAMM domain proteins, such as
Af JAMM and Prp8.18,60−63 As seen in AMSH-LP and AMSH,
the catalytic site is lined mostly by residues from the JAMM
core, from the loop between α1 and β2, α3, β6, and the loop
following it (Figure 2a). The catalytic zinc is held in tetrahedral
geometry by residues from the JAMM core, coordinated by
His341, His343 (located on β6 and immediately following it),
Asp354 (located on α3), and a water molecule that is hydrogen
bonded to Glu286 (located on the loop segment following α1)
(Figure 2b). This zinc site is complemented by the conserved
serine residue on α3 (Ser351), which serves as the oxyanion-
stabilizing side chain. The second, structural zinc is located
approximately 14 Å from the active-site zinc and is coordinated
by the residue His356 from the JAMM core and residues
His404, His406, and Cys397 from Ins-2 (Figure 2c), the same
set of equivalent residues that coordinate the second zinc ion in
AMSH-LP and AMSH.
The structure of Sst2 can be superimposed with those of
AMSH and AMSH-LP with Cα root-mean-square deviations
(rmsds) of 0.71 and 0.59 Å, respectively, indicating substantial
structural conservation between these JAMM DUBs. A
noteworthy difference, however, is the presence of a cis peptide
unit in Sst2, Asp387-Pro388. The cis conformation permits the
Table 1. Crystallographic Data Collection and Refinement Statistics for the Catalytic Domain of Sst2
Sst2cat Sst2cat−Zn Edge Sst2cat
Data Collectiona
space group P21 P21 P212121
cell dimensions
a, b, c (Å) 56.1, 69.4, 62.0 56.2, 69.4, 61.9 54.8, 58.1, 187.5
α, β, γ (deg) 90.0, 104.8, 90.0 90.0, 104.7, 90.0 90.0, 90.0, 90.0
wavelength (Å) 1.033 1.283 1.033
resolution (Å) 50.0−1.45 (1.48−1.45) 50.0−1.67 (1.70−1.67) 50.0−1.80 (1.83−1.80)
Rmerge
b (%) 6.0 (68.5) 7.2 (51.4) 8.7 (62.8)
I/σI 19.3 (2.02) 20.8 (3.5) 17.8 (2.9)
completeness (%) 99.7 (99.2) 96.9 (90.9) 97.9 (96.6)
redundancy 3.8 (3.7) 7.7 (7.2) 6.0 (6.1)
Refinement
resolution (Å) 1.45 1.67 1.80
no. of reflections 80642 51582 55256
Rwork
c/Rfree
d 16.7/19.2 17.7/21.1 20.2/23.8
no. of atoms
protein 3017 2981 4436
ion 4 4 6
water 212 268 217
rmsd
bond lengths (Å) 0.007 0.006 0.008
bond angles (deg) 1.260 1.120 1.143
Ramachandran plot
preferred (%) 97.7 98.6 97.3
allowed (%) 1.9 1.1 2.3
disallowed (%) 0.3 0.3 0.4
average B factor (Å2)
protein 26.1 25.8 35.7
ion 21.7 25.4 31.5
water 33.8 34.1 34.4
ligand 38.3 34.7 54.3
aValues in parentheses are for the highest-resolution shell. bRmerge = ∑∑|Ihkl − Ihkl(j)|/∑∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the
final average intensity. cRwork = ∑||Fobs| − |Fcalc||/∑|Fobs|. dRfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys are calculated using a randomly
selected test set of 5% of the data and all reflections excluding the 5%, respectively.
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carbonyl group of Pro388 to engage in a hydrogen bond with
the backbone NH group of Gly256, from the turn segment of
the N-terminal β-hairpin of Sst2cat (Figure 2d). The significance
of the cis peptide unit is unclear at the moment. Perhaps such
hydrogen bonding could provide extra stability to the helix
starting from Pro388, a helix that contributes a critical cysteine
(Cys397) for holding the structural zinc in position.
Structure of the Complex with Lys63-Linked Diubi-
quitin. Crystallization of Sst2 and Lys63-linked diubiquitin
(K63-Ub2) was accomplished by using an Sst2 construct,
termed Sst2Δ220, which spans residues 221−435 and was
designed to contain the SBM motif from AMSH by
incorporation of three point mutations: Tyr234Val, Thr235Asp,
and Glu239Lys. To prevent the cleavage of diubiquitin, we also
introduced two mutations into the active site; Glu286, which
binds to the nucleophilic water, and Asp354, which coordinates
the catalytic zinc, were both mutated to alanine, resulting in an
inactive form of Sst2 [unlike the Glu286Ala mutant alone,
which exhibited residual activity (see below)]. As described
before, crystals containing the complex of Sst2Δ220 and K63-
Ub2 formed from a mixture purified via gel filtration
chromatography comprising Sst2Δ220, the UIM-SH3 domain
from HseI, and K63-Ub2. It is likely that K63-Ub2 forms a tight
complex with Sst2, as indicated by ITC measurements with a
catalytically inactive mutant, revealing a KD of 1.1 ± 0.1 μM
(Table 6), whereas the UIM-SH3 construct may have
somewhat weaker affinity for the binary complex, which
could explain why we are unable to crystallize the ternary
complex. The structure was determined by molecular
replacement using a model of Sst2−K63-Ub2 generated by
superimposition of Sst2cat with the structure of AMSH-LP
bound to K63-Ub2 (PDB entry 2ZNV
23) and refined yielding
satisfactory crystallographic, free R factors and good stereo-
chemistry (Table 2). The 27 N-terminal residues (221−247) of
Sst2Δ220 were not resolved in the crystal structure. Moreover,
because of a lack of side-chain density, the final model has
alanine substitutions of the following residues in Sst2: Phe248,
Lys249, Glu297, Asn331, and Val434. Furthermore, poor
density in chain C (proximal ubiquitin), presumably resulting
from positional disorder (Figure 2 of the Supporting
Information), forced us to delete residues 7−11, 28−42, 47,
and 70−76 from chain C.
The overall three-dimensional fold of Sst2Δ220−K63-Ub2 is
highly similar to the structure of the DUB domain of AMSH-
LP bound to K63-Ub2 (PDB entry 2ZNV) with an rmsd of 1.19
Å of Cα atoms over 266 residues from both Sst2 and K63-Ub2.
K63-Ub2 binds to Sst2
Δ220 in an extended conformation around
the isopeptide linker (Figure 3a), with the majority of the
protein contacts contributed by the distal ubiquitin (Figure 3c),
consistent with the mode of diubiquitin binding observed in
AMSH-LP. Comparison of the buried surface areas for distal
and proximal ubiquitin using PISA,64 1120 and 426 Å2,
respectively, further augments this observation. Sst2Δ220
features a catalytic channel spanning approximately 20 Å,
occupied largely by the C-terminal tail of the distal ubiquitin,
allowing proper orientation of the isopeptide bond in the active
site. The active site of Sst2 normally coordinates zinc, but our
structure is in the apo (unmetalated) state, because of two
mutations in residues contributing to zinc coordination:
mutation of Asp354 to alanine has a direct impact on metal
Figure 2. Structure of the catalytic domain of Sst2. (a) Ribbon diagram representing secondary structures of Sst2cat. The JAMM core, Ins-1, and Ins-
2 of Sst2 are colored aquamarine, yellow, and green, respectively. The insets show the active-site zinc and the structural zinc. (b) Expanded view of
zinc coordination in the active site. Zinc binds the His-His-Asp motif of Sst2 and one water molecule in a tetrahedral coordination. (c) Expanded
view of the structural zinc coordination site, located 14 Å from the catalytic center. (d) Cis peptide conformation of Pro388 in Sst2 (aquamarine)
forming a hydrogen bond with backbone NH groups of Gly256. AMSH is colored pink for reference.
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affinity, because it is a member of the catalytic triad that
coordinates to zinc. Metal affinity is further diminished by an
additional mutation, to Glu286, which indirectly coordinates
zinc by binding the nucleophilic water. In place of zinc, the
active site of Sst2Δ220−K63-Ub2 contains a water molecule. This
structure also reveals an alternative rotameric conformation of
Cys288 in Sst2, resulting in the formation of a partially
occupied disulfide bond with Cys317 (see below).
Proximal Ubiquitin Recognition. Proximal ubiquitin binding
is similar to that observed in the crystal structure of AMSH-LP
bound to K63-Ub2. Figure 3d shows the superposition of
Sst2Δ220−K63-Ub2 and AMSH-LP bound to K63-Ub2 (PDB
entry 2ZNV23). The primary areas of Sst2 contributing to the
recognition of proximal ubiquitin stem from the Zn2+
coordination loop of Ins-2 and a loop that links helix α3 to
strand β6 in the JAMM core. The residues engaged in proximal
ubiquitin recognition via van der Waals interactions or
hydrogen bonding, are completely conserved between
AMSH-LP and AMSH. Phe403 makes three van der Waals
contacts with the isopeptide segment of diubiquitin: the Cζ and
Cε2 atoms of Phe403 form van der Waals contacts with the Cδ
atom of Lys63 from the proximal ubiquitin (4.1 and 3.9 Å,
respectively), and the Cε2 atom of Phe403 makes an additional
contact with the carbon atom of Gly76 from the distal
ubiquitin. Additional hydrophobic contacts with proximal
ubiquitin are likewise formed from the Cβ atom of Phe403
and the Cζ atom of Phe349 with the Cγ atom of Gln62 and the
Cγ atom of Lys63 from proximal ubiquitin, while Pro405 forms
a stacking interaction with Phe4 of the proximal ubiquitin
(Figure 3b). Consistent with the AMSH-LP−K63-Ub2 crystal
structure, hydrogen bonding interactions from two residues in
Sst2, Thr347 and Ser352, also make an important contribution
to the recognition of proximal ubiquitin. The Oγ atom and NH
from the main chain of Thr347 make hydrogen bonds with the
Oε and Nε atoms of Gln62, while both the Oγ atom and main-
chain NH of Ser352 form hydrogen bonds with Oγ2 of Glu64
(Figure 3b).
Earlier mutational studies in both AMSH and AMSH-LP on
residues that engage in binding of the proximal ubiquitin found
a significant reduction in kcat with a minimal change in KM as
compared to those of the wild-type enzyme, therefore
indicating a role for the proximal ubiquitin in the rate-limiting
step of catalysis with little involvement in the ground-state
interaction with the substrate.23,38 It is likely that through their




space group P21 P212121 P212121
cell dimensions
a, b, c (Å) 71.2, 57.0, 81.2 57.3, 74.6, 139.3 49.5, 56.7, 135.1
α, β, γ (deg) 90.0, 104.6, 90.0 90.0, 90.0, 90.0 90, 90, 90
wavelength (Å) 1.281 1.033 1.033
resolution (Å) 50.0−1.97 (2.0−1.97) 50.0−1.63 (1.66−1.63) 60.0−2.30 (2.34−2.30)
Rmerge
b (%) 13.9 (90.0) 12.2 (92.6) 11.2 (54.9)
I/σI 20.9 (3.5) 17.1 (2.3) 34.5 (4.1)
completeness (%) 98.7 (97.6) 99.8 (96.1) 100.0 (100.0)
redundancy 7.5 (7.0) 7.3 (7.0) 6.8 (6.7)
Refinement
resolution (Å) 1.97 1.63 2.30
no. of reflections 44008 74731 16689
Rwork
c/Rfree
d 17.7/20.7 19.5/21.5 21.3/26.3
no. of atoms
protein 4108 4200 2396
ion 4 8 1
water 304 227 52
rmsd
bond lengths (Å) 0.007 0.006 0.007
bond angles (deg) 1.101 1.112 1.183
Ramachandran plot
preferred (%) 98.0 98.3 98.7
allowed (%) 1.8 1.7 1.3
disallowed (%) 0.2 0.0 0.0
average B factor (Å2)
Sst2cat 26.5 18.2 19.1
distal ubiquitin 40.9 26.4 18.3
proximal ubiquitin − − 14.1
ion 25.6 14.9 23.4
water 35.7 22.9 29.4
ligand 40.8 27.5 37.3
aValues in parentheses are for the highest-resolution shell. bRmerge = ∑∑|Ihkl − Ihkl(j)|/∑∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the
final average intensity. cRwork = ∑||Fobs| − |Fcalc||/∑|Fobs|. dRfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys are calculated using a randomly
selected test set of 5% of the data and all reflections excluding the 5%, respectively.
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interactions with the proximal ubiquitin, these residues play a
critical role in properly orienting the isopeptide for Lys63
linkage specific deubiquitination.
Crystallization of Sst2 in Its Product-Bound State.
Residual Activity in the Glu286Ala Mutant. To improve our
understanding of interactions with Lys63-linked polyubiquitin
substrates, we first attempted to cocrystallize the Glu286Ala
mutant of Sst2cat with Lys63-linked diubiquitin. The mutation
was presumed to render the enzyme inactive on two accounts.
(1) Glu286 plays a role in holding the catalytic water in its
position allowing it to serve as the fourth ligand for the active-
site zinc. Its mutation to Ala is likely to lead to a loss of zinc
from the active site.23,65 With the loss of zinc, there is no water
to act as a nucleophile. (2) The glutamate is also presumed to
function as both a general base and acid in the hydrolysis
reaction, assuming that Sst2 hydrolyzes its substrates following
a thermolysin-like mechanism. Quite unexpectedly, the crystals
obtained from a solution containing both Sst2catE286A and
Lys63-linked diubiquitin (prepared semisynthetically39) proved
instead to be those of Sst2catE286A bound to one ubiquitin
moiety occupying the distal site. Thus, this structure yielded a
view of the enzyme’s product-bound state, in which the product
was actually generated from reaction during crystallization
trials. Because this product-bound structure contained the
E286A mutation in the enzyme, we also cocrystallized Sst2cat
with ubiquitin (herein termed the Sst2cat−Ub complex) to
visualize product contacts with the wild-type enzyme (resulting
in two additional structures of the enzyme bound to its
product). Because the structures share many similarities, we will
use the Sst2catE286A structure to describe the interactions of
Sst2 with ubiquitin.
Sst2cat−Ub crystallized in two different space groups, P21 and
P212121, with two subunits in the asymmetric unit of both
crystal forms (Figure 3 of the Supporting Information). The
structure of the P21 form of wild-type Sst2
cat−Ub was
determined by Zn SAD, and the refined model was used as
the search model for determining the structure of both the
wild-type protein and the E286A mutant ubiquitin complexes
in the P212121 form (see Tables 2 and 3 for crystallographic
data collection and refinement statistics). Interestingly, the
subunits in the asymmetric unit of wild-type Sst2cat−Ub in the
orthorhombic crystal form show zinc-mediated packing at the
interface (Figure 4 of the Supporting Information). Two zinc
ions are found at the interface, related by a 2-fold noncrystallo-
graphic symmetry. The tetrahedral coordination around these
zinc ions is furnished by two His residues from one subunit, a
Glu from the symmetry-related partner, and a chloride ion
(Figure 4b of the Supporting Information). These zinc-
coordinating interactions appear to provide substantial
stabilization leading to the packing of the monomers in the
crystallographic dimer as observed here. Additional hydrogen
bonding interactions (two copies of Ser324-Gln428, each pair
contributing two hydrogen bonds) and van der Waals packing
of aromatic side chains (Phe328) also contribute to dimer
formation. The zinc and chloride ions found at the dimer
Figure 3. Crystal structure of Sst2 in complex with K63-Ub2. (a) Surface representation of Sst2 (purple) bound to diubiquitin. Proximal ubiquitin is
colored dark green, while distal ubiquitin is colored orange. AMSH/Sst2 specific insertions 1 and 2 are colored yellow and green, respectively. (b)
Proximal ubiquitin recognition is limited to a few residues. Hydrophobic interactions are shown with blue dashes and hydrogen bonds with red
dashes. (c) Distal ubiquitin is held tightly in the active site through a number of mostly hydrogen bonding interactions. (d) Superposition of Sst2
(purple) and AMSH-LP (gray) bound to diubiquitin. Proximal ubiquitin bound to Sst2 is colored dark green and proximal ubiquitin bound to
AMSH-LP light green. Distal ubiquitin bound to Sst2 is colored orange and distal ubiquitin bound to AMSH-LP yellow.
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interface might have been from the reservoir solution, which
contained ZnCl2.
Structures of Sst2cat−Ub (1.6 Å) and Sst2catE286A−Ub (1.7
Å) provide insights into the product-bound state of the enzyme.
Like the distal moiety of the substrate in the diubiquitin-bound
structure, ubiquitin as the product is held tightly by a number
of intermolecular interactions that include hydrogen bonding,
van der Waals contacts, and salt bridges, with most of the
interactions contributed by contacts holding its extreme C-
terminal hexapeptide LRLRGG motif in the active-site cleft
(Figure 4). This hexapeptide segment, as observed in the
substrate-bound state, aligns itself at the active-site cleft as an
extended β-strand, in register with strand β5 of Ins-1, and is
engaged in backbone and side-chain interactions with strand β5
on one side and helix α3 from the JAMM core on the other.
Interestingly, the JAMM core residues involved in ubiquitin
binding on helix α3 are conserved in AMSH, AMSH-LP, and
Sst2, while residues from strand β5 of Ins-1 that contribute to
distal ubiquitin recognition are not entirely conserved in all
three proteins (Figure 5 of the Supporting Information),
suggesting that the JAMM core residues are structurally
important while the insertion residues, which evolved later,
are more interchangeable.
Generally, ubiquitin-interacting proteins recognize a hydro-
phobic patch surrounding Ile44 of ubiquitin (the I44
patch).66−68 Like other cysteine protease DUBs and AMSH-
LP, Sst2 also recognizes the I44 patch in the distal ubiquitin.
The structures of both ubiquitin and diubiquitin complexes of
Sst2 show contacts with residues in this patch, which consists of
Leu8, Ile44, Val70, and the Cβ atom of His68 of ubiquitin
(Figure 4a). In the case of AMSH-LP, the aliphatic side chains
of Val328 and Phe332 in Ins-1 interact with the residues of the
hydrophobic patch. However, in both Sst2 and AMSH, Val328
is substituted with Glu322 and Glu316, respectively. The model
of AMSH244 bound to Lys63-linked diubiquitin predicts that
Glu316 of AMSH might form electrostatic and polar
interactions with Arg42 and Gln49;20 however, in Sst2, the
equivalent residue, Glu322, forms an electrostatic interaction
with only Arg42 of ubiquitin. Our structures of ubiquitin- and
diubiquitin-bound complexes of Sst2 reveal that Phe326 in Ins-
1 makes a number of van der Waals contacts with the residues
of the I44 patch, while Gln329 in Ins-1 makes van der Waals
contacts with the side chain of Leu8 (Figure 4a). These
complex structures also reveal the interactions of Met364 from
the JAMM core of Sst2 with Ile36, Leu69, Leu71, and the Cγ
atom of Thr7 in the distal ubiquitin, which forms the
hydrophobic pocket opposite the I44 patch (Figure 4c).
Table 3. Crystallographic Data Collection and Refinement Statistics for Catalytic Mutants of Sst2
E286A−Ub T319I D354A−Ub
Data Collectiona
space group P212121 P21 P21
cell dimensions
a, b, c (Å) 57.0, 95.3, 112.9 58.1, 74.1, 64.8 42.4, 58.0, 56.2
α, β, γ (deg) 90.0, 90.0, 90.0 90.0, 113.4, 90.0 90.0, 108.9, 90.0
wavelength (Å) 1.033 1.033 1.033
resolution (Å) 50.0−1.74 (1.78−1.74) 50.0−1.90 (1.93−1.90) 60.0−2.05 (2.09−2.05)
Rmerge
b (%) 11.6 (86.7) 7.0 (56.5) 8.6 (62.5)
I/σI 19.4 (2.7) 18.7 (2.9) 16.8 (2.6)
completeness (%) 100 (100) 100 (100) 100 (100)
redundancy 5.8 (5.5) 3.8 (3.8) 3.8 (3.7)
Refinement
resolution (Å) 1.74 1.90 2.05
no. of reflections 63007 39791 16420
Rwork
c/Rfree
d 19.5/22.5 18.9/21.6 20.5/25.3
no. of atoms
protein 4130 2911 2042
ion 4 4 1
water 409 164 78
rmsd
bond lengths (Å) 0.02 0.006 0.008
bond angles (deg) 2.0 1.122 1.213
Ramachandran plot
preferred (%) 98.0 97.8 95.7
allowed (%) 2.0 1.9 4.3
disallowed (%) 0.0 0.3 0.0
average B factor (Å2)
Sst2cat 22.6 24.7 31.1
distal ubiquitin 25.5 − 29.7
ion 20.2 18.0 29.9
water 29.9 27.8 31.8
ligand 33.6 43.3 33.8
aValues in parentheses are for the highest-resolution shell. bRmerge = ∑∑|Ihkl − Ihkl(j)|/∑∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the
final average intensity. cRwork = ∑||Fobs| − |Fcalc||/∑|Fobs|. dRfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys are calculated using a randomly
selected test set of 5% of the data and all reflections excluding the 5%, respectively.
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Thus, as the foregoing discussion has indicated, many of the
interactions seen with the distal ubiquitin in the structure of
Sst2Δ220−K63-Ub2 are preserved in the product-bound
structure.
Superposition of the DUB domain of AMSH, the AMSH-
LP−K63-Ub2 complex, and the Sst2catE286A−Ub complex
reveals that most of the residues involved in distal ubiquitin
recognition are conserved (Figure 5a). However, the two
substitutions of Thr313 and Glu316 in AMSH and Thr319 and
Glu322 in Sst2 in place of Met325 and Val328 in AMSH-LP
imply that the catalytic domain of Sst2 shares more similarities
with AMSH than AMSH-LP as far as ubiquitin binding is
concerned. Comparison to the structures of AMSH and
AMSH-LP shows three substitutions in the distal binding site
(Figure 5b). Interestingly, despite these substitutions, the
number of interactions with ubiquitin is not significantly
altered. For example, substitution of Gly at position 318 of Sst2
in place of Asn in AMSH and Asp in AMSH-LP leads to a loss
of hydrogen bonding and salt bridge interaction with Arg74 of
ubiquitin, but hydrogen bonding of Arg74 with Thr319 of Sst2
reestablishes this interaction. Overall, these structures show that
the distal site is evolutionarily less constrained than the
proximal site.
Product Specific Interactions. In the diubiquitin-bound
structure, the Cα atom of Gly76 forms a hydrophobic
interaction with the Cε2 atom of Phe403 and is located
adjacent to the metal center, showing how the scissile peptide
bond in the substrate would be placed adjacent to the
Figure 4. Ubiquitin binding in Sst2. (a) Interactions of Phe326 with the Ile44 hydrophobic patch of ubiquitin. (b) Surface representation of the
DUB domain of Sst2 (aquamarine) bound to ubiquitin (orange) highlighting the residues (red) involved in interactions with the hydrophobic
patches of ubiquitin. (c) Interactions of Met364 with the residues in the hydrophobic pocket opposite the Ile44 patch. (d) van der Waals interactions
of Leu73 of ubiquitin with residues of Sst2 shown with blue dashes. (e) Residues of Sst2 involved in distal ubiquitin recognition. Hydrogen bonds are
shown with red dashes. (f) Formation of a potential disulfide bond in Sst2. One of the alternative conformations of Cys288 forms a disulfide bond
with Cys317. The disulfide bond-forming residues are outlined by electron density from a 2Fo − Fc map contoured at 1.2σ.
Figure 5. Structural comparison of AMSH, AMSH-LP, and Sst2. (a) Superposition of catalytic domains of AMSH (pink), AMSH-LP (gray), and
Sst2 (aquamarine). (b) Superposition of AMSH (pink), AMSH-LP bound to K63-Ub2 (gray), and Sst2
cat−Ub (aquamarine) showing the residues
involved in the recognition of distal ubiquitin binding. Ubiquitin is colored orange.
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nucleophilic water (Figure 3b). Contrary to our expectation,
the hydrolysis of diubiquitin by the E286A mutant means that
the active-site water and the metal are still intact in this mutant.
Interestingly, the structure of Sst2catE286A−Ub does reveal
zinc in the active site and water coordinating the zinc ion. Some
interesting differences can be seen between the E286A product-
bound structure and that represented by wild-type Sst2cat−Ub.
In the latter, the carboxylate group of Gly76 of ubiquitin
coordinates the catalytic zinc to maintain its tetrahedral
coordination while also forming a hydrogen bond with
Glu286 (Figure 6a). In contrast, the former shows the same
carboxylate group displaced from Zn2+ by a water that has taken
its place in the metal coordination sphere (Figure 6b). This is
remarkable because it appears as if we have managed to
crystallize a form of the product complex representing a
transient solution species in which the product is about to
depart and the catalytic water is about to reestablish its contact
with the active-site metal.
Although subtle, changes in a loop (flap) located at the top of
the active site (near the proximal ubiquitin binding site) could
also be observed. The prime residues of interest in this loop are
Leu402 and Phe403 (Figure 7a), coming from the Ins-2
segment that also is responsible for coordination of the
structural zinc. The loop appears to have moved away from van
der Waals contact with Thr316, creating an opening, likely to
accommodate the displaced carboxylate in Sst2catE286A−Ub.
This is significant because in all of our other structures (free
form, substrate-bound form, and product-bound form in which
the C-terminal ubiquitin carboxylate coordinates with zinc),
Phe403 and Leu402 make van der Waals contacts with Thr316
and Asp315, resulting in a closed conformation (Figure 7b,c,e).
Comparison of the van der Waals contacts made in all four
structures is summarized in Table 4.
In Sst2cat−Ub, Phe403 and Thr316 reaching out to one
another across the cleft are located 4.0 Å apart, a distance that is
close to that of a van der Waals contact between the two. Also
contributing to the closed conformation are Leu402 and
Thr316, which are 4.4 Å apart, while Phe403 approaches the
Cα atom of Gly76 of ubiquitin from the top, making a close van
der Waals contact with this residue. In the free form of Sst2cat,
the closed conformation at the active-site cleft is maintained in
the absence of substrate, as well; however, the mobility of the
loop results in Phe403 establishing a contact with Asp315
(instead of Thr316) and Leu402 makes a contact with Thr316.
This slight change in interacting partners has completely closed
the active-site cleft from the proximal end. Interestingly, the
structure of Sst2Δ220 bound to K63-Ub2 also reveals a closed
position of the loop, which makes van der Waals contact with
the hydrocarbon portion of the acceptor Lys residue in the
proximal ubiquitin. However, this residue, in fact, the two-
Figure 6. Active sites of Sst2cat, Sst2catE286A, and Sst2catD354A bound to ubiquitin. (a) The carboxylate group of Gly76 from distal ubiquitin (P-
product fragment) replaces the catalytic water molecule and coordinates with zinc. (b) In Sst2catE286A, a water molecule is observed in coordination
with zinc, displacing the carboxylate group of Gly76. (c) In Sst2catD354A, water is occupying the zinc site. In all panels, electron density from a 2Fo −
Fc map is shown as blue mesh (at 1.0σ).
Figure 7. Subtle changes in the loop at the top of the active site (near
proximal ubiquitin) appear to open and close the active site. (a)
Superposition of our Sst2 structures highlights conformational changes
of a loop containing residues Leu402 and Phe403. The free form of
Sst2 is colored limon and bound diubiquitin purple, and our two
product-bound forms are colored blue-gray (wild-type Sst2) and cyan
(E286A). (b−e) Surface representations of Sst2 comparing the
position of the loop (red) in all structures.
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residue turn segment, Leu402-Phe403, needs to move apart
relative to Thr316 to make room for the diubiquitin substrate
to position itself correctly in the active site. (These observations
are also true in the structure of AMSH-LP bound to
diubiquitin.) It seems likely that the β-turn segment is dynamic,
fluctuating between open and closed forms; the substrate binds
to the open form, perhaps by conformational selection.
Superposition of all of our structures for the catalytic domain
of free Sst2, ubiquitin-bound Sst2 (Sst2cat−Ub and
Sst2catE286A−Ub), and diubiquitin-bound Sst2 reveals that
Leu402 and Phe403 are mobile (Figure 7a). The different
mobility of side chains of Asp315, Leu402, and Phe403 shows
that these three residues are involved in a conformational
change between the free form and ubiquitin-bound form.
It is likely that the dynamics of the active-site flap may
contribute to the recognition of specific Ub lysine linkages in
addition to its role in catalysis. To probe whether the dynamics
from this flap are associated with linkage specificity, we mutated
Phe395 in AMSH to alanine (corresponding to the same
residue as Phe403 in Sst2). The mutant exhibits significantly
impaired catalytic activity;20 however, like the wild-type
enzyme, it was still unable to cleave Lys48-linked diubiquitin
[we used up to 2 μM enzyme and 23 h reaction time, but failed
to detect any product (Figure 7 of the Supporting
Information)]. This observation does not rule out the
possibility that dynamics of the flap could be a factor behind
linkage specificity. More detailed studies using point mutants of
the other residues from the flap and Thr316 and Asp315 are
required to probe the contribution of the flap to linkage
specificity. Of note, Sst2, unlike AMSH, appears to cleave
Lys48-linked diubiquitin, albeit with an efficiency significantly
lower than that of the Lys63-linked chain. Under conditions in
which formation of the product from K63-linked diubiquitin is
essentially complete in 1 h, the enzyme takes nearly 24 h to
produce an appreciable amount of product from Lys48-linked
diubiquitin (see Figure 8 of the Supporting Information). The
plant orthologue AMSH3 appears to be adept at cleaving both
Lys63- and Lys48-linked chains.69 It will be interesting to know
the basis of relaxed specificity in going from AMSH to AMSH3
and if the dynamic nature of the flap is an underlying factor.
Structural Effect of the MIC-CAP Disease-Causing Thr to
Ile Mutation. Recently, a whole-exome sequencing analysis led
to the discovery of recessive mutations in the gene encoding
AMSH that cause microcephaly capillary malformation (MIC-
CAP) syndrome.59 MIC-CAP syndrome, diagnosed at or
shortly after birth, is characterized by severe microcephaly (a
condition in which an infant’s head is significantly smaller than
the heads of other children of the same age and sex) with
progressive cortical atrophy, intractable epilepsy, profound
developmental delay, and excessive small capillary malforma-
tions on the skin.38,70−72 The phenotype is attributed to the
accumulation of ubiquitinated proteins, suggesting a loss of
enzymatic function of AMSH, consistent with similar
accumulation of polyubiquitinated species seen in knockout
mice studies.38,72 The study that discovered that mutations in
AMSH could lead to MIC-CAP syndrome reported six
missense mutations, two nonsense mutations, two translational
frameshift mutations, and three intronic mutations.59 Five of
the six missense mutations occur within the MIT domain of
AMSH, and the sixth, Thr313Ile, occurs within the JAMM
domain. Because the crystal structure of AMSH bound to
ubiquitin is not known, we took advantage of our structure to
gain insights into possible effects the mutation may have on the
structure of AMSH and its ubiquitin recognition.59
In Sst2, the corresponding residue is Thr319, which makes a
hydrogen-bonding contact using its side-chain OH group with
the backbone NH group of Leu73 of ubiquitin as seen in the
structure of Sst2cat−Ub (and other ubiquitin-bound structures
reported here, as well). In the structure of Sst2cat, this side chain
is solvent-exposed. Mutation to Ile is unlikely to cause any
serious perturbation to its overall three-dimensional structure.
It thus appears that the mutation may weaken interactions with
ubiquitin required for substrate recognition and/or catalysis. It
is also possible that mutation to Ile may introduce additional
steric clash with ubiquitin. To examine this, we generated an in
silico model of the mutant based on the ubiquitin-bound
structure of the wild-type enzyme and subjected it to
refinement for generating a model with optimized contacts.
The final model shows that isoleucine could be accommodated
Table 4. Comparison of van der Waals Contacts in Residues
near the Active Site Indicates That Interactions between
Phe403/Leu402 and Thr316 That Result in an Open Form
May Play a Role in the Release of the Second Ubiquitin
sample Sst2cat Sst2cat−Ub E286A−Ub Sst2Δ220−K63-Ub2
Phe403 Cζ−Cγ2
Thr316
6.0 Å 4.0 Å 5.9 Å 3.9 Å
Phe403 Cζ−Cβ
Asp315
3.7 Å 4.9 Å 6.1 Å 4.7 Å
Leu402 Cδ2−Cγ2
Thr316
4.4 Å 4.4 Å 6.2 Å 4.1 Å
Phe403 Cζ−C Ub-
Gly76




− − − 4.1 Å/3.9 Å
Figure 8. Structural consequences of the MIC-CAP mutation. (a) Superposition of Thr319 of Sst2cat (aquamarine) and Ile319 of mutant
Sst2catT319I (light yellow) showing the change in the orientation of Glu322. The electron density for Ile319 is rendered from the 2Fo − Fc map
contoured at 1.2σ. (b) Hydrogen bonding interactions made by Thr319 observed in the Sst2cat−Ub complex. Residues of Sst2 and Ub involved in
interaction are colored aquamarine and orange, respectively. Hydrogen bonds are shown with black dashes.
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in place of threonine without causing any serious steric clash
with ubiquitin. Indeed, the X-ray structure of the Thr319Ile
mutant of Sst2cat in its free form reveals minimal changes in the
protein structure adjacent to the Ile319, with the global
structure of the mutant remaining largely unchanged relative to
that of the wild-type enzyme. The most noticeable change in
the Ile mutant was localized around the site of mutation: the
side chain of Glu322, adjacent to Ile319, is oriented
perpendicular to its original conformation in the free and
ubiquitin-bound forms of Sst2cat (Figure 8a). This is interesting
because when ubiquitin is bound to Sst2cat, Thr319 makes a
hydrogen-bonding contact with Glu322 (distance of 2.6 Å
between Oγ of Thr and Oδ of Glu), which is the only contact
the latter residue makes with a protein atom. This contact
appears to hold Glu322 in a position so that it could engage in
hydrogen-bonding and electrostatic contacts with Arg42 of
ubiquitin as seen in the crystal structure of Sst2cat−Ub (Figure
8b). Thus, it is possible that substitution with Ile may lead to a
loss of this interaction as well, explaining the substantial effect
on the enzyme’s catalytic activity (Table 5).
On the basis of the structural analysis presented above, we
expected that loss of contacts with Leu73 and perhaps also with
Arg42 of ubiquitin with the T319 mutant may destabilize the
Michaelis complex relative to the wild-type enzyme. However,
our kinetic analysis shows a substantial effect on kcat with little
change in KM, consistent with results from a similar study with
the Thr313Ile mutant of AMSH.20 It appears that interactions
involving the Thr residue are particularly important in aligning
the scissile peptide bond in the proximity of the catalytic groups
during formation of the transition state in the enzyme-catalyzed
reaction.
A Reactive Cysteine Adjacent to the Active Site. A pair of
cysteines (Cys288 and Cys317), with one of them adjacent to
the catalytic site and solvent-exposed (Cys317), appears to be
conserved within AMSH-like DUBs, as seen by comparison of
the sequences of AMSH, AMSH-LP, and Sst2 (Figure 5 of the
Supporting Information). The distance between the two thiol
groups is 4.4 Å. Cys317 contributes to two interbackbone
hydrogen bonds with Gly75 of ubiquitin. Interestingly, in two
of our structures (Sst2Δ220−K63-Ub2 and the free form of
Sst2cat from the P21 space group), the Fo − Fc map shows
residual positive density that could be easily interpreted as an
alternative rotameric conformation of Cys288, a conformation
that brings the two cysteines within disulfide-forming distance,
allowing us to model a disulfide bridge between the two
cysteines (Figure 4f). It is possible that under oxidative
conditions this pair will exist as a fully occupied disulfide bridge
(DTT in our purification buffer may be responsible for
reduction of the disulfide, giving us only a partial population of
the oxidized form and none in other structures). A similar
observation was also made in the case of AMSH, while a fully
occupied disulfide bond was observed in AfJAMM, the first ever
JAMM domain protein to be structurally characterized.18,20 The
reason behind the presence of the cysteine pair with the
potential to form this disulfide bond is not clear at the moment.
One possibility may be the endosome-bound form requires the
disulfide bond. Association with ESCRT-III through the MIT
domain is required for deubiquitination of the cargo before
formation of intraluminal vesicles in MVBs, an interaction that
is especially tight (KD ∼ 60 nM).73 It has been proposed that
the VPS4 complex will catalyze the dissociation of AMSH from
the ESCRT-III members at the end of MVB biogenesis so that
the DUB and the ESCRT members can be reused for another
around of endocytic sorting.33,74 It is tempting to speculate that
the disulfide bridge may render AMSH stable enough so that it
can be dissociated from the ESCRT-III complex after the action
of VPS4 but still remain folded.
■ DISCUSSION
As mentioned earlier, AMSH is thought to share distinct
mechanistic similarities with the well-studied metalloprotease
thermolysin.23 On the basis of this assumed similarity with
thermolysin, the mechanism of diubiquitin cleavage by AMSH
and closely related enzymes (such as Sst2) is illustrated in
Figure 9. Abstraction of a proton by the active-site glutamate
(Glu286 in Sst2), the presumed general base, activates the zinc-
bound water, converting it into a potent nucleophile. This
nucleophilic water then attacks the carbonyl group of the
scissile peptide bond, leading to a tetrahedral intermediate,
which is stabilized by the interaction of the oxyanion with a
nearby serine serving as the oxyanion-stabilizing residue
[Ser351 in Sst2 (Figure 4e)]. The leaving group, the proximal
ubiquitin, then departs, being aided by the transfer of a proton
to the amine group by the same glutamic acid, now working as
a proton donor. The departure of the leaving group is
accompanied by the collapse of the tetrahedral intermediate
forming the carboxylate group of the P (unprimed) fragment.
At this stage, the carboxylate group of the P-product fragment,
which corresponds to the distal ubiquitin in the diubiquitin
substrate, is coordinated to the catalytic zinc (Figure 9). Finally,
the P fragment dissociates, making room for the catalytic water
to reestablish its coordinating position adjacent to the active-
site zinc. The mechanism dictates that Glu286 be an essential
residue for catalysis. In contrast, we observed that the
Glu286Ala mutant of Sst2 still has some residual activity,
much like the case of matrilysin,65,75 suggesting that Glu286 in
Sst2 may not be playing the role of the general base in the
hydrolysis reaction. Instead, it may be required for stabilization
of the transition state through hydrogen bonding with the
carbonyl group of the scissile peptide bond and for donation of
a proton to the leaving group. This is consistent with the
observation that Glu286 is seen as the donor in the hydrogen
bonding interaction with the carboxylate of Gly76 of ubiquitin
(Figure 6 and Figure 6 of the Supporting Information) in our
crystal structures. Because these crystals were grown from
solutions with pH values ranging from 7 to 8, our data indicate
that Glu286 may have a relatively high pKa, at least 7, and
would therefore remain protonated during catalysis. To be an
effective general base, the glutamate must ionize readily below
pH 7, as seen in the case of thermolysin.76,77 Although the exact
nature of the active-site Glu in Sst2 and related enzymes
remains to be characterized, our structural studies point to the
possibility that, in Sst2, the zinc-bound water may be ionized
significantly to serve as the nucleophile directly, as was
proposed for matrilysin.65,75 Future studies aimed at delineating
the pH dependence of activity should reveal more insight into
the mechanism of Sst2 and related enzymes. Moreover,
Table 5. Steady-State Kinetic Parameters of Sst2 and Its
Substrate, Lys63-Linked Diubiquitin
sample KM (μM) kcat (s
−1) kcat/KM (×10
−3 μM−1 s−1)
Sst2 18.8 ± 8.4 1.5 ± 0.2 79.8
T319I 19.7 ± 4.0 0.043 ± 0.002 2.2
E286A not determined not determined not determined
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Figure 9. Proposed mechanism of hydrolysis by Sst2 and related enzymes, based on a thermolysin-like mechanism. UbP (green) denotes proximal
ubiquitin, while UbD (orange) indicates distal ubiquitin. Steps of the mechanism that we have captured crystallographically are shown in boxes i., ii.,
v., and vi. In boxes ii. and vi., atoms that were modeled in because they were absent due to mutation are colored pink.
Figure 10. Isothermal titration calorimetry (ITC) thermograms of binding of ubiquitin to the catalytic domain of Sst2. (a) ITC thermogram of
binding of ubiquitin to the catalytic domain of Sst2 revealing a KD of 10.2 ± 0.6 μM. (b) ITC thermogram of binding of ubiquitin to the catalytic
mutant of Sst2, E286A, revealing a KD of 2.98 ± 0.56 μM. (c) ITC thermogram of binding of Lys63-linked diubiquitin to the catalytic mutant of Sst2,
D354A, revealing a KD of 1.1 ± 0.1.
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mutation of Glu to Ala in thermolysin-like enzymes leads to
loss of Zn, unlike the case for Sst2 and matrilysin. On the basis
of these observations, we propose that Sst2 may behave more
like matrilysin rather than like thermolysin. It remains to be
seen whether AMSH and other related enzymes behave like
Sst2.
In the context of diubiquitin hydrolysis, the fate of the P-
product fragment after hydrolysis may become relevant as this
fragment is engaged in a number of interactions with the
enzyme. This is especially important because the binding to the
substrate occurs predominantly through interactions of the
distal ubiquitin (which corresponds to the P fragment of the
substrate). The proximal ubiquitin does not seem to contribute
significantly to substrate binding, although its interactions are
important during the transition state of the reaction, as revealed
by site-directed mutagenesis experiments with AMSH, which
showed that mutation of residues that bind to the proximal
ubiquitin affects kcat but not KM.
38 Consistent with this
observation, isothermal titration calorimetry (ITC) studies
reveal that like that of AMSH, Sst2’s affinity for ubiquitin is
similar to the KM for diubiquitin hydrolysis (Figures 10 and
11).
Our structures provide insight into the nature of the
interaction with the P-product fragment. All of the interactions
with the distal ubiquitin of the substrate are still intact in the
product-bound form. The major difference between the
substrate-bound state and the product-bound state is with
respect to interactions of the Gln62-Lys63-Glu64 tripeptide
segment with Phe4 of the proximal ubiquitin, interactions that
would be relevant only to substrate binding but will be absent
in the product. These interactions are replaced by interactions
associated with metal-coordinating binding of the carboxylate
group in the product-bound form. One of the carboxylate
oxygens of ubiquitin’s Gly76 occupies the void left by the
nucleophilic water. The other oxygen is engaged in a hydrogen
bonding interaction with Glu286 working as the hydrogen
bond donor (the distance between the oxygen atoms is 2.7 Å).
These interactions of the carboxylate on Gly76 of ubiquitin
may contribute to the tight binding of the product, although,
surprisingly, mutation of Glu286 to Ala did not result in any
loss of ubiquitin affinity. In fact, the mutant actually appears to
bind ubiquitin slightly stronger than the wild-type enzyme
(Table 6). It is possible that the active-site structure in the
mutant has changed, which might account for the anomalous
behavior we are observing here. The role of Glu286 and
ubiquitin’s Gly76 interaction is therefore not clear at the
moment. Nevertheless, our studies seem to provide a rationale
for the observation that, for both AMSH and Sst2, the affinity
for the product (KD for ubiquitin) matches the KM value
observed with the diubiquitin substrate (Table 7). The
structural data may provide a rationale for this observation if
we assume that the carboxylate group of the product binding to
zinc offsets the loss of interactions contributed by the proximal
ubiquitin. This may imply that the free cytosolic form of AMSH
may remain inhibited by binding to ubiquitin, as the
concentration of free ubiquitin in cells is close to the KD
values we have measured.78
Proteases in general are tightly regulated, revealing their full
catalytic potential only when desired. Several means of
regulation of protease activity have been well characterized,
examples of which include sequestration of proteases through
compartmentalization, such as caspases,79−83 proteasome,84−86
and lysosomal proteases,87−89 and conversion of precursor
enzymes to active forms through zymogen activation,90 such as
digestive enzymes like trypsin and chymotrypsin, and reversible
posttranslational modification. However, the mechanism under-
lying regulation of the catalytic activity of DUBs is relatively
poorly understood.91 Recent reports show that some cysteine
DUBs can be regulated by reversible oxidation of their catalytic
cysteine.92,93 More generally, however, a substantial number of
DUBs appear to be regulated via association with other
proteins, including ubiquitin, serving as both a part of their
substrates and their product.94−97 Accordingly, a number of
DUBs feature additional domains appended to or inserted into
Figure 11. Representative plot of the initial velocity (divided by the
total enzyme concentration) as a function of substrate concentration
for wild-type Sst2. The inset shows a gel from kinetic reactions,
showing ubiquitin standards and different concentrations of the
substrate (K63-Ub2) sampled. Each reaction mixture contained 25 nM
Sst2cat, and each reaction proceeded for 7.5 min at 20 °C before being
quenched with 5× SDS−PAGE sample buffer. Bands corresponding to
monoubiquitin were integrated using ImageJ.
Table 6. Thermodynamic Parameters Deduced from ITC Data
protein titrant KD (μM) ΔH (kcal/mol) ΔS (cal mol−1 K−1)
Sst2 ubiquitin 10.2 ± 0.6 11.9 ± 0.4 62.9
Sst2catE286A ubiquitin 3.0 ± 0.56 8.0 ± 0.7 52.2
Sst2catD354A diubiquitin 1.1 ± 0.1 11.8 ± 0.3 66.9
Table 7. Comparison of KD and KM between Sst2 and AMSH
enzyme substrate or product KD (μM) KM (μM)
Sst2 ubiquitin 10.2 ± 0.6 −
Sst2catD354A diubiquitin 1.1 ± 0.1 18.8
AMSH ubiquitin 19 ± 3 −
AMSH diubiquitin 19 ± 4 32 ± 5
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their catalytic domain for associating with other proteins
(activators), which in turn induce productive forms of the
associated DUB.14,15 Activation upon binding to other
macromolecules can be allowed by realignment of active-site
residues, if they were misaligned in the unbound state, or
removal of steric occlusion by a conformational transition
induced upon activator binding.98,99 This is especially
important for DUBs that exist in two distinct pools, in the
free form when not bound to anything and in their active form
as a population of protein-bound enzymes.
It appears from our studies that, for AMSH and related
enzymes like Sst2, the close correspondence between the
affinity for ubiquitin and the KM value for the substrate may
serve to regulate their catalytic activity. They could be inhibited
when present in the free enzyme pool but manifest their full
catalytic prowess upon assembly with other proteins, such as
ESCRT-0 in the case of AMSH. Because the intracellular
concentration of free ubiquitin is expected to be higher than
that of the K63-linked polyubiquitin chain and is close to the
dissociation constant for free ubiquitin (our studies),78 one
would expect the free enzyme would be inhibited. Assembly
with other protein complexes may serve to activate these
enzymes by providing additional factors that tip the balance
toward better recognition of the substrate over free ubiquitin,
such as the ubiquitin-binding UIM domain present in STAM,
in whose case the UIM domain appears to provide additional




Supplemental Figures 1−8. This material is available free of
charge via the Internet at http://pubs.acs.org.
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A., Buccione, R., and Isidoro, C. (2000) The lysosomal protease
cathepsin D is efficiently sorted to and secreted from the regulated
secretory compartments in the rat basophilic/mast cell line RBL. J. Cell
Sci. 113, 3289−3298.
(88) Brumell, J., Volchuck, A., Sengelov, H., Borregaard, N., Cieutat,
A., Bainton, D., Grinstein, S., and Klip, A. (1995) Subcellular
distribution of docking/fusion proteins in neutrophils, secretory cells
with multiple exocytic compartments. J. Immunol. 155, 5750−5759.
(89) Stinchcombe, J., and Griffiths, G. (1999) Regulated secretion of
hemopoietic cells. J. Cell Biol. 147, 1−5.
(90) Stroud, R., Kossiakoff, A., and Chambers, J. (1977) Mechanisms
of zymogen activation. Annu. Rev. Biophys. Bioeng. 6, 177−193.
(91) Huang, O., and Cochran, A. (2013) Regulation of
deubiquitinase proteolytic activity. Curr. Opin. Struct. Biol. 23, 806−
811.
(92) Cotto-Rios, X. M., Bekes, M., Chapman, J., Ueberheide, B., and
Huang, T. T. (2012) Deubiquitinases as a Signaling Target of
Oxidative Stress. Cell Rep. 2, 1475−1484.
(93) Kulathu, Y., Garcia, F., Mevissen, T., Busch, M., Arnaudo, N.,
Carroll, K., Barford, D., and Komander, D. (2013) Regulation of A20
and other OTU deubiquitinases by reversible oxidation. Nat. Commun.
4, 1569.
(94) Boudreaux, D., Maiti, T., Davies, C., and Das, C. (2010)
Ubiquitin vinyl methyl ester binding orients the misaligned active site
of the ubiquitin hydrolase UCHL1 into productive conformation. Proc.
Natl. Acad. Sci. U.S.A. 107, 9117−9122.
(95) Hu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J., Gu, W., Cohen, R.,
and Shi, Y. (2002) Crystal structure of a UBP-family deubiquitinating
enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111,
1041−1054.
(96) Keusekotten, K., Elliott, P., Glockner, L., Fill, B., Damgaard, R.,
Kulathu, Y., Wauer, T., Hospenthal, M., Gyrd-Hansen, M.,
Krappmann, D., Hofmann, K., and Komander, D. (2013) OTULIN
antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked
polyubiquitin. Cell 153, 1312−1326.
(97) Faesen, A., Dirac, A., Shanmugham, A., Ovaa, H., Perrakis, A.,
and Sixma, T. (2011) Mechanism of USP7/HAUSP activation by its
C-terminal ubiquitin-like domain and allosteric regulation by GMP-
synthetase. Mol. Cell 44, 147−159.
(98) Samara, N., Datta, A., Berndsen, C., Zhang, X., Yao, T., Cohen,
R., and Wolberger, C. (2010) Structural insights into the assembly and
function of the SAGA deubiquitinating module. Science 328, 1025−
1029.
(99) Yao, T., Song, L., Xu, W., DeMartino, G., Florens, L., Swanson,
S., Washburn, M., Conaway, R., Conaway, J., and Cohen, R. (2006)
Proteasome recruitment and activation of the Uch37 deubiquitinating
enzyme by Adrm1. Nat. Cell Biol. 8, 994−1002.
Biochemistry Article
dx.doi.org/10.1021/bi5003162 | Biochemistry 2014, 53, 3199−32173217
239
Dynamics of an Active-Site Flap Contributes to Catalysis in a JAMM
Family Metallo Deubiquitinase
Amy N. Bueno,†,# Rashmi K. Shrestha,†,# Judith A. Ronau,†,‡ Aditya Babar,† Michael J. Sheedlo,†
Julian E. Fuchs,§,∥ Lake N. Paul,⊥ and Chittaranjan Das*,†
†Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States
§Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom
⊥Bindley Biosciences Center, Purdue University, West Lafayette, Indiana 47907, United States
*S Supporting Information
ABSTRACT: The endosome-associated deubiquitinase (DUB) AMSH is a member of the JAMM family of zinc-dependent
metallo isopeptidases with high selectivity for Lys63-linked polyubiquitin chains, which play a key role in endosomal−lysosomal
sorting of activated cell surface receptors. The catalytic domain of the enzyme features a flexible flap near the active site that
opens and closes during its catalytic cycle. Structural analysis of its homologues, AMSH-LP (AMSH-like protein) and the fission
yeast counterpart, Sst2, suggests that a conserved Phe residue in the flap may be critical for substrate binding and/or catalysis. To
gain insight into the contribution of this flap in substrate recognition and catalysis, we generated mutants of Sst2 and
characterized them using a combination of enzyme kinetics, X-ray crystallography, molecular dynamics simulations, and
isothermal titration calorimetry (ITC). Our analysis shows that the Phe residue in the flap contributes key interactions during the
rate-limiting step but not to substrate binding, since mutants of Phe403 exhibit a defect only in kcat but not in KM. Moreover, ITC
studies show Phe403 mutants have similar KD for ubiquitin compared to the wild-type enzyme. The X-ray structures of both
Phe403Ala and the Phe403Trp, in both the free and ubiquitin bound form, reveal no appreciable structural change that might
impair substrate or alter product binding. We observed that the side chain of the Trp residue is oriented identically with respect
to the isopeptide moiety of the substrate as the Phe residue in the wild-type enzyme, so the loss of activity seen in this mutant
cannot be explained by the absence of a group with the ability to provide van der Waals interactions that facilitate the hyrdolysis
of the Lys63-linked diubiquitin. Molecular dynamics simulations indicate that the flap in the Trp mutant is quite flexible, allowing
almost free rotation of the indole side chain. Therefore, it is possible that these different dynamic properties of the flap in the Trp
mutant, compared to the wild-type enzyme, manifest as a defect in interactions that facilitate the rate-limiting step. Consistent
with this notion, the Trp mutant was able to cleave Lys48-linked and Lys11-linked diubiquitin better than the wild-type enzyme,
indicating altered mobility and hence reduced selectivity.
Ubiquitination, covalent attachment of the 76-amino-acidprotein ubiquitin to target proteins via formation of an
isopeptide bond between the side chain of the amino group of a
lysine residue of the target and the terminal carboxylate group
(Gly76) of ubiquitin, has emerged as an important form of
protein posttranslational modification that rivals phosphoryla-
tion in scope and complexity.1−5 This protein modification,
catalyzed by the sequential action of three enzymatic systems,
E1 (ubiquitin activating enzyme), E2 (ubiquitin conjugating
enzyme), and E3 (ubiquitin ligase), usually results in the
attachment of polyubiquitin chains to target proteins via
successive addition of subsequent ubiquitin groups in a chain-
like manner, emanating from the first ubiquitin directly
appended to the target.6−9 In the case of homotypic chains,
the linking pattern involves a specific amino group of an
internal ubiquitin, either the ε-amino group of one of
Received: June 9, 2015
Revised: September 13, 2015
Published: September 14, 2015
Article
pubs.acs.org/biochemistry
© 2015 American Chemical Society 6038 DOI: 10.1021/acs.biochem.5b00631
Biochemistry 2015, 54, 6038−6051
240
ubiquitin’s seven Lys residues or its N-terminal amino group
(Met1), linked to the carboxylate group of Gly76 of a
succeeding monomer in a repetitive fashion. The eight distinct
linkage isomers of such homotypic polyubiquitin chains are
characterized by a distinct three-dimensional architecture,
which gives rise to distinct biological outcomes for proteins
that bear these chains.6,7,9,10 For example, polyubiquitin chains
linked via Lys48 of internal ubiquitin groups are used for
signaling protein degradation, whereas Lys63-linked polyubi-
quitin chains, having different architecture, are used for
receptor internalization, DNA repair, and protein−protein
interactions in the nf-κB pathway. Functions of polyubiquitin
chains of other linkage types are beginning to be assigned, some
of which could also play an important role in cell cycle control
(Lys11-linked polyubiquitin chains) and other signaling events,
such as the linear Met1-linked chains in the nf-κB pathway.11,12
Most ubiquitination events are dynamically controlled by the
action of deubiquitinating enzymes or DUBs (deubiquitinases),
which counteract ubiquitination by hydrolytically removing
ubiquitin from protein adducts. Deubiquitination is achieved by
hydrolyzing the isopeptide bond after Gly76 (or the peptide
bond in the case of Met1-linked polyubiquitin chains).13−16
The human genome encodes for nearly 100 DUBS, which are
emerging as key players in a wide array of physiological
processes. Accordingly, deregulation of DUB activity has been
linked to a number of human diseases such as cancer and
neurodegeneration.17−20 DUBs are grouped into five categories
based on the structure of their catalytic domains: ubiquitin
carboxy-terminal hydrolases (UCHs), ubiquitin specific pro-
teases (USPs), Machado Joseph Disease proteases (MJDs),
ovarian tumor proteases (OTUs) and JAB1/MPN/MOV34
proteases (JAMMs).16,21 The first four groups are cysteine
proteases, whereas the JAMM members are zinc metal-
loproteases, containing a catalytic zinc and sharing mechanistic
similarities with the well-known zinc protease thermolysin.21−23
Members of the zinc metalloprotease family include Rpn11
(POH1), a highly conserved proteasome component whose
DUB activity is coupled to protein degradation at the
proteasome, CSN5, the catalytic unit of the CSN deneddylating
complex that regulates ubiquitination through cullin modifica-
tion, AMSH, associated molecule with the SH3 domain of
signal transducing adaptor molecule (STAM) and its yeast
ortholog, Sst2, AMSH-LP (AMSH-like protein) with unknown
function, and BRCC36 of the BRISC DNA repair com-
plex.24−31
AMSH and AMSH-LP are highly selective for Lys63-linked
polyubiquitin chains, the type of chain used in endosomal-
lysosomal sorting of cell-surface receptors.32−34 A key biological
function of AMSH is to regulate degradation of cell-surface
receptors in the lysosomes mediated by the ESCRT machinery,
which comprises four distinct macromolecular complexes,
ESCRT-0, ESCRT-I, ESCRT-II, and ESCRT-III.35−37 The
members of ESCRT machinery work in tandem to capture
polyubiquitinated receptors on endosomes and sequester them
into multivesicular bodies that eventually fuse with lysosomes
where the receptors are degraded.33,37−39 AMSH possesses
binding sites for both the initial ESCRT-0 complex as well as
the terminal ESCRT-III complex and plays an important role in
regulating the ESCRT-mediated sorting process.34,40,41 The
catalytic activity of AMSH is enhanced upon binding to the
STAM component of the ESCRT-0 complex.42−44 The precise
manner in which AMSH controls receptor trafficking through
the ESCRT pathway remains unknown; however, its critical
role in endosomal-lysosomal sorting is underscored by the
recent discovery of a genetic defect known as microcephaly
capillary malformation (MIC-CAP) syndrome, which is caused
by mutations in the gene.45,46
The structural basis for high selectivity toward Lys63-linked
polyubiquitin chains has been provided by the X-ray structural
studies of AMSH-LP bound to Lys63-linked diubiquitin.32
These structural studies, combined with the recent structure
determination of Sst2 with Lys63-linked diubiquitin and
ubiquitin (a part of the product), have revealed structural
features in the active-site that contribute to substrate
recognition and catalysis.47 One such structural feature is a
loop segment adjacent to the active-site cleft, referred to here as
the active-site flap, that seems to open and close during catalytic
steps of the enzyme (Figure 1a,b). The flap under consideration
is part of a loop segment located in a structural element called
insertion 2, a characteristic feature shared by AMSH and closely
related enzymes, such as AMSH-LP and Sst2.31 The flap in Sst2
is defined to encompass the tripeptide segment Gly401-
Leu402-Phe403. The corresponding residues, Gly406-Phe407
in AMSH-LP and Gly394-Phe395 in AMSH, occur as a
dipeptide segment as opposed to the tripeptide segment in Sst2
(Figure 2a−c). In the structure of the unbound enzyme, the
flap is in a closed state, with a Phe residue in the flap making
contact with residues on the opposite side of the cleft,
Figure 1. Changes in the active-site flap forming a closed cavity or a
narrow tunnel in the cavity indicating the flexibility of the flap. (a), (c),
(e), (g) Surface representations of active-site area of wild-type Sst2
(PDB ID: 4JXE) and its mutants in their free form. Residues that
constitute either side of the flap (Asp315, Thr316, Leu402, and
Phe403) are marked red. (b), (d), (f), (h) Surface representations of
Sst2 (PBD ID: 4K1R) and its mutants bound to ubiquitin comparing
the opening of the flap (red) in all structures. Wild-type Sst2 is shown
in cyan, Sst2F403A in gray, Sst2F403W subunit A in dark blue and
Sst2F403W subunit B in green. The Gly76 carboxylate group of ubiquitin
is shown in sticks.
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particularly with an Asp side chain (Asp 315 in Sst2), both of
which are highly conserved in AMSH (yeast to human) and
also in AMSH-LP. The distance between the aromatic ring and
the carboxylate group is close to 4.0 Å, a feature shared with
AMSH and AMSH-LP (Figure 3c). In the substrate-bound
state, Phe349 and Phe403 interacts with the aliphatic portion of
the side chain of Lys63 of the proximal ubiquitin (in a
diubiquitin motif, the Gly76 carboxylate group of one ubiquitin,
called the distal ubiquitin, is covalently attached to the ε-amino
group of a Lys residue of the other ubiquitin, called the
proximal ubiquitin), whereas Thr347 and Ser352 form
hydrogen bonds with Gln62 and Glu64, neighboring residues
of Lys63, respectively. Indeed, the observation that Phe403
alone makes three van der Waals contacts with the isopeptide
segment of diubiquitin seems to underscore its importance
toward proper alignment of the isopeptide segment for catalysis
(Figure 3a). It also appears that the Phe side chain, through its
interaction with the facing Asp residue across the active-site
cleft, may contribute to the dynamics of the flap, in addition to
contributing key interactions with the Lys63 side group on the
proximal ubiquitin (Figure 3b). To gain insight into the nature
of the contribution of this flap residue to catalysis, we generated
mutants of this conserved side chain by replacing with Ala, and
with a bulkier aromatic side chain of Trp. These mutants were
studied by a combination of X-ray crystallography of both free
and ubiquitin-bound forms, enzyme kinetics, isothermal
titration calorimetry (ITC), and molecular dynamics simu-
lations.
■ MATERIALS AND METHODS
Cloning, Expression, and Purification. The catalytic
domain of Sst2 (residues 245−435) and human ubiquitin (Ub)
were subcloned into a pGEX-6P1 vector as described
previously.47 Phe403Ala, Phe403Trp, Asp315Asn, and Cy-
s397Ala mutations were then introduced individually into the
catalytic domain of Sst2 via site directed mutagenesis and
confirmed with DNA sequencing. The resulting N-terminally
fused glutathione-S-transferase (GST)-tagged recombinant
DNA were expressed in Escherichia coli Rosetta cells and
purified as described earlier47 using standard GST affinity
chromatography followed by size exclusion chromatography on
a Superdex S75 column (GE Lifesciences). All proteins were
concentrated, flash frozen, and stored at −80 °C. Final
concentrations were determined via UV−vis by measuring
absorbance at 280 nm.
In order to avoid issues arising from the cloning artifact in
GST fusion proteins, addition of the pentapeptide sequence
Gly-Pro-Leu-Gly-Ser (GPLGS) to the protein’s N-terminus,
ubiquitin used for ITC was instead prepared from a pRSETA
plasmid as described earlier.47 Lys63-linked diubiquitin was
enzymatically synthesized using Lys63Arg and Asp77 ubiquitin
mutants, following published methods.32 Human E1, two E2s
(Uev1a, and Ubc13), and the two mouse ubiquitin mutants
were purified separately, then mixed in a reaction buffer
containing 80 mM Tris-HCl, 20 mM ATP, 20 mM MgCl2, 1
mM DTT. The reaction mixture was then incubated overnight
at 37 °C, and quenched at room temperature with 10-fold
excess Buffer A (50 mM sodium acetate pH 4.5). The
quenched reaction mixture was loaded onto a MonoS cation
exchange column (GE Healthcare) to separate synthesized
diubiquitin from unreacted ubiquitin. Diubiquitin was eluted
using a linear gradient with Buffer B (50 mM sodium acetate
pH 4.5, 1 M NaCl).
Crystallization and Data Collection. Purified Sst2
Phe403Ala, Phe403Trp and ubiquitin were concentrated to
37, 6.7, and 40 mg/mL respectively. All crystallization was
performed at room temperature by sitting drop vapor diffusion.
Crystals of Sst2 Phe403Ala, referred to here as Sst2F403A, were
Figure 2. Structures of Sst2, AMSH, and AMSH-LP. (a) Superposition
of the catalytic domain of Sst2 (PBD ID: 4JXE), AMSH (PDB ID:
3RZU), and AMSH-LP (PDB ID: 2ZNR). Sst2, AMSH, and AMSH-
LP are shown in cyan, pink, and gray, respectively. (b) Stick
representation of flap segment in Sst2, AMSH, and AMSH-LP. Sst2
consists of tripeptide segment in the flap, whereas AMSH and AMSH-
LP consists of dipeptide segment. Sst2, AMSH, and AMSH-LP are
shown in cyan, pink, and gray respectively (c) Sequence alignment of
flap residues in Sst2, AMSH, and AMSH-LP. The inset represents the
flap segment. (d−f) Conformational dynamics of the active site flap in
Sst2, AMSH, and AMSH-LP: 20 equal-spaced snapshots were
extracted from the molecular dynamics simulation and loop ensembles
were superposed with their respective starting structures. The native
protein conformation for Sst2, AMSH, and AMSH-LP are shown in
orange, blue, and green cartoon representation respectively, with Zn2+
ions as gray spheres. All three enzymes Sst2 (d), AMSH (e), and
AMSH-LP (f) are highly flexible in the flap region and sample
conformations resembling open and closed states.
Figure 3. Phe403 forms interactions with the isopeptide linkage of the
diubiquitin substrate and residues across the active-site cleft. (a) The
scissile isopeptide is stabilized by several contacts with the aromatic
group of Phe403 through interactions with both Lys63 of the proximal
ubiquitin (forest green) and Gly76 of the distal ubiquitin (orange). (b)
Upon binding of Lys63-linked diubiquitin (PDB entry 4NQL),
Phe403 is stabilized by a 3.9 Å van der Waals contact between Phe403
and Thr316 and forms a 4.1 Å anion-π interaction between the ring of
Phe403 and the carboxylate of Asp315. (c) Phe403 in its free form lost
contact with Thr316 (6 Å shown in magenta) but forms 3.9 Å anion-π
interaction between Cζ of F403 and the carboxylate of Asp315.
Hydrophobic interactions are shown in blue dashes.
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crystallized in 0.8:1 ratio with the mother liquor containing 0.2
M sodium citrate tribasic dihydrate, 20% (w/v) polyethylene
glycol (PEG) 3350 (pH 8.3) and were grown in 3−5 days.
Crystals of Phe403Trp, referred to here as Sst2F403W, were
crystallized in 1:1 ratio with the mother liquor containing 0.2 M
ammonium tartrate dibasic (pH 7.0) and 20% (w/v) PEG 3350
which attained maximum size in 5−7 days.
Noncovalent complexes of each Sst2 mutant and ubiquitin
were prepared by mixing each mutant with ubiquitin
(containing a N-terminal cloning artifact GPLGS, as a remnant
of GST-affinity purification) at a ratio of 1.5:1. Crystals of the
complex formed between Sst2F403A and Ub grew in a week from
the mother liquor containing 0.2 M sodium citrate tribasic
dihydrate, 0.1 M HEPES sodium pH 7.5, 20% v/v 2-propanol.
Crystals of the complex of Sst2F403W and Ub were grown in 2−
5 days in 0.04 M citric acid, 0.06 M Bis-TRIS propane pH 6.4,
20% w/v PEG 3350. Complex formation of both constructs was
verified by silver staining of an SDS-PAGE gel run with
dissolved crystals.
Crystals were soaked briefly in a cryoprotectant solution of
25% (v/v) ethylene glycol in the mother liquor and flash frozen
with liquid nitrogen. X-ray diffraction data for all described
mutants and protein complexes were collected at 100 K using a
Mar300 CCD detector at beamline 23 ID-B of the Advanced
Photon Source at Argonne National Laboratory in Argonne, IL
and processed with HKL2000 program.48
Structure Determination and Refinement of Sst2F403A
and Sst2F403W in Its Free Form. The structures of Sst2F403A
and Sst2F403W mutants, which crystallized in the P21 space
group and diffracted to 2.1 and 1.6 Å, respectively, were solved
by molecular replacement with MolRep49 of the ccp4 suite50
using the previously solved structure of the catalytic domain of
Sst2 (PDB entry 4JXE) as the search model.47 Initial
refinements for each structure were carried out in Refmac5
using rigid body refinement followed by restrained refinement.
The model for Sst2F403A was built using Coot51 and refined
using the program Refmac552 yielding Rcrys and Rfree values of
20.04% and 24.18% respectively. The model for Sst2F403W was
built in Coot and rounds of refinement of refinement were
done in PHENIX,53 ultimately yielding a Rcrys of 17.0% and Rfree
of 19.9%.
Structure Determination and Refinement of Sst2F403A-
Ub and Sst2F403W-Ub structures. Crystals of Sst2F403A bound
to ubiquitin, referred to here as Sst2F403A-Ub, crystallized in the
P21 space group and diffracted to 1.7 Å, while the crystal
structure obtained for Sst2F403W bound to ubiquitin, referred to
here as Sst2F403W-Ub, belonged to the P212121 space group and
diffracted to 2.3 Å. Both structures were solved by molecular
replacement using MolRep49 using the previously solved
structure of the catalytic domain of Sst2 bound to ubiquitin
(PDB entry 4K1R) as the search model. Initial refinements
were carried out in Refmac552 using rigid body refinement
followed by restrained refinement. The model for Sst2F403A-Ub
was built using Coot51 and refined using Refmac552 yielding
Rcrys and Rfree values of 20.07% and 23.81%, respectively.
During refinement, TLS treatment of atomic displacement
parameters was also performed, taking chain A of the
asymmetric unit as one group.54 Likewise, a model for
Sst2F403W-Ub was built using Coot, and rounds of refinement
of refinement were done in PHENIX,53 ultimately yielding a
Rcrys of 19.2% and Rfree of 23.5%. All figures for the structures
described were rendered with PYMOL (version 1.7.0.0).55
Determination of Kinetic Parameters. Kinetic parame-
ters of diubiquitin cleavage by Sst2F403A and Sst2F403W mutants
were determined by incubating 100 nM of the enzyme with
varying concentrations of Lys63-linked diubiquitin, ranging
from 20 to 100 μM in a reaction mixture consisting of 50 mM
Tris-HCl (pH 7.0), 20 mM KCl, 5 mM MgCl2, and 1 mM
DTT. For Sst2C397A, 2 μM of the enzyme was used for
diubiquitin cleavge. Reactions proceeded at room temperature
for 15 min before quenching with 5× SDS-PAGE sample
buffer. Samples were loaded and run on an SDS-PAGE gel
along with 6, 20, and 40 μM ubiquitin standards. Ubiquitin
bands were quantified and integrated using ImageJ56 and
plotted with a calibration plot of the previously mentioned
standards in order to determine the amount of ubiquitin
produced through the cleavage of diubiquitin. All data was
analyzed with Kaleidagraph and fit to the Michaelis−Menten
equation of Vi = (Vmax[S])/(KM + [S]) to determine kcat and
KM for each mutant.
Circular Dichroism. The secondary structure of wild-type
Sst2, the active-site flap mutants Sst2F403A and Sst2F403W and the
Sst2C397A mutant was determined in solution using circular
dichroism (CD). Protein samples were diluted in 100 mM
phosphate buffer (pH 7.4) to make a final concentration of 0.2
mg/mL. Native CD spectra were recorded in a Jasco J-1500
spectrophotometer in the far-UV region (200−260 nm) in a
cuvette with a path length of 0.1 cm. To test the stability of the
mutants in solution, we also monitored changes in ellipticity at
222 nm via thermal melt by heating the protein from 20 to 86
°C with a temperature gradient of 0.5 °C. Data were recorded
after every increase of 2 °C. Each spectrum was composed of an
average of four scans (speed scan of 100 nm/min) and
corrected with a subtraction of a spectrum of the phosphate
buffer alone. Mean residue molar ellipticity was calculated
according to the following equation:
θ θ= × M Cln[ ] ( 100 )/( )
where θ is the ellipticity in degrees, l is the path length in
centimeters, C is the concentration is mg/mL, M is molecular
mass, and n is the total number of residues in the protein.
Calculated mean residue molar ellipticity is given in deg cm2
dmol−1. The protein secondary structures from CD spectra
were estimated using two different analysis tools: K2D257 and
K2D3.58
ITC. ITC experiments were carried out at 25 °C in order to
quantify the binding affinity of the Sst2 mutants with ubiquitin
using a GE/MicroCal ITC200 calorimeter. The proteins were
dialyzed overnight in a buffer of 50 mM Tris-HCl (pH 7.6) and
50 mM NaCl that was exchanged four times. 500 μM ubiquitin
was titrated into a 50 μM solution of protein. Twenty-two
injections with 1.4 μL of ubiquitin per injection were done for
the experiment. 180 s was allowed between each injection to
ensure that baseline was reached prior to the next injection.
Baseline correction was performed by NITPIC59 and analyzed
using a one-site model from SEDPHAT.60
Diubiquitin Cleavage Assay. A diubiquitin cleavage assay
was performed in order to deduce whether the mutants were
able to cleave Lys11-linked and Lys48-linked diubiquitin chains
in addition to Lys63-linked diubiquitin. 250 nM of wild-type
and mutant enzymes were incubated in a reaction of 50 mM
Tris-HCl (pH 7.0), 20 mM KCl, 5 mM MgCl2, and 1 mM
DTT in the presence of 20 μM of each variant of diubiquitin.
Reactions were allowed to occur at room temperature for 5 h
before being quenched with 5× SDS-PAGE sample buffer.
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Samples were loaded and run on an SDS-PAGE gel and
ubiquitin bands were quantified and integrated using ImageJ.56
Ratios of monoubiquitin:diubiquitin were determined for each
sample after the reactions.
Molecular Dynamics Simulations. We performed mo-
lecular dynamics simulations within the Amber14 package61 to
investigate molecular motions in three apo Sst2 systems: native
enzyme, Sst2F403A, and Sst2F403W mutants. Therefore, we used
the previously reported crystal structure of the native enzyme
(PDB: 4JXE)47 as well as the newly reported structures of the
Sst2F403A and Sst2F403W mutants as starting configurations.
Additionally, we investigated the homologous enzymes AMSH
and AMSH-LP using starting coordinates from published
crystal structures (PDB: 3RZU40 and PDB: 2ZNR).32 We
discarded ethylene glycol and other cocrystallized small
molecules and prepared all proteins using MOE’s protonate3D
function for simulations.62 The five systems were parametrized
using the Amber force field 99SB-ILDN63 and soaked in an
explicit box with TIP3P water molecules64 with a minimum
wall distance of 10 Å. Two Zn2+ ions were included per system
using nonbonded parameters suggested by the R.E.D. server65
(r = 1.95 Å, e = 0.25 kcal/(mol·cm)) and were held in place
over simulation time by applying flat bottom harmonic
restraints to the coordinating amino acids.
After a careful equilibration66 we sampled conformational
space over 1 μs and saved 50 000 snapshots per system for later
analysis. Simulation analysis was performed using cpptraj from
Ambertools67 as well as in-house scripts. We quantified global
dynamics of the Cα of the conserved Phe residue (F403 in Sst2,
F395 in AMSH, and F407 in AMSH-LP) as B-factor after
performing a global alignment to all Cα atoms in the enzymes.
Furthermore, we characterized local dynamics of the backbone
atoms of this residue by following a local alignment strategy.68
Additionally, we estimated dihedral entropies for all backbone
torsions involving the conserved residue.69 Hydrogen bonds
were extracted using cpptraj’s default criteria.
■ RESULTS
Design of the Mutants. The crystal structure of the
catalytic domain of AMSH-LP bound to its substrate Lys63-
linked diubiquitin (PBD ID: 2ZNV) reveals the flap adopting a
closed position over the active site.32 Specifically, the flap
appears to have collapsed around the isopeptide bond,
particularly onto the aliphatic portion of the side chain of
Lys63 from the proximal ubiquitin, bringing Phe407 (Phe403
in Sst2) into close van der Waals contact with the side chain
atoms of the Lys residue. The recently determined crystal
structure of the catalytic domain of the yeast AMSH ortholog,
Sst2, bound to Lys63-linked diubiquitin reiterates this
observation (Figure 3a).47 The proximity of the aromatic side
group of the Phe residue to the Lys63 side chain moiety of the
scissile isopeptide bond is indicative of a role in substrate
recognition and/or catalysis. In addition to the scissile
isopeptide bond, Phe403 is stabilized by a 3.9 Å van der
Waals contact between Cζ of Phe403 and Cγ of Thr316 and a
close contact (4.1 Å) between Cδ1 of the Phe403 ring and Oδ
of the carboxylate of Asp315 (Figure 3b). Interestingly, a recent
analysis of such distance pairs in the Protein Data Bank has
revealed some evidence of an anion-π interaction, a stabilizing
interaction between the partially electropositive edge of the
aromatic ring with the negatively charged Asp (or Glu) residue
that is proposed to contribute toward protein stabilization and
protein−protein interactions.70 The active-site flap also
assumes a slightly different closed conformation in structures
of the substrate-free form of the enzyme (AMSH, AMSH-LP,
and Sst2). In Sst2, the van der Waals contact with Thr316 has
been lost due to repositioning of the aromatic group from
Phe403 such that the Cζ of Phe403 now forms a 3.9 Å anion-π
interaction with Oδ of the carboxylate of Asp315 (Figure 3c).
Although the flaps form a narrow tunnel near the active site
cavity in the enzyme’s closed state, as seen in structures of both
the free and substrate-bound forms of Sst2, PBD ID: 4JXE and
4NQL, respectively, the flaps must open for the substrate to
bind in a proper orientation so that the C-terminal tail of the
distal ubiquitin, particularly the scissile isopeptide bond, is
adjacent to the catalytic center. Thus, the flap must be
intrinsically dynamic, oscillating between an open and closed
form so that the enzyme can bind its substrate in the open form
and interact with the Lys63 side chain of the proximal ubiquitin
in the closed from. The crystallographic B-factors of residues in
the flap are consistent with the dynamic nature of the flap
(Supplemental Table 1). To explore this further, microsecond
molecular dynamics simulations of Sst2, AMSH, and AMSH-LP
were carried out, which confirmed that the active-site flap is
indeed quite mobile in all these proteins (Figure 2d−f). During
the time scale of the simulation, the conserved Phe residue
explored both multiple side chain conformations and increased
mobility of the backbone atoms (this is discussed further
below). On the basis of the results from the MD simulation,
along with the crystallographic observations of substrate-bound
and free enzymes (AMSH-LP and Sst2), we decided to focus
on the conserved Phe residue to probe the possible role of the
dynamics of the flap in catalysis. In the closed, substrate-bound
form, the van der Waals interactions between the aromatic ring
of Phe403 and the Lys63 side chain of the proximal ubiquitin
appear to be important for the rate-limiting step rather than
ground-state substrate binding, based on the following
observations. First, mutation of this residue to Ala in both
AMSH-LP and AMSH causes a significant loss only in kcat with
relatively minor change in KM.
32,44 Second, ITC data show that
the affinity for diubiquitin is similar to that for ubiquitin alone
(bound in the distal site), implying that interactions with the
entire proximal ubiquitin portion of the substrate contributes
little to ground-state substrate affinity.44,47
It is possible that mutation of the Phe residue to Ala might
have caused a change in dynamic properties of the flap
accounting for the loss of activity, at least to some degree. In
other words, the conserved Phe side chain may have a role in
modulating the dynamics of the flap to be in tune with the
catalytic steps of the hydrolysis reaction. To gain insight into
the nature of the catalytic contribution of Phe403 in
polyubiquitin processing, and hence the role played by the
active-site flap, we mutated Phe403 in Sst2 to Trp and Ala. We
expected that the presence of a bulkier aromatic side chain in
the Trp mutant may alter the dynamic properties of the flap by
providing a larger surface area for contact with the residues
opposite the active-site cleft (such as the γ-CH3 group of
Thr316, Figure 3) while still maintaining the contacts necessary
for accurate positioning of the isopeptide segment of Lys63-
linked polyubiquitin chains. Although the mutation of the
corresponding Phe to Ala residue was recently studied in both
AMSH-LP and AMSH for its role in catalysis,32,44 these
previous studies lacked structural and binding characterization
of the Ala mutant, so one could not rule out other factors such
as change in ubiquitin binding affinity (product release) or
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structural changes arising from the mutation accounting for the
loss of activity in the mutant.
Kinetic Characterization of the Flap Mutants. Mutation
of Phe403 to Ala leads to a substantial loss of catalytic activity,
with a major effect on kcat while KM remains relatively
unchanged compared to the wild-type enzyme (Table 1, Figure
4, and Supplemental Figure 2), consistent with observations
from the same mutant in AMSH-LP and AMSH.32,44 This
suggests that the role of the aromatic side chain is conserved
from the yeast enzyme to human counterparts. Like the Ala
mutant, the Phe403Trp mutant exhibits a significant defect in
catalyzing the deubiquitination reaction, with a reduction
mainly in kcat and a minimal effect on KM (Table 1, Figure 4,
and Supplemental Figure 2). Taken together, these kinetic
results implicate a role for Phe403 mainly in the rate-limiting
step, since both of these mutations led to a loss in kcat and not
in ground state substrate binding indicated by a relatively minor
change in KM.
As mentioned before, the flap constitutes the tip of a
structural element in AMSH-like enzymes known as insertion 2
(Supplemental Figure 1). The insertion 2 region is stabilized by
the presence of a structural zinc atom, coordinated by a three
histidine, 1 cysteine motif that provides rigidity to the overall
structure. Since the tip of the flap is arranged distally from the
zinc-coordination site, it is flexible enough to allow for
oscillation between open and closed conformations during
key catalytic steps of the enzyme. The absence of the structural
zinc would render insertion 2 highly disordered. Accordingly,
mutation of a zinc-coordinating residue, Cys397, to Ala leads to
a substantial loss of activity, once again with a reduction only in
kcat (Table 1, Figure 4, and Supplemental Figure 2). This is
consistent with the results obtained with a similar mutant in
AMSH-LP (Cys402 to Ser).32 It is possible that the insertion,
having lost its native structure due to impaired binding of the
structural zinc atom, might have adopted a non-native fold
keeping the flap away from the active-site cleft, which would
make the Phe residue less accessible for binding to the
isopeptide moiety of the substrate during catalysis. Alter-
natively, the extreme conformational flexibility may mean a
higher entropic penalty in organizing the flap into a productive
orientation during the rate-determining step of the hydrolysis
reaction.
Structural Properties of the Flap Mutants. We
wondered whether mutation of Phe403 to Ala or Trp reduced
the enzyme’s catalytic efficiency by imposing either global
changes to the protein’s overall structure or by imparting
structural changes in the local environment of the active site
flap that manifest as either altered dynamics or impaired ability
to recognize and bind the substrate. To address the effect of
each mutation, we crystallized both the Sst2F403A and the
Sst2F403W mutants in their apo and ubiquitin-bound forms.
Diffraction data collection and refinement statistics are
summarized in Table 2. The structures were solved by
molecular replacement using the previously solved wild-type
structure of Sst2 (PDB ID: 4JXE) as the search model for both
apo structures and the previously solved structure of Sst2
bound to ubiquitin (PDB ID: 4K1R) as the search model for
both ubiquitin-bound mutant structures. Crystals of Sst2F403A
(apo) and Sst2F403A-Ub diffracted to 2.1 and 1.7 Å, respectively,
while Sst2F403W (apo) and Sst2F403W-Ub diffracted to 1.6 and
2.3 Å, respectively. The free R factors after refinement for all
structures were within 2.5−4.3% of crystallographic R factors.
The structure of the Sst2F403A mutant in its free form shows
that, as in the wild-type enzyme, the flap assumes a closed form.
A minor difference is that a narrow tunnel has formed in the
cavity due to the absence of the aromatic side chain, which can
no longer form the anion-π interaction with Asp315 from the
adjacent loop (Figure 1c). Ubiquitin binding to Sst2F403A leads
to formation of a wider cavity with a more open conformation,
instead of a narrow tunnel observed in the wild-type, Sst2-Ub
structure (Figure 1d). Despite the more open conformation of
the Sst2F403A mutant, the C-terminal tail of ubiquitin maintains
the same orientation observed in the ubiquitin-bound structure
of wild-type Sst2. The Ala residue appears to be somewhat
more disordered as judged from the weak electron density
enveloping the side chain as compared to internal residues that
are defined by stronger electron density covering the side chain,
consistent with an increased flexibility of the flap in the mutant
(Supplemental Figure 3c,d and Supplemental Table 1).
However, the structures of both the free and ubiquitin-bound
forms indicate that the mutation to Ala does not have any
serious effect on either the overall structure or the active-site
area of the enzyme. Moreover, circular dichroism (CD)
spectroscopy indicated no major perturbation in secondary
structure for either Sst2F403A or Sst2F403W in solution (Figure 5a,
Supplemental Table 2). Deconvolution of the CD spectra of
mutants produced similar α-helical and β-sheet content as in
the wild-type protein (Supplemental Table 2). Thermal melting
performed using CD also revealed nearly identical melting
temperatures for the Sst2F403A mutant and the wild-type
enzyme, indicating the overall stability of the enzyme is
unaffected by mutation of Phe403 to Ala (Figure 5b, Table 3).
Interestingly, reduced affinity for the structural zinc metal, and
thus increased disorder of the insertion 2 segment, led to a
drastic reduction in melting temperature for the Sst2C397A
mutant (Figure 5 and Table 3).
Table 1. Steady-State Kinetic Parameters of Sst2 and Its
Substrate, Lysine 63-Linked Diubiquitin
sample KM (μM) kcat (s
−1) kcat/KM × 10
−3 (μM−1 s−1)
Sst2 18.8 ± 8.4 1.5 ± 0.2 79.8
Sst2F403A 33.6 ± 8.3 0.082 ± 0.007 2.4
Sst2F403W 44.1 ± 8.2 0.085 ± 0.007 1.9
Sst2C397A 32.8 ± 4.6 0.004 ± 0.0002 0.1
Sst2D315N 33.7 ± 11.8 0.26 ± 0.032 7.7
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Table 2. Crystallographic Refinement Statistics for Catalytic Domain of Sst2
Sst2 F403A Sst2 F403A-Ub Sst2 F403W Sst2 F403W-Ub
Data collection
space group P21 P21 P21 P212121
cell dimensions
a, b, c (Å) 57.7, 74.9, 64.6 42.1, 58.2, 56.4 58.6, 73.7, 64.6 56.8, 89.4, 117.8
α, β, γ (deg) 90.0, 112.9, 90.0 90.0, 109.3, 90.0 90.0, 113.2, 90.0 90.0, 90.0, 90.0
wavelength (Å) 1.033 1.033 1.033 1.033
resolution (Å) 50.0−2.1 (2.14−2.10) 50.0−1.7 (1.75−1.72) 50.0−1.6 (1.66−1.63) 50.0−2.3 (2.34−2.30)
Rmerge
b (%) 10.5 (73.3) 4.7 (56.1) 9.5 (56.2) 13.1 (84.8)
I/σI 11.6 (2.0) 23.6 (2.3) 18.1 (2.5) 18.7 (2.3)
completeness (%) 99.9 (99.9) 99.9 (99.9) 97.3 (96.2) 100.0 (100.0)
redundancy 3.8 (3.8) 3.8 (3.6) 3.9 (7.7) 14.6 (13.8)
Refinement
resolution (Å) 2.1 1.7 1.6 2.3
no. unique reflections 28834 26060 60880 25792
Rwork
c/Rfree
d 20.0/24.2 20.1/23.7 17.0/19.9 19.2/23.5
no. atoms
protein 2926 2027 2946 4059
ion 4 2 4 4
water 93 43 151 79
r.m.s. deviations
bond lengths (Å) 0.018 0.018 0.007 0.015
bond angles (Å) 1.935 1.896 1.111 1.728
Ramachandran Plot
preferred (%) 97.1 96.46 98.3 95.9
allowed (%) 2.9 3.2 1.7 3.7
disallowed (%) 0.0 0.39 0 0.39
average B-factors (Å2)
Sst2 32.5 18.9 24.4 42.8
ubiquitin 39.9 47.1
ion 28.0 34.2 20.0 40.8
water 31.0 38.0 30.0 41.1
ligand 42.6 33.4 43.5 51.6
aValues in parentheses are for the highest resolution shell. bRmerge = ∑|Ihkl − Ihkl(j)|/∑Ihkl, where Ihkl(j) is the observed intensity and Ihkl is the final
average intensity. cRcrys = ∑||Fobs| − |Fcalc||/∑|Fobs|. dRfree = ∑||Fobs| − |Fcalc||/∑|Fobs|, where Rfree and Rcrys are calculated using a randomly selected
test set of 5% of the data and all reflections excluding the 5% test data, respectively.
Figure 5. Circular dichroism (CD) spectroscopy of Sst2 and its mutants. (a) Native CD spectra of catalytic domain of Sst2, Sst2F403A, and Sst2F403W
show that the secondary structure of the enzyme is mostly unperturbed in solution as a result of either mutation. (b) Thermal melting curves indicate
nearly identical melting temperatures of the F403 mutants with wild-type Sst2, suggesting that the stability of the enzyme in its folded state is
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Figure 6 shows key areas near the active-site cleft in the
mutant as compared to those in the wild-type enzyme. There is
little difference between the structures in the environment
around the active-site metal. The Sst2F403A structure also
explains why the KM of the mutant is similar to that of the wild-
type enzyme; the contacts with the distal ubiquitin are
maintained nearly identically with respect to the wild-type
enzyme (Figure 7). To probe if these interactions are indeed
maintained in solution, we performed isothermal titration
calorimetry (ITC) studies to extract the binding affinity of the
mutant for ubiquitin (Table 4, Figure 8a), which yields KD
values somewhat similar to that obtained with wild-type
enzyme. Together, with the aforementioned results, our
structural analysis provides strong support in favor of the
assertion that the loss in activity of the Ala mutant is neither
due to any gross structural change near active-site cleft induced
by the mutation nor due to changes in substrate binding (KM is
not affected significantly). Furthermore, it seems unlikely that
product release would be affected due to the mutation since the
KD for ubiquitin is comparable for the Ala mutant relative to the
wild-type enzyme. For the Trp mutant, the KD for ubiquitin
binding is nearly 3 times lower than that of the wild-type
enzyme which may indicate some level of interference in
product release caused by the mutation; however, this cannot
be a major factor behind the loss of activity in the mutant
compared to the wild-type enzyme as the mutant is impaired
nearly 30 fold in kcat, whereas the change in product affinity is
only by a factor of ∼3.
The Trp mutant in both its free form and ubiquitin-bound
form crystallizes with two subunits in the asymmetric unit. Both
subunits in the free and ubiquitin-bound forms can be
superimposed with each other with Cα root-mean-square
deviations (RMSDs) of 0.198 and 0.304 Å, respectively,
indicating structural conservation between the two subunits.
Interestingly, both the subunits show a slight change around the
flap region. Subunit A of the free form reveals a closed form of
the flap with a completely occluded cavity resembling that of
wild-type Sst2, whereas subunit B shows that the flap is also in a
closed form, but has a narrow tunnel in the cavity (Figure 1e,g).
The ubiquitin-bound structure reveals that in subunits A and B,
the active site flap forms a narrow channel around the C-
terminal tail of ubiquitin (or what would be the distal ubiquitin
moiety in diubiquitin), which would be used to enable binding
of the isopeptide linkage of diubiquitin. Strikingly, the size of
the tunnel in subunit B appears to be wider than subunit A
(Figure 1f,h). These subtle changes indicate that the dynamics
of the flap in the Trp mutant are consistent with the lack of
strong electron density enveloping the side chain of Trp,
especially in subunit B of both the free form and the ubiquitin-
bound form as shown in (Supplemental Figure 3b and Figure
9b). There is also a difference in the crystallographic contacts of
the two subunits in both the free form and in the ubiquitin-
bound form. In the free form, the Trp side chain of subunit A
appears to be interacting with Thr345 of subunit B from its
symmetry mates, whereas the Trp side chain of subunit B does
not appear to form any interactions (Supplemental Figure 4a).
Table 3. Stability Parameters Deduced from CD Data





Figure 6. Structural comparison of Sst2 and its mutants. (a)
Superposition of catalytic domain of Sst2 (cyan), Sst2F403A (gray),
and Sst2F403W (green) indicate no gross conformational changes to
Sst2 as a result of either mutation. (b) Superposition of Sst2 (cyan),
Sst2F403A (gray), and Sst2F403W (green) highlighting the residues of
active-site along with the residues of the active-site cleft. Active-site
residues are colored in yellow. Active-site zinc is shown in gray
whereas the zinc stabilizing insertion 2 is shown in black.
Figure 7. Ubiquitin binding in Sst2 mutants. (a) Surface
representation of the catalytic domain of Sst2 mutant Sst2F403A
(gray) bound to ubiquitin (orange). Residues of the flap region are
highlighted in red. (b) Surface representation of the catalytic domain
of mutant Sst2F403W (green) bound to ubiquitin (orange) highlighting
the residues (red) in the flap region. (c) Superposition of the
structures of Sst2 (cyan), Sst2F403A (gray), and Sst2F403W (green)
showing residues involved in distal ubiquitin recognition. Hydrogen
bonds are shown in black dashes. Ubiquitin residues are shown in
orange.
Table 4. Thermodynamic Parameters Deduced from ITC
Data





Sst2 Ub 10.2 ± 0.6 11.9 ± 0.4 62.9
Sst2F403A Ub 6.2 ± 0.5 12.1 ± 0.4 64.3
Sst2F403W Ub 3.6 ± 0.3 12.8 ± 0.4 67.9
AMSH-LP Ub 17.3 ± 4.3 1.95 ± 0.4 28.3
AMSH-LPC402S Ub 12.4 ± 3.2 8.5 ± 2.0 51.0
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Likewise, in the ubiquitin-bound form, the Trp side chain of
subunit A appears to be held in place in the crystals by an
additional interaction with the Lys48 side chain of the other
ubiquitin-bound complex of the asymmetric unit (Supplemen-
tal Figure 4b). It is possible that the structural difference at the
Trp residue between the two subunits may be a result of these
crystallographic contacts. However, overall inspection of the
structures reveals no appreciable change in the enzyme that
could result from the mutation. Ubiquitin is bound in an
identical fashion as in the wild-type enzyme and the Ala mutant
(Figure 7).
Thermal melting using CD spectroscopy revealed a
comparable melting temperature with respect to both the
wild-type enzyme and the Ala mutant (Table 3 and Figure 5).
Moreover, ITC studies also reveal similar affinity for ubiquitin
and thermodynamic parameters to the wild-type enzyme
(Table 4, Figure 8b). Collectively, our structural studies
indicate that the loss of activity observed with the Trp mutant
is not due to any gross structural changes from the mutation
that may impair substrate and product binding.
Increased Dynamics of the Phe403Trp Active Site
Flap. We expected that, unlike the Ala mutant, stabilizing
interactions with the substrate (Lys63 side chain of the
isopeptide link) in the Trp mutant would be maintained as in
the wild-type enzyme. Using the crystal structure of the
Sst2F403W bound to ubiquitin and the structure of Sst2 bound to
diubiquitin (PDB ID: 4NQL), we generated a structural model
of the mutant bound to Lys63-linked diubiquitin to gain insight
into interactions with the substrate. The model shows that the
side group of Trp is not in any steric conflict with any part of
the proximal ubiquitin (consistent with the KM of the mutant
not changing appreciably compared to the wild-type enzyme).
Remarkably, the side chain of Trp403 in the mutant overlaps
nicely onto the side chain of Phe in the wild-type enzyme,
indicating that the isopeptide interaction would be maintained
during key catalytic steps of the hydrolysis reaction (Figure 9
shows a superposition of the mutant onto the crystal structure
Figure 8. Determination of thermodynamic parameters for Sst2 mutants: (a) Isothermal titration calorimetry (ITC) thermogram for binding of
ubiquitin to the catalytic domain of Sst2F403A revealing a KD of 6.2 ± 0.5 μM. (b) ITC thermogram of binding of ubiquitin to the catalytic domain of
Sst2F403W revealing a KD of 3.6 ± 0.3 μM.
Figure 9. A model of Sst2F403W bound to Lys63-linked diubiquitin. (a) Superposition of catalytic domain of Sst2F403W (green) bound to ubiquitin and
the catalytic domain of Sst2 (cyan) bound to Lys63-linked diubiquitin (PDB ID: 4NQL). The proximal ubiquitin and distal ubiquitin is shown in
forest green and orange, respectively. (b) Superposition of Sst2F403W (green) bound to ubiquitin and Sst2 (cyan) bound to Lys63-linked diubiquitin
showing the active-site flap residues. The electron density for Trp403 is rendered from the 2Fo-Fc map contoured at 1σ (corresponding to the X-ray
structure of Sst2F403W bound to ubiquitin) showing weak density enveloping the side chain of Trp403. (c) Hydrophobic interaction of the aromatic
group of Trp403 interacts with Lys63 of the proximal ubiquitin (forest green) and Gly76 of the distal ubiquitin (orange). Hydrophobic interactions
are shown in blue dashes.
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of the wild type Sst2 bound to diubiquitin). Thus, the loss in
activity of the Trp mutant, as reflected by the reduction in kcat,
is not due to a lack of van der Waals interactions that facilitate
catalysis of Lys63-linked diubiquitin.
It is plausible that the loss of activity is due to altered
dynamics of the flexible flap in the Trp mutant although one
expects a similar anion-π interaction with Asp315 involving the
six-membered ring of the Trp side chain. We probed this effect
by performing molecular dynamics simulations of the native
system and the two mutants on the microsecond time scale and
compared flap dynamics to the homologous enzymes AMSH
and AMSH-LP. We analyzed stable simulations of the five
systems with a maximum RMSD lower than 2.5 Å compared to
the respective starting structures. All simulations highlighted
the active site flap as a flexible region (Supplemental Figure 5,
Figure 10a−e), as indicated by the relative mobility of
backbone atoms and side chains of the flap residues. Local
backbone B-factors consistently exceeded 0.3 Å2 for all
simulated systems, dihedral entropies were found larger than
94 J/(mol·K) reflecting the high flexibility of the flap region.
Supplemental Figure 5 shows the overlay of 20 MD frames for
Sst2 with the polypeptide backbone of the region near the
active-site flap shown in gray ribbon. The mutated residue,
Phe403 in Sst2, is highly mobile both on backbone as well as
side chain level (Supplemental Figure 5, and Figure 10b,c). We
observe almost free rotation of both phenylalanine and
tryptophan at this position. Dimensionless relative side chain
flexibilities68 are 0.92 for Phe403, 0.83 for Trp403, and 0.99 for
Ala403, indicating free rotation for the latter residue. The free
rotation is paralleled by a loss of molecular interactions with the
opposing side of the active-site flap. Hydrogen-bonding of the
Trp403 side chain with Asp315, as seen in the static crystal
structure, is observed in less than 1% of the snapshots.
Additionally, we observe some compensation by hydrogen-
bonding between Trp403 and the side chain of Thr316 (3%).
In general, all residues at position 403 sample a broad
conformational space, including open configurations closely
resembling the ubiquitin-bound state. Highest flexibilities are
consistently observed for Trp403 among Sst2 mutants using
three different metrics capturing dynamics on a global and local
scale (Figure 10f−h). The simulated homologous AMSH
systems show similar flexibilities in the flap region using all
three metrics.
To get further insight into the effects of altered dynamics in
Sst2 mutants, we probed Lys48 and Lys11-linked diubiquitin as
alternate substrates for the variants studied here. As noted
earlier, Sst2, like AMSH and AMSH-LP, is highly selective for
Lys63-linked polyubiquitin chains. This selectivity is mainly due
to interactions with the proximal ubiquitin, many of which
manifest only during the rate-limiting step of the reaction. The
flap may contribute to selectivity by virtue of its dynamic
properties. If the flap were too flexible, in the extreme case of
being completely disordered, it may be reflected in the enzyme
losing selectivity. That is, a mutant with a more flexible flap
would be expected to show more activity toward Lys48 and
Lys11-linked diubiquitin substrates than the wild-type enzyme.
On the other hand, a more rigid flap may mean a reduction in
the association rate constant for substrate binding. If the latter
factor was important, one would expect a loss of activity with
substrates regardless of linkage types. We find that the Trp
mutant has higher activity with Lys48- and Lys11-linked
substrates than the wild-type enzyme, consistent with a loss of
selectivity (Figure 11). This observation is in contrast to the
Sst2F403A mutant, which shows a reduced activity with all the
three substrates tested, perhaps due to the essential
contribution of the aromatic ring of the Phe residue to binding
of the Lys side chain of the proximal ubiquitin in all the three
linkage types studied here. These results, in connection with
the molecular dynamics data, indicate that the Trp mutant has a
more dynamic flap than the wild-type structure and hence
reduced selectivity. Although one cannot rule out other factors
behind this reduced selectivity, it seems unlikely that selective
Figure 10. Molecular dynamics of the active site flap in native Sst2, the Phe403Ala and Phe403Trp mutants as well as AMSH and AMSH-LP: (a−e)
Ensembles of 20 conformations extracted over 1 μs simulation time in equal spacing depict the high mobility of the respective side chains. Almost
free rotation is observed for all residues, including the bulky aromatic systems in the native enzyme, the Phe403Trp mutant, AMSH and AMSH-LP.
Phe403, Ala403, Trp403 in Sst2 are shown in green, blue and dark pink respectively, Phe395 in AMSH is shown in light pink and Phe407 in AMSH-
LP is shown in purple. (f) B-factors of the Cα atom of the conserved phenylalanine and mutant residues after a global alignment, thus depicting loop
flexibility. Aromatic residues show highest flexibility in the flap region. (g) An increase of intrinsic flexibility is observed for both mutants when
capturing flexibility via B-factor calculation after a local alignment to the backbone atoms. (h) Dihedral entropies over backbone torsions involving
residue 403 in Sst2 indicate a similar trend as the local backbone B-factors, thus confirming gains in loop flexibility by mutations at this position.
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interactions with the alternative substrates is behind the loss of
selectivity observed with the mutant, given that Lys11- and
Lys48-linked substrates are structurally quite different (Figure
11c). Structural models of the Sst2 and its Ala and Trp mutants
bound to Lys11- and Lys48-linked diubiquitin, generated based
on the cocrystal structure of Sst2 bound to Lys63-linked
diubiquitin, suggest that active-site flap (Phe403) may impede
accurate alignment of these alternative substrates in the active
site (see Supplemental Figure 6 and its caption for a description
of the method used in model building). Therefore, increased
mobility of the flap may result in better accommodation of the
scissile peptide bond of these noncognate substrates in the
active site of Sst2. However, these models have limited utility
since they depict a static snapshot of binding and, more
importantly, do not take into account the flexibility of the
substrates themselves.
■ DISCUSSION
It has been widely appreciated that the active sites of enzymes
bear flexible loop elements that help in catalysis.72−75 In the
absence of a substrate, such active-site loops are generally
disordered, but adopt specific conformations upon substrate
binding, often becoming immobilized by forming specific
contacts with the substrate. The active-site flap in AMSH is
somewhat peculiar in the sense that it oscillates between open
and closed states independent of substrate binding. X-ray
crystal structures of the DUB domains of both AMSH-LP and
Sst2 bound to diubiquitin shows Phe403 collapsed onto the
Lys63 side chain of the proximal ubiquitin; however, the flap
residues appear to retain their mobility even in the presence of
bound substrate or product (indicated by relatively weak
electron density enveloping these residues and higher B-factors
than internal residues). This is consistent with our observation
that mutation of a key conserved residue in the flap (Phe403 in
Sst2) does not affect the KM significantly, implying that the flap
residues contribute little to substrate binding in the ground
state (to formation of the Michaelis complex). This is
particularly clear in the Sst2C397A mutant that is defective for
binding to the structural zinc. Loss of the structural zinc causes
the active-site flap to become substantially more flexible than
the wild-type enzyme, indicated by a significant loss of thermal
stability. Yet the mutant does not affect its substrate binding
significantly (Table 1). A similar mutant in AMSH-LP (Cys402
to Ser), defective only in kcat like the Sst2
C397A mutant, retains
nearly the same level of affinity for the ubiquitin product
compare to the wild-type enzyme (Table 4 and Supplemental
Figure 7), we could not measure KD for ubiquitin for the
Sst2C397A mutant because the mutant could not be isolated in
amounts suitable for ITC experiments). However, the loop is
especially important for the rate-limiting step, since the
Sst2C397A mutant and other mutants studied here are defective
primarily in kcat. Immobilization of the active site loop during
the key catalytic steps of the reaction, so that Phe403 forms a
contact with the Lys63 side chain moiety of the scissile
isopeptide bond, imposes a higher entropic penalty as the loop
becomes increasingly disordered. This is especially reflected in
the significant loss in kcat observed in the Sst2
C397A mutant,
whose active site loop has become quite flexible due to loss of
the structural zinc.
Our results seem to indicate that the flexibility of active-site
flaps is precisely tuned to be in step with catalytic events. It is
possible that, while keeping the catalytic mechanism conserved,
evolution may fine-tune flexibility for selectivity.71 The
flexibility of the flap in Sst2 appears to be controlled by (1)
the structural zinc in the insertion 2 component of AMSH and
AMSH-like enzymes and (2) by an additional interaction of the
flap residue Phe403, which makes a contact with the Asp side
chain across the active-site cleft. This may be why the Phe403
residue and Asp315 are strictly conserved among AMSH-like
JAMM proteases. The contact distance between Phe403 and
Asp315 is approximately 4.0 Å in the crystal structures of
AMSH, AMSH-LP and Sst2, a distance indicative of a
stabilizing interaction termed anion-π interaction.70,76 A recent
analysis of the PDB reveals a widespread presence of such
contacts, indicating a role of anion-π interactions in protein
stability. Perhaps the loss of the anion-π interaction in the
Sst2F403A mutant leading to increased loop flexibility, and thus
an increased entropic penalty, contributes to the loss of activity
observed with the Ala mutant. Mutation of the Asp residue to
Figure 11. Activity assay conducted by monitoring cleavage of
different substrates (Lys63-, Lys48-, and Lys11-linked diubiquitin) by
different DUBS (wild-type Sst2, Sst2F403A, and Sst2F403W mutants). (a)
SDS-PAGE gel comparing the activity of wild-type Sst2 and its
mutants with different substrates. Each reaction mixture contained 250
nM Sst2 catalytic domain or Sst2F403A mutant or Sst2F403W mutant with
20 μM concentrations of Lys63- or Lys48- or Lys11-linked diubiquitin,
and each reaction proceeded for 5 h at 20 °C before quenching with
5× SDS-PAGE sample buffers. (b) Representative plot of mono-
ubiquitin:diubiquitin ratio as a function of different substrates (Lys63-,
Lys48-, and Lys11- linked diubiquitin) and different enzymes (wild-
type Sst2, Sst2F403A and Sst2F403W mutants). Bands corresponding to
monoubiquitin and diubiquitin were integrated using ImageJ. (c)
Different chain morphologies of Lys63-, Lys48-, and Lys11-linked
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Asn indeed results in a defective enzyme, by a nearly 7-fold loss
in activity, primarily due to a reduction in kcat (Table 1). It is
possible that this loss of activity reflects loss of the anion-π
interaction. Loss of this interaction might have the effect of
making the flap more dynamic and is expected to produce an
effect in line with the Trp mutant. However, a closer inspection
of the diubiquitin-bound crystal structure reveals that the Asp
residue is 4 Å from amino-group of Met1 of the proximal
ubiquitin of the diubiquitin substrate, a distance range in which
there maybe appreciable electrostatic attraction between the
carboxylate and the amino group (likely protonated at the
nearly neutral pH of the assay buffer). The loss of activity in the
Asn mutant might also reflect, at least to a degree, a loss of the
columbic attraction.
Contrary to our expectation, it appears that the active-site
flap in the Trp mutant has higher flexibility than the wild-type
enzyme. Since our crystal structure shows the Trp side chain is
identically positioned to interact with the substrate as the
Phe403 residue in the wild-type enzyme, we propose that the
loss of activity in the mutant, due to decreased kcat, is suggestive
of altered dynamics and is supported by our molecular
dynamics data. However, we cannot rule out other factors
contributing to impaired catalysis seen here, such as the precise
orientation of the Trp side chain during the catalytic steps
relative to the Phe side chain in the wild-type enzyme. Some
evidence of this higher flexibility can be seen in B-factors of the
flap in the crystal structure of the mutant. Despite the flap being
somewhat immobilized by the crystallographic contacts
(Supplemental Figure 4), the elevated B-factors of these
residues are indicative of the loop’s mobility in solution
(Supplemental Table 1). Molecular dynamics simulations
clearly indicate that the active-site flap of Sst2 is quite mobile
and samples various conformations on the microsecond time-
scale. The Sst2F403W mutant shows the highest mobility on
three different flexibility metrics, thus underlining a gain in
mobility in this mutant. An additional but indirect evidence of
higher flexibility can be the observation that Lys11- and Lys48-
linked diubiquitin substrates are cleaved more readily by the
mutants than the wild-type enzyme. It is possible that this
reflects enhanced flexibility of the flap, giving rise to a more
open active-site cleft. This more open active-site cleft can better
accommodate alternative diubiquitin substrates, while the wild-
type enzyme is more selective for Lys63 linkage due to a strict
steric requirement imposed by the active-site flap. While not
contributing to substrate binding per se, higher flexibility of the
flap could mean a higher probability that it spends more time
away from the active-site, which could mean the active-site cleft
is somewhat more exposed than when the flap has less
flexibility. This “open” active-site may therefore pose less
stringency on the precise nature of the substrate. That is, the
enzyme with a more flexible flap may be less selective. The
implication of this observation could be that the flap in AMSH-
like enzyme might have evolved to increase selectivity by
discriminating against other types of polyubiquitin chain
substrates due to diminished flexibility.
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